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ABSTRACT 
Objective: To examine dietary quality and weight status among HIV-infected and HIV-
uninfected youth. 
Methods: A cross-sectional dietary intake study was conducted with 264 HIV-infected and 
127 HIV-uninfected youth from the REACH cohort study (67% black/non-Hispanic; 75% 
female). Dietary intake was collected using the Block Food Frequency Questionnaire (98.2). 
The REACH study provided additional clinical, biochemical, and demographic data. 
Logistic and linear regression models were used for the analyses. 
Results: Dietary quality: HIV was associated with a mixed effect on dietary intake; 
however, differences in macro- and micronutrient intakes were noted only among males. 
HIV-infected males had higher energy, fat, saturated fat, and cholesterol intakes than HIV-
uninfected males. Although HIV-infected males had higher intakes of vitamin E, almost 
40% of all participants had vitamin E intakes below the Estimated Average Requirements 
(EAR). A modified USDA's Healthy Eating Index (HEI) was used to look at overall dietary 
quality. The HEI was lower (indicating poor dietary quality) among HIV-infected compared 
to HIV-uninfected participants. Increased television watching was also associated with a 
lower HEI. Being female and having a higher self-perceived health was associated with a 
higher HEI. Obesity: Half of the HIV-infected (50.4%) and HIV-uninfected (54.3%) were 
overweight or obese. Prevalence of obesity decreased once CD4+ T-cells were <500 
cells/µL. HIV did not modulate the effect of factors that increased the risk of obesity 
(female, living independently from parents/family, watching television ~3 hours/d, previous 
dieting, and being from the Northeast or South). 
Summary: These results demonstrate two important areas of health concern among HIV-
infected adolescents. First, the dietary quality is poor, intakes of energy and dietary fat 
components are excessive, and the prevalence of obesity is high. Overweight and obese 
individuals with HIV infection may be at greater risk of developing metabolic abnormalities 
associated with HIV and antiretroviral therapy, such as hyperlipidemia, lipodystrophy, and 
insulin resistance. Second, the high prevalence of inadequacy in vitamin E intake may place 
individuals at increased oxidative stress associated with HIV infection. Nutrition educators 
IX 
should focus on developing individualized behavioral goals emphasizing improved dietary 
quality and physical activity to improve health and quality of life for these adolescents. 
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CHAPTERl. GENERALINTRODUCTION 
Thesis organization 
This thesis contains a general introduction, a review of literature, two manuscripts 
prepared for submission to scientific journals, general conclusions, and appendices. The 
references cited in each chapter are listed at the end of the chapter using numeric citation 
style. References for the appendices are listed within each appendix. The conceptual 
framework and study hypothesis are described at the end of the literature review. 
Introduction 
This thesis focuses on the relationship between dietary intake and two public health 
concerns facing adolescents and young adults in the U.S.: obesity and human 
immunodeficiency virus (HIV) infection. Nutrition plays an integral role in both the 
prevention and treatment of obesity as well as HIV disease progression. Adolescents have 
increased demands for nutrients needed to support growth and development at the same time 
that they experience changes in life-style and eating habits that affect their ability to meet 
their nutritional needs. 
The prevalence of overweight and obesity has increased among adults as well as 
adolescents. Numerous health consequences have been associated with increased weight. 
While the physiological consequences are most often seen among overweight adults, more 
adolescents are developing health consequences including type 2 diabetes and 
hyperlipidemia. Psychosocial issues can have negative consequences on an individual's 
mental health and social adjustment. In addition, overweight adolescents are more likely to 
be overweight as adults. The prevalence of HIV infection has also increased in the past 
decade among adolescents and young adults. Nutrition plays a vital role in slowing the 
progression of HIV infection. Adolescents with HIV infection may be at increased risk 
nutritionally due to the energy and nutrient demands necessary to support growth as well as 
compensate for infection. 
Although significant research has been done in these areas, there is still much yet to 
be discovered. Little is known about the relationship between dietary intake and HIV 
infection among adolescents and young adults. As more is understood about this 
relationship, health-care professionals will be able to better serve this unique population. 
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CHAPTER 2. LITERATURE REVIEW 
Dietary intake during adolescence 
Adolescence is a defined as the period oflife beginning with the appearance of 
secondary sex characteristics and ending with the cessation of somatic growth (1). Food 
choices and dietary intake during adolescence can have a profound effect on long-term health 
benefits. Numerous nutritional concerns have been identified among adolescents. 
Adolescents with high fat and saturated fat intake have increased risk for coronary heart 
disease (2); inadequate calcium intake and lack of physical activity can result in decreased 
bone density and osteoporosis (3); and being overweight as an adolescent has been associated 
with adult obesity ( 4-8), which can lead to other co-morbid conditions such as type 2 
diabetes. In addition, adolescents are more susceptible to weight-related eating disorders 
such as anorexia nervosa, bulimia nervosa, binge eating disorder and other abnormal dieting 
behaviors, which have been related to the physiological, psychological and social changes 
that occur during adolescents (9). 
Food intake among adolescents and young adults 
Dietary intake information from national nutrition surveillance surveys including the 
1994-1996 Continuing Survey of Food Intake by Individuals (CSFII) and the 1988-1994 
National Health and Nutrition Examination Survey (NHANES III) has been compared to the 
Healthy People 2010 food and nutrient consumption goals (Table 1) ( 10). Intakes of dark 
green or orange vegetables and whole grains were low among both males and females aged 
12-39 y. Among females aged 9-19 y, few met the recommended calcium intake. More 
males met the vegetable, grain, and calcium intake recommendations than females; however, 
more females met the recommendations for total fat, saturated fat, and sodium intake than 
males. No difference was seen between fruit intake by sex. Ethnic differences among 
adolescents were not available (10). 
Munoz et al. ( 11) reported similar trends among adolescents aged 12-19 y from the 
1989-1991 CSFII. White youth aged 2-19 y were more likely than black/non-Hispanic or 
Hispanic children to meet grain and dairy recommendations but less likely than black/non-
Hispanics to meet vegetable requirements. Among 12-19 year olds, 7 .1 % of males and 
18.4% of females did not meet any of the recommended food group servings; and only 1.6% 
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of males and 0.6% of females in this age group met all of the recommendations. As 
expected, youth who met none of the food group recommendations had average intakes well 
below the RDA for vitamin B6, calcium, iron, and zinc. On the other hand, those who met all 
of the recommendations had micronutrient intakes above the RD As. Youth who met only the 
grain, vegetable, or fruit recommendation had especially low intakes of calcium and zinc. 
Table 1. Prevalence(%) of U.S. adolescents and young adults meeting the Healthy 
Peo~le 2010 food and nutrient consum~tion goals (10) 
Daily dietary intake goal Target Females Females Males Females 
Goal 12-19 ~ 20-39 ~ 12-19 ~ 20-39 ~ 
~2 fruit servings 75 23 20 22 23 
~3 vegetable servings 50 38 43 55 68 
~ 1 /3 from dark green or 50 7 7 4 4 
orange vegetables 
~6 grain servings 50 49 40 77 70 
~3 whole grain servings 50 6 5 9 11 
<30% energy from total fat 75 36 38 30 29 
~ 10% energy from saturated fat 75 34 41 27 32 
~2400 mg sodium 65 29 30a 4 6a 
Meet calcium recommendation 75 19b 40c 52b 64c 
a ~20 years; b 9-19 years; c 20-49 years 
Micronutrient intakes 
A large proportion of adolescents have been identified with low micronutrient 
intakes. The relationship between dietary intake and vitamin/mineral supplement use was 
examined among adolescents aged 13-18 y from the 1994 CSFII (Table 2) (12). In this 
study, inadequacy was defined as intake less than 75% of the 1989 RDA. Regardless of 
supplement use, 25% or more of the adolescents had inadequate dietary intakes of calcium, 
iron, zinc, and vitamins A and E. More females (>37%) than males (<25%) had inadequate 
iron intake. The prevalence of inadequacies was highest among non-supplement users 
compared to supplement users regardless of frequency of supplement use, except for iron. 
However, more than one-third of daily supplement users still had inadequacies for vitamins 
A and E, calcium and zinc. 
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Table 2. Percentage of U.S. adolescents receiving less than 75% of the RDA for selected 
nutrients, by category of supplement use (12) 
(n=423) 
Vitamin B6 
Folic acid 
Vitamin A 
Vitamin C 
Vitamin E 
Calcium 
Iron 
Zinc 
Non use Less-frequent 
(n=280) (n=77) 
37.5 31.2 
27.l 18.2 
55.0 42.9 
35.0 23.4 
55.0 42.9 
62.9 53.2 
28.6 
48.9 
32.5 
49.4 
Daily use 
(n=66) 
21.2 
16.7 
36.4 
16.7 
36.4 
47.0 
25.8 
51.5 
Adolescents who used vitamin/mineral supplements even occasionally had healthier 
diets than those who do not use supplements. Non-supplement users had a greater proportion 
of energy intake from total fat and saturated fat and less from carbohydrates than daily 
supplement users (12). Among 1532 eight graders from the Child and Adolescent Trial for 
Cardiovascular Health (CATCH) study, higher micronutrient intakes from foods were 
reported among vitamin/mineral supplement users than non-supplement users (13). 
Factors influencing eating behaviors 
Various sociodemographic characteristics and psychosocial factors have been 
associated with inadequate food intake patterns and overweight status among ih through l21h 
grade adolescents in the Minnesota Adolescent Health Survey (Table 3) (14). The majority 
(86%) of the participants were white while 8% were black/non-Hispanic. Socioeconomic 
status (SES), determined by parental education and employment status, was grouped into 
three levels: 14% were low, 56% medium, and 30% high. Low socioeconomic status (SES) 
was associated with low fruit, vegetable, and dairy intake and overweight status. The 
relationship between SES and overweight status was stronger for females than males. While 
sex was not associated with inadequate fruit or vegetable intake, being female was associated 
with inadequate dairy intake. As expected, weight dissatisfaction was associated with 
inadequate fruit, vegetable, and dairy intake as well as overweight status. 
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Table 3. Key findings from the Minnesota Adolescent Health Survey regarding food 
intake patterns and overweight status (n=36,284) (14). 
Food Intake Associations with Associations with 
Patterns and sociodemographic psychological factors and 
overweight status characteristics weight concerns 
Low fruit and • Low SES a • Weight dissatisfaction 
vegetable intake: • Black/non- • Poor school achievement 
28% and 36%, Hispanic • Low family connectedness 
respectively 
Low dairy 
intake: 
7% Mb, 13% Fe 
Overweight 
status 
>85th percentile: 
18% M, 12% F 
>95th percentile: 
4%M, 3%F. 
•F 
•Non-white 
•Low SES 
•Low SES 
(stronger 
association for F 
than M) 
Male; Female; Socioeconomic status 
• Weight dissatisfaction 
• Poor school achievement 
• Low family connectedness 
• Weak association with 
global 
psychological concerns 
• Strong assoc. with 
weight-specific concerns 
Patterns of covariation with 
other behaviors 
• Modest assoc. with binge 
eating, substance use, & 
suicide attempts 
• Strongly assoc. with chronic 
dieting 
• Modest assoc. with binge 
eating, substance use, & 
suicide attempts 
• More frequent dieting and 
binge eating behaviors 
Factors influencing food choices among adolescents were identified through focus 
group discussions (15). The most important factors identified were hunger/food cravings, 
appeal or taste of the food, time, and convenience. Other factors mentioned less frequently 
include: food availability, parental influence, perceived benefits, situational factors, mood, 
body image, habit, cost, media, and vegetarianism. Perceived barriers to healthful eating 
identified during these focus group discussions included: 1) lack of priority; 2) fruits, 
vegetables, and dairy products are less appealing than other options; 3) healthy options are 
not promoted or as appealing than other options when eating out; 4) fruits and vegetables are 
less convenient than other foods; and 5) healthful foods are more expensive. Of these listed, 
the first two were identified as the most important barriers since they were discussed more 
frequently or with greater intensity. 
Adolescents, in general, have poor dietary quality as evidenced by inadequate 
micronutrient intake and excessive intake of fat and saturated fat. To better understand how 
eating behaviors impact weight status and other health conditions associated with poor diet 
quality, an understanding of growth and body composition changes that occur during 
adolescence is necessary. 
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Adolescent growth and body composition changes 
Growth during adolescence is related to both growth hormones and sex hormones, 
testosterone in males and estrogen and progesterone in females. Several physiological 
changes occur during adolescence. Adolescents gain about 20% of their adult height and 
50% of their weight during this period (1 ). The adolescent growth spurt is a period of rapid 
growth usually lasting 18-24 months. Peak height velocity (PHV) is the fastest rate of 
growth during the growth spurt and occurs at approximately 12 and 14.5 years for girls and 
boys, respectively. 
Sexual maturation, growth, and body composition changes during puberty 
Since adolescents begin puberty at different ages and mature at different rates, 
accounting for sexual maturation when assessing physical growth is important. Sexual 
maturity ratings (SMR), also called Tanner stages, have been widely used when evaluating 
growth during adolescence (16). Males have three components in the SMR: the size of the 
testes, the length of the penis, and the development of pubic hair; females have two 
components: breast and pubic hair development. Stage 1 is associated with early sexual 
development while stage 5 is related to completion of the sexual maturation process. The 
growth spurt occurs typically two years earlier in females than males (17). In males, the 
growth spurt occurs relatively late in relationship to the development of genitalia. In 
females, menarche usually occurs 1.3 years after PHV. Most females gain no more than 2-3 
inches in height following menarche. 
As the body matures, changes in body composition occur as well. In prepubertal 
period, the adipose and muscle composition between males and females tend to be fairly 
similar with body fat averaging about 15% and 19%, respectively (1 ). During puberty, 
females gain more adipose tissue than males while males gain twice as much lean tissue as 
females. In adulthood, females have about 22% to 26% body fat, compared to 15% to 18% 
in males. The rate of maturation affects body composition. A faster maturing child has 
significantly larger total body fat, percent body fat, and fat-free mass than a slower-maturing 
child at the same age (18). 
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Overweight in adolescents and later consequences in adulthood 
Body mass index (BMI) has become widely accepted as a screening tool for obesity 
in the adult population and recently BMI-for age growth charts have been developed by the 
Centers for Disease Control and Prevention (CDC) (19) for use in assessing weight status in 
children and adolescents from 2 to 20 years old (Appendix A). Recent discussions about 
how to describe excessive body weight among adolescents have lead to new terminology. 
"At risk of overweight" (851h to <951h percentile BMI-for-age) and "overweight" (?'.:951h 
percentile BMI-for-age) are the preferred terms due to the negative connotations associated 
with the term "obesity" (20). Additional information on classification of adolescent 
overweight will be discussed in a later section. 
The increase in overweight and obesity has become a growing public health concern 
not only among adults but also among adolescents. Results from the 1999 National Health 
and Nutrition Examination Survey (NHANES IV) revealed approximately 61 % of adults 
over age 20 were overweight (BMI ?'.:25) or obese (BMI ?'.:30), a 5% increase from NHANES 
III (1988-1994); 14% of adolescents ages 12-19 years were overweight, about a 3% increase 
from NHANES III and a 9% increase from earlier surveys (1963-1970) (21,22). Results 
from NHANES III demonstrated that obesity (BMI ?'.:30) was highest among ethnic 
minorities; 38% of black/non-Hispanic and 35% of Hispanic women were obese compared to 
24% of white women (10). The effect of ethnicity appears to be less pronounced among 
adolescents; 13-14% of Hispanics and black/non-Hispanics were overweight (2::951h BMI-for-
age percentile) compared to 11 % of white adolescents (10). The revised growth charts were 
developed for use with all children and adolescents in the United States regardless of their 
race or ethnicity based on the rational that "the most important influences on growth potential 
appear to be economic, nutritional, and environmental" (20). 
Physiological and psychosocial consequences of overweight 
Obesity in adults has been associated with numerous adverse health consequences. 
Several cardiovascular risk factors have been associated with obesity including glucose 
intolerance and diabetes, hypertension, and dyslipidemia (23,24). Obesity has also been 
associated with increased risk of gallbladder disease, especially in women, osteoarthritis, and 
breast, prostrate, and colon cancers. In addition, upper gastrointestinal problems, such as 
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gastroesophageal reflux and hiatal hernia, and sleep disorders, such as sleep apnea, have been 
associated with adult obesity (2,23,24). Among adults, a U-shaped relationship has been 
described between BMI and mortality with increased mortality seen with low BMI ( <20 
kg/m2) as well as high BMI (>30 kg/m2) (24). While health consequences associated with 
obesity are commonly seen in adults, there are an increasing number of overweight-related 
problems seen also in adolescents. These increased health complications during adolescence 
are precursors to adult disease (2). Numerous conditions, such as hypertension, hepatic 
steatosis, sleep apnea, cholelithiasis and orthopedic problems, have been documented among 
obese adolescents. Those conditions pertinent to this project will be discussed. 
H yperlipidemia 
Abnormal blood lipid concentrations, namely elevated serum low-density lipoprotein (LDL)-
cholesterol and triacyl-glycerol (TAG) (also referred to as triglycerides) and lowered high-
density lipoprotein (HDL)-cholesterol, have been found in overweight adolescents (2). 
These patterns are similar to those commonly seen in adults. Hyperlipidemia has been 
related to central fat distribution. Increased free fatty acids produced by increased lipolysis 
relating to visceral adipocytes and hyperinsulinemia, promoting increased TAG and LDL 
cholesterol synthesis (25-28). 
Glucose intolerance and type 2 diabetes 
Impaired glucose tolerance has been reported in 25% of obese children ( 4-10 y) and 
21 % of obese adolescents (11-18 y) with type 2 diabetes identified in 4% of the obese 
adolescents (29). After adjusting for BMI, insulin resistance was the best predictor of 
impaired glucose intolerance. As with hyperlipidemia, the mechanism for development of 
type 2 diabetes among adolescents is similar to that with adults. Visceral fat is positively 
associated with basal insulin secretion, stimulated insulin secretion, and insulin resistance 
(27). 
Psychosocial consequences 
In the U.S. culture, strong messages encouraging thinness, especially among women 
prevail. Negative attitudes resulting in social stigmatization towards obese individuals often 
translate into discrimination in employment opportunities, college acceptance, job earnings, 
rental availabilities, and opportunities for marriage (2,24). These societal pressures can 
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result in a preoccupation with weight and the development of eating disorders and other 
unhealthy eating patterns. Binge eating disorder, characterized by eating larger amounts of 
food with a lack of control during these episodes (30). Most obese binge eaters do not 
engage in purging behaviors. In addition to being more susceptible to binge eating disorder, 
obese individuals are more likely to have other psychological illnesses such as depression 
(24). Binge eating has been associated with higher prevalence of depression and anxiety 
(31). 
As mentioned earlier, more black/non-Hispanic women are overweight and obese 
than white/non-Hispanic women. Ethnic differences in body image and self-esteem have 
been studied. Among college female students, body image and self-esteem were more 
positive among black/non-Hispanic than white/non-Hispanic women (32). Among 
overweight adolescent females, both black/non-Hispanic and white/non-Hispanic females 
expressed a desire to be thinner, felt dissatisfied with their body shape and size, and felt self-
conscious about their weight; however, black/non-Hispanic adolescents were more likely to 
discuss the positive aspects of their bodies than white/non-Hispanics (33). This ethnic 
difference in body image may relate to differences in cultural perceptions and social 
stigmatizations of obesity (34). Black/non-Hispanic women described themselves with more 
masculine or androgynous traits and believed that black/non-Hispanic men prefer larger 
women (32). Other cultural influences have been related to positive body image seen among 
black/non-Hispanic women (34). 
Adolescent BMI as a predictor of adult BMI 
Investigators have studied the relationship between adolescent BMI and adult BMI 
(4-8). Must et al. (4) studied overweight adolescents (13-18 y) who participated in the 
Harvard Growth Study from 1922 to1935 with subsequent morbidity and mortality. Of the 
surviving subjects who were overweight (>751h percentile), 52% were overweight as adults in 
1988. Being overweight as an adolescent was a more powerful predictor of adulthood 
morbidity and mortality than adulthood overweight. 
Scrinivasan et al. (5) examined the impact of adolescent overweight on adult 
overweight and related cardiovascular risk factors in a biracial cohort from the Bogalusa 
Heart Study. The risk of overweight adolescents (>751h percentile) remaining overweight as 
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adults was 58%; black males had the lowest risk (52%) and black females had the highest 
risk (62%). As young adults, the overweight adolescent cohort had increased abdominal fat 
distribution, hypertension, hyperlipidemia, hyperglycemia, and hyperinsulinemia compared 
to the lean adolescent cohort (25th to 75th percentile). 
Whitaker et al. (6) studied childhood and adolescent obesity (1-17 y) and parental 
obesity as a predictor of obesity during young adulthood (21-29 y). Of those who were obese 
during childhood, the chance of adulthood obesity was lowest (8%) for those aged 1-2 y 
without obese parents and highest (79%) for those aged 10 -14 y with at least one obese 
parent. After adjusting for parental obesity, the odds ratio for adulthood obesity was greatest 
for overweight children aged 10-14 y (22.3, 95% CI: 10.5-47.1) and those aged 15-17 y 
(17.5, 95% CI: 7.7-39.5). 
Guo and Chumlea (7) investigated the predictive value of childhood BMI for 
overweight adults, defined as BMI >28 and >26 for men and women, respectively. Data 
from 555 white children indicated that overweight at age 35 y could be predicted from BMI 
at younger ages. The strongest prediction was BMI at 18 y followed by BMI at 13 y. BMI at 
ages <13 y was only a moderate predictor of adult BMI. For 18 year olds with BMI >60th 
percentile, the probability of being overweight at age 35 y was 34% for men and 37% for 
women. 
Guo et al. (8) further examined the BMI-adult overweight relationship with data from 
the Fels Longitudinal Study. BMI parameters for early childhood, pubescence, and post-
pubescence (age 2 to 25 y) were compared to adult BMI values at 35 to 45 y. The BMI 
rebound period (early childhood) was a significant predictor of adult overweight in females 
but not in males. BMI patterns during and post adolescence were more important than BMI 
rebound for adult total body fat and percent body fat. The BMI at approximately 20 y was a 
strong predictor of adult BMI. In addition, the pattern ofBMI changes from 2 to 25 y had 
stronger effects on subsequent adult overweight than birth weight and adult lifestyle factors. 
Lifestyle habits among adolescents including eating behaviors and physical activity 
can have lasting health implications. Overweight adolescents are more likely to be 
overweight as adults as well as develop immediate and long-term health consequences 
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associated with increased weight. In this study, adolescents and young adults had an 
additional health concern related to HIV infection. 
HIV/AIDS 
Definition of disease 
Acquired Immune Deficiency Syndrome (AIDS) is characterized by a decreased 
immune function and opportunistic infections caused by the human immunodeficiency virus 
(HIV) (35). HIV binds to the CD4+ T-lymphocyte cell surface receptor. The viral DNA is 
integrated into the host cell's DNA. As a retrovirus, HIV replicates using the enzyme reverse 
transcriptase to copy RNA into DNA. The disease is primarily characterized by a gradual 
deterioration in immune function due to the destruction of CD4+ T-cells resulting in 
immunodeficiency, neurological complications, wasting, opportunistic infections, and 
neoplasms (35). 
Prevalence of HIV infection in the U.S. 
The number of AIDS cases reported in the 1980s to the CDC dramatically increased 
after the first cases of AIDS were reported in the U.S. in 1981 (36). In 1993, reported cases 
peaked corresponding to the expansion of the CDC classification to include CD4+ T-cells 
(3 7). The most dramatic decline in reported cases and deaths has been since 1996, 
corresponding to the increased use of antiretroviral therapy (ART). As of December 2000, 
774,467 cases of AIDS have been reported in the U.S. of which 58% have died with AIDS 
(37). Since people with AIDS are surviving longer, the number of people with HIV infection 
or AIDS has steadily increased. Through the end of 2000, 450,151 cases of individuals 
living with HIV infection or AIDS had been reported to the CDC. However, the CDC has 
estimated that 800,000 to 900,000 individuals in the U.S. in 1999 were living with HIV 
infection or AIDS. This discrepancy may be due to the fact that reporting of those diagnosed 
with HIV infection has not been implemented in all states and territories, anonymous tests 
are excluded from case reports, and many individuals are unaware of their HIV status. 
The prevalence of HIV infection is growing among the adolescent and young adult 
population in the U.S. Of the 31,293 AIDS cases reported in adolescents and young adults 
under age 25 y through December 2000, approximately 70% were male and 65% were 
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black/non-Hispanic or Hispanic. More females (78%) than males (59%) were from a 
minority background; about 60% of the females were black/non-Hispanic (36). 
Classification system for HIV infection 
To account for the relationship between decreased CD4+ T-cells and impaired 
immune function, the CDC revised the classification system for HIV infection to include 
CD4+ T-cells in addition to clinical conditions associated with HIV infection (37). As the 
CD4+ T-cell count decreases, the risk and severity of opportunistic illnesses increase. Three 
ranges of CD4+ T-cells have been defined: ~500, 200-499, and <200 cells/µL. Three clinical 
categories were defined as asymptomatic HIV infection, symptomatic HIV infection, and 
AIDS-indicator conditions. A detailed description of the classification system has been 
provided (Appendix B). 
The first stage of HIV infection, called acute HIV infection, occurs 4-7 weeks after 
primary infection when there is rapid viral replication. Symptoms seen during this period 
include fever, malaise, lymphademopathy syndrome (swollen lymph nodes), pharyngitis, 
headache, myalgia (widespread muscle pain), and occasionally a rash (38). The first stage of 
infection is not included in the CDC classification system since individuals may not test 
positive for HIV infection yet. The time between initial infection and seroconversion, or the 
development of HIV antibodies, varies from one week to several months (39). Once HIV 
antibodies appear in the blood, an individual will test positive for HIV infection. 
During asymptomatic HIV infection, few if any noticeable symptoms occur. While 
the progression of HIV infection has large individual variability based on treatment as well as 
health-related factors, this stage averages about eight years ( 40). Symptomatic HIV infection 
occurs when symptoms such as fevers, sweats, skin problems, fatigue, or other symptoms 
that are not considered AIDS defining conditions (Category B in Appendix B). 
The term AIDS is used for individuals who have at least one well-defined life-
threatening condition linked to immunosuppression. Individuals with CD4+ T-cells <200 
cells/µL are classified with AIDS. A detailed list of AIDS-defining conditions is listed in 
Category C (Appendix B). Classic conditions include AIDS wasting syndrome (A WS), HIV 
encephalopathy, HIV nephropathy, and AIDS enteropathy. A WS is defined as involuntary 
weight loss of>l0% plus chronic diarrhea or chronic weakness and fever for >30 days 
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(CDC, 1993). A 5% weight loss over four months has been associated with an increased risk 
of opportunistic infections and death (Odds ratio: 2.22, p<0.001) (41). AIDS enteropathy has 
been defined as chronic diarrhea in absence of identifiable enteric pathogens. Kotler ( 42) has 
suggested that intestinal injury is related to complications from other conditions rather than 
immunodeficiency related to HIV infection. 
Nutrition and HIV infection 
The relationship between nutritional status and immune function has been studied for 
decades. It is well known that infectious illnesses influence nutritional status, which 
increases susceptibility to additional infection ( 43,44). Many immune function changes seen 
in AIDS are similar to those of protein-energy malnutrition (PEM) ( 45). With PEM, the 
body lacks the necessary protein synthesis required for every immune function. Without new 
protein synthesis, the body draws upon lean tissue stores to meet the basic energy and protein 
needs for survival. Immune changes similar to both HIV infection and PEM include 
decreased CD4+ T-cells, reduced immunoglobulin A (IgA), and impaired primary and 
secondary delayed cutaneous hypersensitivity responses. 
Antioxidants and oxidative stress 
Highly reactive oxidative species (ROS) are produced during normal metabolic 
processes. Some common ROS include singlet oxygen, superoxide radical anion, hydroxyl 
radical, hydrogen peroxide and lipid peroxide ( 46). Most cells have enzymes or other 
molecules with antioxidant properties that detoxify the ROS or free radicals in the body. 
Oxidative stress can result from decreased intake of antioxidants, excessive production of 
free radicals, or a combination of both (47). The immune system is one of the main sources 
of oxidative stress in the body ( 48). Both neurophils and activated macrophages release 
hydrogen peroxide and other ROS as part of their immune fighting properties. 
In HIV infection, the oxidative stress cycle may be activated by depletion of serum 
antioxidants or through overproduction of free radicals (Figure 1) ( 49). In addition, 
increased oxidative stress has been associated with increased disease progression. Oxidative 
stress leads to an impaired immune function and increased apoptosis (cell death) resulting in 
destruction of CD4+ T-cells. In addition, oxidative stress has been related to increased HIV 
replication. Antiretroviral therapy (ART) has been associated with decreased oxidative stress 
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by decreasing viral load and HIV progression. Several mechanisms have been suggested in 
relationship to antioxidant depletion in HIV infection: 1) low dietary intake as a result of 
decreased appetite, 2) changes in intestinal mucosa resulting in malabsorption, excessive 
production of free radicals, and 2) loss of electron-transport capacity resulting in decreased 
recovery of reduced forms of antioxidants ( 49). Some of the micronutrients important to 
immune function and HIV infection will be discussed briefly. 
ART/PI 
Therapy 
Antioxidant Intake 
(Food or Supplements) 
Oxidative 
Stress 
Serum 
Antioxidants 
Infection 
Figure 1. Mechanisms of oxidative stress in HIV infection. 
Adapted from: Tang and Smith ( 49). 
Vitamin A and carotenoids 
. mv 
Infection 
Vitamin A affects many aspects of the immune function. Retinoids are involved in 
the immune cell differentiation and proliferation in response to immune stimuli. Vitamin A 
.. 
deficiency has been associated with reduced leukocytes, impaired T-cell function, and 
decreased growth, differentiation, and activation of B-lymphocytes (50). Carotenoids have 
been shown to enhance immune cell activity via their pro-vitamin A activity as well as their 
antioxidant characteristics. ~-carotene has been associated with increased total white blood 
cells and T-cells in HIV-infected individuals (51). Intakes of vitamin A and beta-carotene 
during early HIV infection had a U-shaped relationship with risk of developing AIDS; both 
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deficiencies and excessive intakes had a subsequent negative association with immune 
function and disease progression (52,53). 
Vitamin E 
Vitamin E, specifically a-tocopherol, is a potent fat-soluble antioxidant blocking the 
chain reaction of lipid peroxidation by scavenging intermediate peroxyl radicals (54). 
Vitamin E is also important for normal immune function particularly with T-lymphocytes 
and natural killer cell activity. Vitamin E supplementation has been associated with 
increased resistance to infections among the elderly (50). Vitamin E intake during early HIV 
infection has also been associated with slower HIV progression (52,53,55,56). 
Vitamin C 
Vitamin C, or ascorbic acid, is another well-known antioxidant that works as a 
scavenger of free radicals, especially environmental pollutants of the respiratory system. 
Vitamin C assists vitamin E in lipid peroxidation by recycling the a-tocopherol free radicals 
(50). Vitamin Chas been shown to improve immune function. The high intracellular 
content of vitamin C in leukocytes provides cellular protection against oxidative damage 
associated with respiratory burst. While vitamin C has known antioxidant properties, in the 
presence of excessive iron or copper, vitamin C can act as a prooxidant generating free 
radicals (47). Vitamin C intake during early HIV infection has also been positively associated 
with CD4+ T-cells and survival after a 6-8 y follow-up period (52,53,55). 
Iron 
The functions of iron relate to its ability to participate in oxidation and reduction 
reaction (57). Iron is highly reactive and can react with oxygen to form intermediates that 
can cause cellular or DNA damage. To prevent these oxidative effects, iron is tightly bound 
to proteins. Iron deficiency has been associated with reduced T-cell numbers, antibody 
production, as well as other immune changes (50). The role of iron in immune function 
relates to its involvement with folate metabolism, mitochondrial energy production, 
respiratory burst, and metalloenzymes. Iron intake during early HIV infection has also been 
positively associated with CD4+ T-cells and survival after a 6-8 y follow-up period 
(52,53,55). 
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Adequate zinc status is essential for many immune functions including division, 
maturation and differentiation of T-cells, lymphocyte response to mitogens, gene 
transcription, and biomembrane function (58). Zinc-dependent thymulin is essential for the 
formation ofT-lymphocytes. Copper-zinc superoxide dismutase (Cu-Zn SOD) is important 
in the antioxidant defense system. Zinc deficiency may compromise the antioxidant response 
to oxidative stress from free radicals and lipid peroxides, which has been shown to stimulate 
replication of HIV virus (59). 
Individuals with AIDS have exhibited symptoms of zinc deficiency including 
immune deficiencies, impaired taste and appetite, decreased food intake, diarrhea, hair loss, 
skin lesions, hypogonadism and hypospermia (58,60). Thus zinc deficiency may be a 
compounding factor in maintaining adequate oral intake. While zinc deficiency is known to 
decrease immune function (43,61), excessive intake of zinc (300 mg/day) has been associated 
with impaired immune function among healthy adult men (62). Low plasma zinc 
concentrations have been associated with a three-fold increase in risk of HIV-related death in 
HIV-infected drug users (63). Among HIV-infected men, increased zinc intake was 
associated with increased disease progression and death (52,53). This suggests a similar U-
shaped relationship between zinc intake and immune function, which was described earlier 
with vitamin A. 
No general consensus has been reached about the use of zinc supplementation in 
HIV-infected individuals (64). Short-term zinc supplementation of one month has been 
shown to be beneficial in reduction, prevention or elimination of certain opportunistic 
infections in HIV-infected individuals (65). Supplementation may be helpful to prevent 
disease progression and opportunistic infections in those individuals with low dietary intake 
(64). However, due to the adverse effects of excessive zinc on the immune function, 
supplementation should be used with caution. Additional research is needed to determine the 
mechanisms and interactions of zinc on the immune systems of HIV-infected individuals. 
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Dietary intake studies and HIV infection 
Numerous studies have been looked at the association between dietary intake and 
HIV infection (Table 4). Intakes ofthiamin, riboflavin, niacin, vitamins A, B6, C, and E, and 
iron during early HIV infection have been positively associated with CD4+ T-cells and 
survival after a 6-8 y follow-up period (52,53,55). Other studies have found a positive 
association between macro- and micronutrient intakes and CD4+ T-cells (66,67). 
Many of the above mentioned studies had micronutrient intakes at or above the RDA 
for the majority of nutrients with intake for some micronutrients far exceeding the RDA. The 
prevalence of deficiency, compared to either the 1989 RD As or the new DRis, was low for 
the majority of subjects in these studies. Differences in macro- and micronutrient intakes 
have also been seen between HIV -infected and HIV-uninfected individuals (Table 5). The 
majority of these studies reported higher dietary intakes for HIV-infected compared to HIV-
uninfected individuals (68,69,70,71,72). A similar trend was seen by Sharkey et al. (66); 
however, did no reach significance. 
Differences in serum micronutrient concentrations have also been seen between HIV-
infected and HIV-uninfected individuals (68,69). While intakes at the RDA were associated 
with normal serum micronutrient concentrations in HIV-uninfected participants, HIV-
infected participants required intakes much greater than the RDA to achieve normal serum 
concentrations (69). These discrepancies between dietary intake and serum concentrations 
among HIV-infected individuals may be related to a variety of mechanisms including altered 
intestinal absorption, increased needs related to HIV infection and altered immune function., 
altered utilization related to metabolic changes, or a combination of factors (73,74). 
Vitamin/mineral supplementation is common among HIV-infected individuals 
(55,67,69,75,76). Among the above studies, 46% to 71 % of the individuals used 
vitamin/mineral supplements. Micronutrient intake from food alone was higher among 
supplement users compared to non-supplement users (55,69). This was consistent with 
dietary intake studies on the general population of U.S. adolescents (12,13). This suggests 
that individuals who take supplements make more micronutrient-dense food choices 
compared to those who do not take supplements. 
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Table 4. Studies comearing dietar~ intake and HIV disease erogression 
Study Sample (n) Dietary Micronutrient intake/ Relationship to disease 
intake Prevalence of deficiencl'. ~rogression 
Sharkey et Homosexual M a 7-day food No significant differences by Positive relationship 
al. 1992 HIV+ (n=28) record HIV status in any nutrient between energy intake, 
(66) HIV- (n=8) intakes weight, & CD4+ T-cells 
Abrams et San Francisco HHHQ Food intake: *36% (107) incidence of 
al. 1993 Men's Health *Supplement users > non- AIDS in 6 y period 
(55) Study (n=296) Current supplement users *Protective relationship 
supplement *Intakes> RDA (except zinc, against developing AIDS 
Homo/bisexual use was thiamin, & vitamin E) with iron, vitamin E, 
HIV+M reported Food & supplement intake: Riboflavin, (p<0.05) 
(25-50 y) Intakes >RDA (except for vitamin C, thiamin 
zinc) (p<0.10) vitamin A 
*Lowest quartile of most (p<0.12). 
nutrients> RDA (Iron: 200% *Supplement use 
RDA, vitamin E: 300% RDA, associated with 31 % .,!, in 
vitamin C: 400% RDA) AIDS risk 
Tang et al. Multi center Willett FFQ Food Intake: *38% developed AIDS 
1993 (52) AIDS Cohort ~RDA except for thiamin, during next 6.8 y. 
study (n=281) Current vitamin E, & zinc *Highest quartiles of 
supplement Food & supplement intake: vitamin C, niacin, 
Homo/bisexual use was ~RDA for all nutrients thiamin associated with 
HIV+M reported Vitamin A: >75% of sample decreased risk of AIDS; 
(>18 y) consumed> 180% RDA & tendencies seen with 
HIV status 25% consumed >400% RDA riboflavin & vitamin B6. 
not known at Vitamin C: >75% consumed *The 2°d & 3rd quartile of 
time ofFFQ >250% of RDA for C vitamin A associated 
Zinc: >50% consumed< RDA with .,!, progression to 
for zinc & -25% consumed AIDS 
130%RDA *i zinc associated with i 
rrogression to AIDS 
Tang et al. See Tang et al. See Tang et See Tang et al. 1993 *58% survived 8 y 
1996(53) 1993 (52) al. 1993 ( 52) *91. 6% of deaths due to 
Thiamin, vitamins B6 & E, & AIDS 
8y zinc: >20% had intakes< *Highest quartile of 
follow-up RDA. thiamin, riboflavin, 
from Tang niacin, & vitamin B6 
et al. 1993 50% of subjects had zinc associated with i 
(52) intake <RDA survival 
*U-shaped relationship 
with ~-carotene & 
vitamin A 
Woods et HIV+ cohort 3-day food *Intake >NHANES III *M: CD4+ T-cells ~500 
al. 2002 M (n=386), records *F: 21-64% consumed <75% associated with i intakes 
(67) F (n=130) DRI for vitamins A, B6' C, & for all micronutrients 
Current E, iron, & zinc except zinc 
Mean age 40 y supplement *M: 26-40% intakes <75% 
use was DRI for vitamins A & E, & 
re orted zmc 
a Age not available; Abbreviations: DRI=Dietary Reference Intake, F=Fernale, FFQ=Food frequency 
questionnaire, HHHQ=Health Habits and History Questionnaire, M=Male, NHANES III=Third National Health 
and Nutrition Examination Survey, RDA=Recommended Daily Allowances 
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Table 5. Studies comparing dietary intake between HIV-infected (HIV+) and HIV-
uninfected (HIV-} U.S. adults 
Study Sample Dietary intake Micronutrient intake/ Relationship to serum 
erevalence of deficienc~ concentration 
Sharkey et Homosexual M a 7-day weighed No differences by HIV NA 
al. 1992 HIV+ (n=28) food record status in any nutrient intakes 
(66) HIV- (n=9~ 
Beach et al. Homosexual M Willett FFQ *Mean intakes > RDA for Vitamin A, riboflavin, 
1992 (68) (20-55 y) all subjects copper serum values J.. 
HIV+ (n=lOO); Current *Intakes for HIV+ > HIV- for HIV+ vs. HIV- after 
HIV- (n=42) supplement use *Percent< RDA: adjusting for intake. 
was reported HIV+: Vit E (10%), Zinc 
(21%) 
HIV-: Riboflavin & vitamin 
B6 (>15%), zinc (48%), 
vitamin E (26%) folate 
(35%) 
Baum et al. Homosexual M Willett FFQ *Mean intakes HIV+ > *HIV-: Intake ofRDA 
1994 (69) HIV+ (n=88) HIV- associated with normal 
HIV- (n= 108) Current *Supplement use greater in serum concentration 
(20-55 y) supplement use HIV+ *HIV+ required intakes 
was reported *Majority of all participants >RDA to achieve 
consumed at least the RDA normal plasma 
for most essential nutrients concentration 
Smit et al. IV drug abusers: FFQ & 24-hour *Energy, total fat, saturated NA 
1996 (70) HIV+ (n=45) recall fat, vitamins B6 & B 12, 
HIV- (n=59) panothenic acid, 
36%F phosphorus, & selenium 
(Mean age 40 y) intake: HIV+ > HIV-
*Vitamins A & E, calcium, 
& zinc > RD A for both 
rou s 
Hogg et al. Homosexual M 24-hour recall Energy, protein, NA 
1996 (71) HIV+ (n=139) carbohydrates & cholesterol 
HIV- (n=l45) intake: HIV+> HIV-
(24-64 )'.) {micronutrient intake-NA) 
McDermid HIV+ (n=58) 24 hour recall M: Vitamin C & E intakes: NA 
et al. 2002 HIV- (n=31) & modified HIV+ >HIV-
(72) M&F FFQ 
(Mean a e 27 
•Age not available; Abbrevations: F=Female, FFQ=Food frequency questionnaire, IV=Intravenous, M= Male, 
NA=Not available, RDA=Recommended Daily Allowances 
Despite different dietary intake methods, findings from the above studies (Table 4, 5) 
were relatively consistent. These dietary intake studies included primarily homosexual adult 
men. More recently, studies have included more minority groups and women (67,70). 
However, little is known about the dietary intake patterns of adolescent and young adults 
with HIV infection. 
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Metabolic and body composition changes related to HIV and drug therapy 
Wasting 
Wasting was a common occurrence with HIV-infection. Even in early stages ofHIV-
infection, depletion of lean body mass has been seen among HIV-infected adults without a 
significant change in BMI or body weight (77). Timing of death in persons with AIDS has 
been predicted as body cell mass reaches 55% of normal weight or when body weight nears 
66% of ideal body weight (78). While the exact mechanism of wasting among HIV-infected 
individuals is unknown, some potential mechanisms for weight loss and decreased lean body 
mass are inadequate intake, gastrointestinal malabsorption, and abnormal energy utilization 
(79). 
Inflammation and ulcers of the mouth, esophagus, and stomach can lead to decreased 
intake and anorexia. Pancreatic and biliary tract disease can result in vomiting and 
abdominal pain. HIV encephalopathy can affect the ability to consume adequate energy due 
to decline in physical coordination and mental function (80). Furthermore, medications 
commonly used among HIV-infected individuals can result in gastrointestinal side effects 
resulting in decreased intake (79). Malabsorption is prevalent among advanced HIV 
infection regardless of other opportunistic pathogens (81 ). Small intestine dysfunction has 
been identified by abnormal D-xylose absorption tests, Schilling tests, and by presence of 
steatorrhea reflecting malabsorption of carbohydrates, vitamin B12, and lipids, respectively 
(81). 
Increased energy metabolism has been reported among HIV-infected individuals 
(82,83). Increased energy expenditure may be due in part to increased cytokine production. 
Cytokine production has been associated with "futile cycling" where fatty acids are 
transported from adipose tissue to the liver and then back to adipose tissue resulting in 
greater energy requirements to meet energy demands (79). 
Antiretroviral therapies 
Since some of the metabolic and body composition changes have been associated 
with antiretroviral therapy (ART), the three main categories of ART currently used for 
treatment will be briefly discussed: 1) Nucleoside Reverse Transcriptase Inhibitors (NRTI) 
and Nucleotide reverse transcriptase inhibitors (NtRTI), 2) Protease inhibitors (PI), and 3) 
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Nonnucleoside reverse transcriptase inhibitors (NNRTI) (84). Often these medications are 
given in combination of three or more different drugs referred to as highly active 
antiretroviral therapy (RAART) (39). NRTls and NtRTis inhibit the replication of RN 
through incorporation into the DNA by viral reverse transcriptase and thus terminate the 
DNA chain (85). Pis inhibit the RN protease and prevent the maturation of the virus. 
NRTis bind directly to the reverse transcriptase and block RNA and DNA causing a 
disruption of the enzymes site. 
Patients with advanced RN disease clearly benefit from ART, which slows the 
progression of disease, improves survival rate, and reverses some opportunistic infections 
(86). While use of Pis has improved the morbidity and mortality of RN infection, several 
metabolic side effects have been identified, such as include insulin resistance, lipodystrophy 
or fat redistribution, and hyperlipidemia (86-89). These complications are similar to those 
associated with the metabolic syndrome known as Syndrome X (90). While the majority of 
the metabolic and body composition changes have been associated with ART, they have also 
been seen among RN-infected individuals not receiving ART (91-93). 
Insulin resistance 
Insulin resistance occurs at the cellular level preventing insulin from exerting its 
effect on glucose metabolism (35). Insulin resistance has been associated with development 
of glucose intolerance, type 2 diabetes mellitus, and cardiovascular disease (94,95). 
Individuals with diabetes have increased risk of developing a number of long-term 
complications, which include coronary heart disease, peripheral vascular disease, cerebral 
vascular disease, dyslipidemia, hypertension, retinopathy, nephropathy and neuropathy. 
Insulin resistance has been seen with ART in RN-infected individuals (96,97). Pl-induced 
insulin resistance can develop in as soon as four weeks after starting therapy and often 
precedes lipodystrophy (discussed below) (87). Although insulin resistance has been 
associated with PI therapy, hyperglycemia is relatively rare since most patients may be able 
to compensate for insulin resistance by increasing insulin secretion to maintain adequate 
glucose levels (86). 
A possible mechanism for PI-induced insulin resistance is the inhibition of the 
insulin-responsive glucose transporter (GLUT-4) (98). Insulin signaling to the intracellular 
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GLUT-4 causes plasma membrane translocation. GLUT-4 translocation accounts for the 
majority of the glucose uptake stimulated by insulin in fat and muscles cells (99). Murata et 
al. (98) studied the effect of PI therapy on insulin resistance in frogs. PI therapy inhibited 
GLUT-4 activity by 45% compared to frogs not receiving PI therapy. They speculated that 
PI inhibited the transport function of GLUT-4 resulting in increased insulin resistance seen in 
HIV individuals. Further, the PI effect on GLUT-4 may account for the observed 
lipodystrophy in addition to the insulin resistance since GLUT-4 activity is involved in de 
nova peripheral adipogenesis primarily from glucose while abdominal adipocytes may obtain 
lipids primarily from circulating triglycerides. 
Lipodystrophy and fat redistribution 
Clinical features of lipodystrophy, or fat redistribution syndrome, include peripheral 
fat loss especially in the face, limbs, and buttocks with a central fat accumulation in the 
abdominal region, breasts, and over the dorsocervical vertebrate (referred to as the "buffalo 
hump") (39,86). Peripheral wasting and/or central adiposity have been noted among patients 
receiving PI. (89 ,91,96,97). 
Carr et al. (100) looked at the occurrence of lipodystrophy in 116 HIV-infected, 
otherwise healthy patients receiving at least one PI, 32 HIV-infected PI na'ive patients, and 47 
healthy male control subjects. Lipodystrophy was observed in 64% of the HIV-infected 
taking PI for an average of 13.9 months but in only one HIV-infected PI na'ive individual 
(p=0.0001). The median time for onset oflipodystrophy was 10 months. Patients with PI-
induced lipodystrophy had significantly longer duration of PI therapy than those without 
lipodystrophy (15.2 and 10.9 months, respectively; p=0.0001). Higher triglyceride, total 
cholesterol, insulin, and C-peptide levels were also seen in patients with lipodystrophy 
compared to those without lipodystrophy. 
Hyperlipidemia 
While increased triglyerides have been seen in HIV-infected patients not taking ART 
(91,101,102), an increase in dyslipidemia has been observed in patients on ART (103,104). 
Hypertriglyceridemia has been seen most frequently although increased very low density 
lipoprotein (VLDL) and low density lipoproteins (LDL) has been noted (104). Henry et al. 
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(103) have identified elevated lipid concentrations in 33% of the 124 HIV-infected patients 
on PI. 
While the exact mechanism of development of hyperlipidemia has not been 
determined, several possible mechanisms have been proposed relating to: 1) apoprotein B 
(Apo B), 2) cytoplasmic retinoic acid binding protein 1 (CRABP-1), and 3) mitochondrial 
toxicity. Hyperlipidemia could be related to synthesis and secretion of apoprotein B (Apo 
B), which is found in low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL) 
and intermediate-density lipoprotein (IDL) cholesterol. In the presence of lipids, Apo B 
increases VLDL assembly and secretion, while in the absence of lipids the protein is 
degraded and no VLDL production results (105). The rate of apo B synthesis was doubled in 
HIV-infected individuals with ART compared to healthy HIV-uninfected individuals (104). 
PI may interfere with the degradation of apo B leading to increased lipoprotein secretion and 
subsequent increased serum lipid concentrations. 
Adipocyte differentiation and lipid metabolism are impaired due to the interaction of 
protease inhibitors with cytoplasmic retinoic acid binding protein 1 (CRABP-1) and the 
lipoprotein receptor-related protein (LRP), a receptor essential for lipoprotein remnant 
removal from the plasma (86,100). The resulting hyperlipidemia could result in abdominal 
redistribution, insulin resistance, and secondary type 2 diabetes (86,104). NRTI-induced 
mitochondrial toxicity could impair oxidative phosphorylation, thus resulting in increased 
triglycerides and subsequent insulin resistance (104). 
Before ART, prognosis for individuals with AIDS was poor; concerns about other 
long-term health problems seemed irrelevant (103). In the early years of the HIV epidemic, 
morbidity (<7%) and mortality (1.1 %) related to cardiovascular disease was relatively low 
( 106). Between 1994 and 1996, cardiac disease was the primary cause of death in 9 .1 % of 
HIV-infected individuals (107). An increasing number of clients will require medical 
nutrition therapy for co-morbidities associated with HIV infection such as renal disease, 
hyperlipidemia, pancreatic dysfunction, diabetes, and liver disease (108). 
Review of methodologies 
Various methodologies were used in this study. To better understand these methods, 
a review of literature has been included for the following: food frequency questionnaires, 
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Dietary Reference Intakes, Healthy Eating Index, BMI, assessment of overweight and 
obesity, television watching, self-reported health status, and Revised Children's Manifest 
Anxiety. 
Assessment of dietary intake using a food frequency questionnaire 
The importance of accurate assessment of dietary intake is essential for appropriate 
identification of population deficiencies for research and public health purposes as well as 
individual dietary patterns for planning education strategies. There are several commonly 
used methods to assess food intake such as food records, 24-hour recalls, and food frequency 
questionnaires (FFQ). FFQs are commonly used in epidemiological studies with the premise 
that the average long-term diet is conceptually more important than intake on a few specific 
days (109). The questionnaire can be given in an interview format or self-administered 
though the later method requires literate individuals (110). FFQs consist of a food list and a 
frequency response section. A more comprehensive food list is typically preferred due to the 
additional information about dietary variety and usual intake. 
There are several advantages to using a FFQ. Individuals are able to describe their 
usual frequency of consuming various foods easier than describe what foods were eaten at a 
specific meal. FFQs are also less expensive and easier to administer. Nutrient analysis of 
questionnaires is often computerized allowing for the processing of large numbers of 
subjects. FFQs have another advantage over 24-hour recalls or food records. One limitation 
of the 24-hour recall or food record is that dietary intake varies from day to day; any 24-hour 
recall or food record from a specific day may not give an appropriate representation of the 
overall diet. For example, 106 days would need to be represented for the Vitamin A intake to 
fall within 20% of the true mean intake (111). The additional time, subject commitment, and 
nutritional expertise needed for multiple 24-hour recalls or food records are much higher than 
that required for administration of a food frequency questionnaire. 
Food frequency questionnaires have some limitations. Food items on the 
questionnaire must be representative of an individual's usual diet otherwise dietary intake 
will be inaccurately assessed. In addition, many foods are often combined into one response 
category and nutrient contents may vary considerably. Another concern is that individuals 
may report recent intake rather than usual intake during the time indicated by the FFQ (i.e. 
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past month, six months, or past year) (112). FFQs do not provide a direct quantitative 
assessment of amounts consumed of individual foods with food lists often limited to those 
considered primary contributors of major nutrients (113,114). FFQs tend to overestimate 
consumption (109). Previous studies with dietary intake and HIV infection have used 
various forms of FFQs (52,53,68-70, 72, 115), including the Health Habits and History 
Questionnaire (HHHQ), an early version of the Block food frequency questionnaire (BFFQ) 
(55). 
Block food frequency questionnaire 
Early versions of the HHHQ were developed in the early 1980's by Dr. Gladys Block 
at the National Cancer Institute for studying the role of diet in disease and health. The food 
list was designed to adequately assess a wide range of nutrients consumed in the typical U.S. 
diet. Foods included in the list represented at least 90% of 18 major nutrients and 93% of 
energy intake based on U.S. consumption from NHANES II data (114). 
The 98.2 Block food frequency questionnaire (BFFQ) is a revision based on the 
NHANES III food intake data (116) (Appendix C). Foods normally eaten by different ethnic 
groups and low-fat foods were added to reflect current trends in food consumption. In 
addition, pictures depicting food portions were included with each questionnaire to help 
subjects visualize portion sizes. The 98.2 version is a computerized scanned questionnaire 
and nutrient analysis is completed by Block Dietary Data Systems (Berkeley, CA). The 
questionnaire has been used in over 700 research groups and universities (117). Other 
studies have found earlier versions of the BFFQ to be reasonably valid for estimating a 
group's mean actual intake for a variety of nutrients (118,119); the questionnaire was 
validated with black/non-Hispanic populations (120). 
Under-reporting of food intake 
With any method of assessing dietary intake, subjects may either underestimate or 
overestimate intake. Over- or under-reporting might be more likely with FFQs than diet 
records due to the greater standard deviations for energy intake seen with FFQs compared to 
other methods (121). Various studies have found under-reporting of energy intake more 
common among overweight or obese subjects (122-127) with similar findings seen among 
adolescents (123,128,129). Under-reporting among obese subjects was seen with different 
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dietary intake methods including food records (122, 123, 129, 130), 24-hour recalls 
(125,126,128), and food frequency questionnaires (124,127). Other factors associated with 
under-reporting included being female (126,127), black/non-Hispanic (126), older (126), and 
oflower SES (125,126). 
Some possible reasons for under-reporting of food intake in obese individuals 
include: 1) a failure to record food eaten in order to misrepresent a lower energy intake or a 
'healthy' diet; 2) a failure to record because it is time consuming and inconvenient or due to 
difficulty qualifying food portions; 3) a failure to record due to memory laps across all or 
selective food items; and 4) accurate food recording but an alteration in habitual intake due to 
alterations in eating habits or dieting (122, 131 ). These reasons may be particularly strong in 
the obese due to negative social attitudes towards overweight and consequent guilt about 
either the quantities or types of food that they are consuming (131 ). 
Dietary Reference Intakes 
The new Dietary Reference Intakes (DRI), established by the Institute of Medicine's 
(IOM) Food and Nutrition Board, differ conceptually from the 1989 Recommended Dietary 
Allowances (RDA) (132). First, where sufficient data were available, reduction of risk for 
chronic disease was considered in addition to the absence of deficiency signs when setting 
recommendations. Second, the upper levels of intake were established where sufficient 
evidence suggest risk of adverse health effects due to excessive intake. Third, components of 
foods that did not met the traditional concept of a nutrient but may have possible health 
benefits were reviewed and reference intakes established where sufficient data were 
available. Finally, the DRis include four components: the Estimated Average Requirement 
(EAR), RDA, Adequate Intake (AI) and Tolerable Upper Intake Level (UL). Each nutrient 
has a set ofDRis if adequate information were available, including either an EAR and an 
RDA, or an AI. Figure 2 shows the EAR, RDA, and UL in relationship to risk of inadequate 
intake or risk of excessive intake. 
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Figure 2. Dietary Reference Intakes including EAR, RDA, and UL (132) 
DRI components 
Estimated Average Requirement 
The Estimated Average Requirement (EAR) is defined as "the median usual intake 
level estimated to meet the requirement of half the healthy individuals in a particular life 
stage and gender group" (132). The EAR is based on specific criteria related to reduction of 
disease risk as well as other health parameters from careful review of literature. The EAR is 
then used to determine the RDA. 
Recommended Dietary Allowances 
The RDA refers to "the average daily nutrient intakes levels sufficient to meet the 
nutrient requirement of nearly all (97 to 98 percent) healthy individuals in a particular life 
stage and gender group" (132). The RDA is a recommended guideline for daily intake of 
individuals and is not appropriate for assessment of group intakes. Under assumption of 
normality, the RDA is calculated from the EAR and the standard deviation of the 
requirements (SDEAR) using the following equation: RDA=EAR + 2 SDEAR· Since the RDA 
is derived from the EAR, if no EAR is available, the RDA cannot be set. 
Adequate Intake 
When an EAR and subsequently an RDA cannot be determined due to insufficient 
data, an AI is determined for the nutrient. The AI is the "recommended average daily 
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nutrient intake level based on observed or experimentally determined approximations or 
estimates of nutrient intake by group (or groups) of apparently healthy people that are 
assumed to be adequate" (132). The AI would not consistently relate to the EAR and its 
RDA even if they could be established. Since the AI is expected to exceed the EAR and 
often the RDA for a nutrient, the AI can be used as the goal for an individual's intake. 
However, there are limitations to the use of the AI in assessment, which will be discussed 
later. 
Tolerable Upper Intake Level 
The UL has been defined as "the highest average daily nutrient intake level likely to 
pose no risk of adverse health effects to almost all individuals in the general population. As 
intake increases above the UL, the potential risk of adverse consequences increases" (132). 
For individuals, this can serve as a recommended upper intake level to avoid adverse effects 
related to excessive intake. For group assessment, the UL can be used to estimate the 
proportion of the population at potential risk related to excessive intake. 
Assessment of group intakes 
For assessing intakes of groups, the EAR is the most appropriate indicator to estimate 
the prevalence of inadequate intakes within a group. The RDA should not be used to assess 
group intake because it overestimates the proportion of individuals with inadequate intake 
(132). There are two methods available to estimate prevalence of inadequacy using the EAR: 
the probability approach and the EAR cut-point method. The probability approach uses the 
distributions of usual intakes and the distribution of requirements to estimate the prevalence 
of inadequate intakes in a group. This approach is based on the concept that at very low 
intakes the risk of inadequacy is high while at very high intakes the risk of inadequacy is 
negligible. Two key assumptions are necessary with the probability approach. First, intakes 
and requirements are independent, and second, the distribution of requirements is known. 
The EAR cut-point method is a simplified version of the probability approach (Figure 
3) (132). Instead of estimating the risk of inadequacy for each individual's intake level, the 
number of individuals in the group with intakes below the EAR is counted. This is based on 
the assumption that the population proportion with intakes above the EAR but below their 
own individual requirements (Figure 4-triangle A) are the same as the proportion with 
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intakes less than the EAR yet above their own individual requirement (Figure 4-triangle B). 
In addition to the assumptions required for the probability approach, the cut-point method 
also assumes that the distribution of the requirements has a symmetrical distribution. The 
mean or median intakes are not appropriate for assessing groups using the EAR because the 
prevalence of inadequacy depends on the shape and the distribution of the usual intake 
distribution, not the mean or median intake. 
When an EAR is not available then the AI can be used but with limitations (132). If 
the mean usual intake is at or above the AI, a low prevalence of inadequate intakes can be 
assumed. However, when the usual intake of a nutrient is below the AI, no conclusions can 
be drawn. Since intake at or about the AI would represent a low prevalence of inadequacy, 
the prevalence of adequacy could be estimated by counting the number of individuals above 
the AI (Carriquiry, personal communication, January 2002). In addition, it is not appropriate 
to estimate an EAR from an AI. The UL can estimate the prevalence of a population at 
potential risk for adverse effects associated with excessive intakes by determining the 
percentage with usual intakes exceeding the UL (132). 
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Assessment of selected micronutrients using the new DRls 
The criteria for adequacy have been determined for each nutrient and may be gender 
and life-stage specific. For some nutrients, new conversion factors have been developed 
based on current bioavailability research. Special considerations with selected 
micronutrients are discussed below. 
Vitamin A 
Dietary sources of vitamin A come from preformed vitamin A and provitamin A 
carotenoids. Retinol activity equivalents (RAE) were developed based on research related to 
the absorption and bioconversion of provitamin A carotenoids to retinol (133). For example, 
dietary p-carotene has a lower bioavailability than a P-carotene supplement since the food 
matrix affects intestinal absorption. In addition, a-carotene and P-cryptoxanthin have 
approximately half the vitamin A activity of P-carotene. The RAE conversion factors for P-
carotene, a-carotene, and P-cryptoxanthin are set at 12, 24, and 24 µg, respectively. Based 
on these new conversion factors, vitamin A intake has been overestimated in the past. 
Vitamin E 
The 2000 DRis (134) have included Vitamin E activity only for a-tocopherol in the 
naturally occurring form (RRR-) and the other three 2R stereoisomeric forms (RSR-, RRS-, 
RSS-). Other forms (p-, 8-, y-) are poorly recognized by the a-tocopherol transfer protein 
and do not contribute to meeting the vitamin E requirement. Dietary vitamin E intake as mg 
of a-tocopherol can be estimated from a-tocopherol equivalents (a-TE) x 0.8. For 
supplements, a conversion factor is used based on the form of vitamin E in the supplement. 
For RRR-a-tocopherol and for all rac-a-tocopherol, the conversion factor of 0.67 and 0.45 
mg/IU are used, respectively. 
Folate 
Fortification of enriched grain products with folic acid began in 1998 in the U.S. with 
fortification levels set at 140 µg of folic acid/100 g of flour (135). Felic acid intakes are 
expected to increase women's average intake by 80-100 µg/day. Dietary folate equivalents 
(DFE) were developed to account for the increased bioavailability of fortification of folic 
acid from foods and supplements. 1 DFE = 1 µg food folate = 0.6 µg of folic acid from 
fortified food or as a supplement consumed with food= 0.5 µg of a supplement taken on an 
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empty stomach. Due to fortification of folic acid in food products as well as the new 
conversion factors based on bioavailability, food composition tables often do not provide up-
to-date accurate information regarding folate content of foods. This poses a challenge in 
using the new DRis to accurately assess prevalence of inadequacy in the population. 
Iron 
The EAR for iron was set using the factorial method using basal iron losses, 
menstrual losses, fetal requirements in pregnancy, increased requirement during growth for 
the expansion of blood volume, and increased tissue and storage iron (133). Information on 
the distribution of iron requirements is needed to estimate the prevalence of inadequacy in a 
population. Because the iron requirement distributions are not symmetrical for all age and 
sex groups, the proportion of individuals with intake below the EAR will not reflect the 
population prevalence of inadequacy. Thus, the full probability approach is recommended. 
An example of this method is shown (Table 6). For this approach, a risk of inadequate intake 
is assigned to each range. The number of individuals with intake in a specific range is 
multiplied by the assigned risk for that range to estimate the number of individuals with 
inadequate intake. The numbers of individuals with inadequate intake for each range are 
totaled. For the example provided, 165 out of 1000 women had inadequate iron intake 
(16.5% prevalence of inadequacy). 
Table 6. Example of EAR probability approach (133) 
Range of usual Risk of Number of women Number of women 
iron intake {mg/d} inadeguate intake with intake in range with inadeguate intake 
<4.42 1.0 1 1 
4.42 -4.88 0.985 1 0.985 
4.89- 5.45 0.925 3 2.775 
5.46- 6.22 0.85 10 8.5 
6.23 -6.87 0.75 15 11.25 
6.88 - 7.46 0.65 20 13.0 
7.47 - 8.07 0.55 23 12.65 
8.08- 8.76 0.45 27 12.15 
8.77 - 9.63 0.35 50 17.5 
9.64-10.82 0.25 150 37.5 
10.83 - 13.05 0.15 200 30.0 
13.06- 15.49 0.075 175 13.125 
15.50- 18.23 0.015 125 4.625 
>18.23 0.0 200 0 
Total 1000 165 
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Limitations using the DRis 
One of the most important keys to assessing nutrient intakes is obtaining accurate 
data on intake. Using intakes collected by FFQs for use with the DRis has several 
limitations. FFQs do not have a direct quantitative assessment of amounts consumed of 
individual foods (113). Foods included in a FFQ are typically limited to those that are 
considered the primary contributors to the major nutrients (114). In addition, many foods are 
often combined into one response category and the content of the different nutrients may 
vary considerably. For example on page 5 of the BFFQ (version 98.2), after listing 13 
specific vegetable categories, a category labeled "any other vegetable, like okra, squash, 
cooked green peppers" is listed (Appendix C). This type of categorization can lead to 
inaccurate representation of the specific micronutrient content. The vitamin A content in a Y2 
cup serving of raw winter squash is considerably higher than of a Y2 cup serving of raw green 
peppers, 235 verses 32 µg retinol equivalents, respectively (136). Thus, the IOM (132) 
suggested that repeated 24-hour recalls or diet records are the most appropriate data 
collection tools for use with the DRis; however, FFQs may be appropriate when accurate 
recall or repeated measurements may be difficult to obtain. 
Since the DRis are recommendations that should be applied to healthy populations, 
using these recommendations should be used cautiously when assessing populations with 
certain disease states or altered nutritional needs. With these populations, the DRis are most 
appropriate to use for comparison purposes between groups within a population. Finally, 
new conversion factors have been established for various micronutrients based on current 
research on bioavailability. Most available food composition tables are not based on these 
new conversion factors; and the increasing number of products with fortification poses a 
challenge to achieve an accurate up-to-date representation of food composition. 
The USDA's Healthy Eating Index 
The United States Department of Agriculture (USDA) developed the Healthy Eating 
Index (HEI) in 1995 as a way to measure overall dietary quality (137-139). The HEI 
measures how well American's eating habits meet the recommendations of the Dietary 
Guidelines (140) and the Food Guide Pyramid (141). The index is a sum of 10 dietary 
components representing various aspects of a healthy diet with each component having equal 
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weight (Table 7). Each component of the HEI has a maximum score of 10 and a minimum 
score of 0 with the maximum overall score being 100. Higher scores represent intakes closer 
to the recommended goals and lower scores indicate less compliance with dietary 
recommendations. A HEI score above 80 implies a good diet, a score between 51 and 80 
indicates that the diet needs improvement, and a score below 51 implies a poor diet. 
Table 7. Components of the Healthy Eating Index and scoring system (138) 
Score Criteria for Maximum Criteria for Minimum 
Range1 Score of 10 Score of 0 
Grain 0 to 10 6 - 11 servings 0 servings 
Vegetable 0 to 10 3 - 5 servings2 0 servings 
Fruit 0 to 10 2 - 4 servings2 0 servings 
Milk 0 to 10 2 - 3 servings2 0 servings 
Meat 0 to 10 2 - 3 servings2 0 servings 
Total fat 0 to 10 ~30% energy ~45% energy 
from fat from fat 
Saturated fat 0 to 10 <10% energy ~15% energy 
from saturated fat from saturated fat 
Cholesterol 0 to 10 ~300 mg ~450 mg 
Sodium 0 to 10 ~2400 mg ~4800 mg 
Food variety 0 to 10 ~8 different ~3 different 
items/day items/day 
1 People with intake between maximum and minimum amounts are assigned scores 
~roportionally 
Number of servings depends on recommended energy allowance-see Table 8 
HEI components 
USDA Food Guide Pyramid components 
The first five components are based on the five major groups in the Food Guide 
Pyramid: grains, vegetables, fruit, milk and meat. The recommended number of servings is 
dependent on a person's energy requirement. Table 8 shows the recommended number of 
servings for the five groups based on age and sex. Scores were computed proportionally 
based on these recommendations. For example, ifthe recommended number of servings for 
a food group was four and the individual consumed two, then they would be assigned a score 
of five points. 
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Table 8. Recommended number of USDA Food Guide Pyramid servings/day (138) 
Age/sex Energy Grains Vegetables Fruit Milk Meat1 
category (kcal) 
Children 2-3 2 1300 6 3 2 2 2 
Children4-6 1800 7 3.3 2.3 2 2.1 
Females51+ 1900 7.4 3.5 2.5 2 2.2 
Children 7-10 2000 7.8 3.7 2.7 2 2.3 
Females 11-24 2200 9 4 3 3 2.4 
Females 25-50 2200 9 4 3 2 2.4 
Males 51+ 2300 9.1 4.2 3.2 2 2.5 
Males 11-14 2500 9.9 4.5 3.5 3 2.6 
Males 19-24 2900 11 5 4 3 2.8 
Males 25-50 2900 11 5 4 2 2.8 
Males 15-18 3000 11 5 4 3 2.8 
One serving equals 2.5 ounces of lean meat 
2 Portion sizes reduced to 2/3 of adult servings except for milk for children age 2-3 y. 
Fat and saturated fat components 
Minimum and maximum scores for total fat and saturated fat are shown in Table 7. The 
percentages of total fat and saturated fat needed for the maximum score were based on the 
Dietary Guidelines for Americans (140). The upper percentages for fat (45%) and saturated 
fat (15%) were based on consultation with nutrition researchers and exploration of the 
consumption distribution of these components. Intake between the percentages assigned to 
the minimum and maximum scores was computed proportionally. 
Cholesterol and sodium components 
Both cholesterol and sodium scores were based on the amount consumed per day in 
milligrams. Table 7 shows the intake amounts assigned to maximum and minimum scores 
with intake between these ranges scored proportionally. The amount assigned to the 
maximum score was based on the recommendations of the Committee on Diet and Health of 
the National Research Council (3). Intakes assigned to the minimum score were determined 
based on consultations with nutrition researchers and exploration of the consumption 
distribution of each component. 
Variety component 
The importance of variety in the diet is stressed by the National Research Council's 
diet and health report, the Dietary Guidelines, and the Food Guide Pyramid (3,140,141); 
however, there is no consensus on how to quantify variety (138). For the HEI, the number of 
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different foods that a person consumed in a day determined variety. For a food item to count 
towards variety, at least one-half of a serving needed to be consumed. Foods that differed 
only by preparation method were grouped together and counted as one food type. For 
example, baked, fried, or boiled potatoes were counted only once. Different types of foods 
were grouped separately. For example, each type of fish such as mackerel, tuna, and trout 
were considered different foods. Food mixtures were divided into their food ingredients and 
assigned to the appropriate food category. The upper and lower limit amounts are shown in 
Table 7 and were based on consultation with nutrition researchers. A modified version of the 
USDA's HEI using 9 of the original 10 components was developed (142). The scores for 
each included component ranged from 0 to 10 with intermediate scores computed 
proportionally; the variety component was excluded. The total score of the modified HEI 
was adjusted to a 100-point scale. 
Studies utilizing HEI as a measure of dietary quality 
Several researchers have used the Healthy Eating Index as a measure of dietary 
quality. Variyam et al. (139) applied the HEI to the 1989-1990 USDA's CSFII. The 
companion Diet and Health Knowledge Survey (DHKS) provided additional information 
about nutrient content knowledge and diet-health awareness information. Higher education 
and incomes were related to higher knowledge of nutrient content of foods, more awareness 
of diet-health problems, and higher HEI scores. People over age 69 had HEI scores that were 
10 points higher than individuals under 30 years. Women had higher HEI scores, nutrient 
knowledge, and diet-health awareness levels than men. Whites had higher HEI scores on 
average than blacks, but Hispanic and non-Hispanic scores were not different. 
Bowman et al. (138) utilized the USDA's 1994-1996 CSFII to examine dietary 
quality. The mean HEI score was 63.6 in 1994, 63.5 in 1995, and 63.5 in 1996. Between 
1994 and 1996, the diets of most people (70%) needed improvement. About 12% had a good 
diet and about 18% had a poor diet. The highest mean HEI component was for cholesterol. 
The cholesterol score was 7 .8 out of 10. Variety received the second highest mean score of 
7.6 out of 10. The fruit and milk components had the lowest mean scores of 3.9 and 5.4, 
respectively. The average scores on the other components were between 6 and 7. Young 
children (2-3 y) had an average HEI of 74, which was the highest score among all children as 
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well as among all age/sex groups. Adolescent females and adolescent males had HEI scores 
of 60.8 and 60.7, respectively. 
HEI scores varied by demographic and socioeconomic characteristics. Females had 
slightly higher scores than males (138). Both males and females 51 years and older had 
higher HEI scores than other adults. Whites had a higher average HEI score than black/non-
Hispanics (64 vs. 59) with black/non-Hispanics scoring lower on dairy and fat components. 
Both income and education level were positively associated with improved dietary quality. 
These findings were similar to those seen by Variyam et al. (139). In addition, regional 
differences were seen with people in the Northeast having higher dietary quality and those in 
the South having lowest dietary quality (138). HEI scores were compared by BMI. For both 
females and males, better dietary quality was associated with lower BMI. 
Hann et al. (143) calculated the HEI on 340 women aged 21-80 y involved in a case 
control study of diet and breast cancer. The HEI scores were compared to dietary intakes as 
well as plasma carotenoids, vitamin C and folate. The average total HEI of this population 
was 77.3. Significantly higher HEI scores were seen among those who were better educated, 
had higher incomes, and were married. Strong correlations between the HEI and dietary 
intake were found for energy, macronutrients, cholesterol, sodium, vitamin C, folate, and 
fiber. When compared to plasma levels, the HEI was positively correlated with vitamin C 
and all carotenoids except lycopene. Folate had a positive correlation though not significant. 
Plasma cholesterol had a negative significant correlation with HEI. 
For epidemiological studies, FFQs are an effective way to collect dietary intake 
information especially for micronutrients were repeated 24-hour recalls are not feasible. 
Caution must be used when interpreting dietary intake information since under-reporting has 
been documented with various groups including females and those who are obese. Dietary 
reference intakes are useful in assessing micronutrient inadequacies and the HEI provides an 
indicator of overall dietary quality. In the next section, current guidelines for assessment of 
weight status among adolescents and adults using BMI will be reviewed. 
Methodology for assessment of overweight and obesity 
Adiposity is defined as excessive body fat expressed either as total fat mass or as a 
percent of the total body mass (144). Overweight indicates excess body weight in children or 
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adolescents (144) while obesity refers to excessive body fat in adults (24). Defining 
overweight and obesity requires a cut-off based on morbidity or mortality risks associated 
with increased adiposity. Since morbidity and mortality associated with overweight in 
children is less prevalent than in adults, the persistence of obesity into adulthood has been 
used as an indicator. The criteria for a suitable measurement method include accuracy in 
measurement of body fat with small measurement error, acceptable to the subject, and 
practical for the clinic or field setting (145). Several methods are available for determining 
or calculating total body fat including densitometry, total body water, total body potassium, 
bioelectric impedance, dual-energy X-ray absorptiometry, and skinfold thicknesses. In this 
section, the use of body mass index (BMI) for assessment of adiposity will be discussed 
including current recommendations for both adults and adolescents and the advantages and 
limitations of using BMI with both populations. 
Body mass index 
BMI is defined as body weight in kilograms divided by height in meters squared 
(kg/m2) (146). Even though accurate methods for assessing body composition are available, 
these techniques are often expensive and are not readily available in most clinics (24). 
Although often impractical in many clinic and field settings, densitometry, or hydrostatic 
weighing, is the generally accepted standard for measuring body composition (or adiposity). 
(147). 
Willett (147) compared numerous epidemiological studies that correlated 
densitometry to BMI (Table 9). Correlations ranged from 0.58 to 0.85. For adolescent 
males, the correlation between densitometry and BMI was 0.61, while the correlation was 
0.77 for adolescent females. While these correlations seem high, many of the studies 
compared had not been adjusted for age. Since BMI increases with age, not adjusting for age 
would lead to an overestimation in this correlation. Thus, Willett estimated that the 
correlation of true percent body fat composition in general populations is approximately 0.5 
or 0.6 for men and slightly higher for women. 
Use of BMI for assessing weight status is attractive in many health care and field 
settings since it is based on commonly measured anthropometric measurements that are 
reliable, non-intrusive, and require little specialized equipment. BMI can be considered an 
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indirect indicator of body fatness and has become widely accepted as a screening tool for 
obesity in the adult population (24). Recently, BMI-for-age growth charts were developed 
by the CDC (19) for use in assessing weight status in children and adolescents from 2- to 20-
years old (Appendix A). 
Table 9. Studies comparing correlation coefficients (Pearson r) between densitometry 
estimates of body fat composition and BMI (147) 
Study Subjects 
Keys et al. 1972 180 students 
W omersley and Durnin 1977 
Roche et al. 1981 
Revicki and Israel 1986 
249 executives 
245 men 
324women 
68 boys (6-12 y) 
49 girls (6-12 y) 
63 boys (13-17 y) 
81 girls (13-17 y) 
141 men (18-49 y) 
135 women (18-49 y) 
474 men 
Age-adjusted 
Classification of overweight and obesity in adults 
r 
0.85 
0.67 
0.71 
0.82 
0.68 
0.55 
0.61 
0.77 
0.77 
0.76 
0.71 
0.58 
The National Heart, Lung, and Blood Institute (NHLBI) developed recommendations 
for the classification of overweight and obesity by BMI (Table 10) (24). This classification 
scheme provides an initial categorization upon which further assessment can be conducted. 
Among adults, there are some limitations with using BMI that could result in inappropriate 
classification. BMI can overestimate body fat in individuals who are very muscular and 
underestimate body fat in individuals with muscle loss such as the elderly. In addition, very 
short individuals (<5 feet) may have high BMis but not be overweight or have excessive 
body fat. Women may have higher percent body fat yet have the same BMI as men. 
However, these differences do not have a huge influence on the validity of the BMI cutoffs 
for classifications of individuals into broad categories of overweight and obesity. 
Underweight 
Normal 
Overweight 
Obesity 
Extreme Obesity 
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<18.5 
18.5-24.9 
25.0-29.9 
30.0-34.9 
35.0-39.9 
~40 
Classification of overweight status in adolescents 
I 
II 
III 
Since growth during adolescence varies by sex, age, and sexual maturation, 
developing a standard for assessing weight status has been a challenge. Growth charts have 
been used to help assess individual growth through childhood and adolescence by comparing 
to a reference population. The 1977 National Center for Health Statistics (NCHS) growth 
charts were limited to assessing weight-for-height in prepubescent children under 145 cm tall 
and younger than 11.5 years for boys and 10 years for girls. (20). 
BMI-for-age growth charts 
The BMI-for-age growth charts were developed with national survey data from 1963-
1994 excluding data from the 1988-1994 NHANES III survey for children older than six 
years (20). This exclusion eliminated the influence of an increased body weight among older 
children in the NHANES III compared to previous national surveys that would have raised 
the 851h and 95th percentiles and underestimated the prevalence of risk for overweight and 
overweight, respectively. There are several advantages for using BMI-for-age growth charts 
as a screening tool for those who should receive further medical assessment (148). There are 
several advantages for using BMI-for-age as a screening tool. Since BMI is a commonly 
used in adults, use with adolescents provides the opportunity to track weight status into 
adulthood. In addition, adolescent BMI has been a predictor of adulthood BMI ( 6). 
In addition to some of the BMI limitations mentioned with adults, individual and 
population differences in timing and rate of the adolescent growth spurt and sexual 
maturation should be considered when interpreting BMI (149). Since there is the potential of 
misclassifying individuals as being overweight despite their normal body fat percentage, 
BMI-for-age should be used as a preliminary screening tool. Additional assessment of the 
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individual's body composition and other health risks should be taken into account for 
determining the appropriate intervention. 
Weight classification in a population including adolescents and young adults 
In the United States, there are currently two separate accepted guidelines based on 
age discussed above. While the development of BMI-for-age growth charts were designed to 
allow for easier transition from adolescent weight assessment into adult standards above age 
20, some problems have been identified. First, the classification terminology is inconsistent. 
Overweight under 20 years refers to ;:::95th percentile associated with the highest level of 
weight classification. Adult classification uses the word "overweight" to define BMI 
between 25 and 30, while "obesity" is used to classify the highest level of weight. With the 
word "overweight" meaning a different level of weight classification for under age 20 and 
over age 20, use of the consistent terminology in a population of adolescents and young 
adults poses a challenge. Second, The cut-offs for the 851h and 95th percentile at 20 y are 
greater than the adult BMI cut offs of 25 and 30. Under age 20 y, the 851h and 951h percentile 
cutoffs are 27.0 and 30.6 kg/m2 for males and 26.5 and 31.8 kg/m2 for females, respectively 
(150). This poses a challenge in having a smooth classification standard across a population 
of both adolescents and young adults. The expert committee on Clinical Guidelines for 
Overweight in Adolescent Preventative Services recommended that overweight be defined as 
BMI ;:::95th percentile for age and sex or when BMI 2:30 kg/m2 (which ever is smaller) with a 
similar recommendation based on the 2:851h and <951h percentile or BMI 2:26 and <30 (which 
ever is smaller) for classifying risk for overweight (151). 
Physical activity, television watching and obesity 
Numerous researchers have studied the relationship between physical activity, 
television watching and obesity particularly among children and adolescents. Television 
viewing has been correlated with between meal snacking, consumption of foods advertised 
on television and the children's attempts to influence their mother's food purchases (152). 
Television viewing may affect both energy intake and expenditure. Energy expenditure may 
be lower for watching television than other recreational activities such as playing tag or 
riding a bicycle. Television viewing tended to increase energy intake by increasing calorie-
dense, between-meal snacking. Others have shown a positive relationship between watching 
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television and fat intake (153). With television being such a pervasive influence, children 
may not be able to decrease energy intake at other meals or increase energy expenditure 
enough to maintain energy balance (152). 
Epidemiological studies 
In 12-17 year old adolescents from NHANES II and III, the prevalence of obesity 
increased by 2% for each additional hour of television viewed (152). Results from the 1990 
Youth Risk Behavior Survey of 11631 American high school students revealed that 3 7% 
reported at least 20 minutes of vigorous physical activity three or more times per week (154). 
Physical activity was higher among males than females (p<0.01) and higher among white 
students than among other race and ethnic groups (p<O.O 1 ). More than 70% of students 
reported spending at least one-hour watching television each school day and more than 35% 
reported watching television 23 hours each school day. Although an inverse relationship 
between television watching and vigorous physical activity was not found among male 
students, more active females were less likely to watch one to three hours of television/day 
compared with less active girls. Black females were the least active (38% sedentary) and 
spent the greatest amount of time watching television with 60.6% reported three or more 
hours per school day compared to other groups (154). A similar inverse relationship was 
found between minutes of physical activity and hours television watching (r = -0.34, p = 
0.04) among Hispanic girls aged 9 to 12 years (155). 
Several researchers examined the relationship between television watching, physical 
activity, and weight status among U.S. males and females aged 8 to 16 years from the 
NHANES III study (153,156,157). Females who were watched more television were more 
likely to be overweight (2951h percentile BMI-for-age) than those who watched less 
television. Among all children in this study, 26% watched 24 hours of television per day 
with the highest rates among black/non-Hispanic children (42%) (157) with more black/non-
Hispanic females being overweight compared with white/non-Hispanic females (156). 
Children, regardless of sex, who watched 24 hours of television each day had higher body fat 
(p<0.001) and BMI (p<0.001) than those who watched >2 hr/day (157). Among females, 
this relationship between television watching and overweight persisted even after controlling 
for age, race/ethnicity, family income, weekly physical activity, and energy intake (153). In 
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addition, females with larger families and males from low-income families were less likely to 
be overweight (156). While 80% of U.S. children reported vigorous activity three or more 
times each week, the prevalence was much lower among black/non-Hispanic and Hispanic 
girls (69% and 73%, respectively) (157). More non-Hispanic white boys reported 
participating in physical activity five or more times per week than any other race/ethnic or 
sex group (153). 
A strong dose response relationship between the prevalence of overweight and hours 
of television viewed among 746 youths aged 10 to 15 years (158). The odds of being 
overweight were 4.6 times greater for youth watching more than five hours of television per 
day compared with those watching for zero to two hours. Similar results were seen when 
adjusting for previous overweight status, maternal weight, SES, ethnicity, and maternal and 
child aptitude test scores. Approximately 60% of overweight incidence could be linked to 
excess television watching. 
Some studies on television watching, physical activity, and health outcomes have 
been conducted. Among adult men, physical activity and television watching were 
significantly associated with several biochemical markers of obesity and cardiovascular 
disease including HDL cholesterol, LDL cholesterol, apolipoprotein Al, leptin, and C-
peptide (159). Health perceptions were negatively associated with the amount of time spent 
watching television for women only (160). 
Intervention studies 
Researchers have studied if overweight could be reduced or prevented through 
decreasing television watching. Faith et al. (161) studied the effects of contingent television 
on physical activity and television viewing in 10 obese children over 12 weeks. In this 
randomized pilot study, television viewing was contingent on pedaling a stationary cycle 
ergometer for experimental participants but not with the control participants. The 
experimental group pedaled 64.4 minutes per week on average compared to 8.3 minutes with 
the controls. Television viewing was significantly less among the experimental group 
compared to the control (1.6 vs. 21.0 hours per week). Total time pedaling was correlated 
with greater decreases in percent body fat (r = -0.68). Thus, contingent television may be 
one method to help treat childhood obesity. 
43 
Robinson et al. (162) used a randomized controlled school-based intervention 
incorporating 18 lessons into the standard curriculum to be taught by 3rd and 4th grade 
teachers. Each lesson included self-monitoring and self-reporting of television, videotape, 
and video game use to motivate children to want to reduce the time they spent in these 
activities. The purpose of this intervention was to decrease media use alone without 
specifically promoting more activity as a replacement. Children who received the 
intervention had significant decreases in BMI, triceps skinfold thicknesses, waist 
circumference, and hip-to-waist ratio compared with the controls (p<0.01). These changes 
were accompanied by statistically significant decreases in reported television viewing and 
meals eaten in front of the television in the intervention group relative to the controls. 
Television watching has been associated with decreased physical activity and increased 
prevalence of overweight adolescents, interventions targeted at decreasing television viewing 
can be an effective way to help prevent or reduce the prevalence of overweight during 
adolescence as well as establish behaviors to continue into adulthood. 
Self-reported health status 
The BFFQ (version 98.2) included a question relating to self-reported health status. 
The question stated "would you say your health is ... " and five response categories (excellent, 
very good, good, fair, poor) were provided (116). Despite the simplicity of this question, 
answers were usually "robust predictors oflater health outcomes" (163). The relationship 
between self-reported health status and mortality was studied among over 700,000 
individuals over 18 years old from different racial/ethnic groups in the National Health 
Interview Survey (164). Participant responses to self-reported health status were grouped 
into a dichotomous variable (excellent, very good, or good responses vs. fair or poor 
responses). Females were more likely to report fair or poor health than males, while blacks 
and Native Americans were more likely to report fair or poor health compared to other 
racial/ethnic groups. For all groups, a greater percentage of those who were older and less 
educated reported poorer health compared to those who were younger or more educated. 
Poor self-reported health has been related to subsequent mortality among various 
racial/ethnic and national groups with those reporting poor health having a higher mortality 
rate than those reporting better health. 
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Idler et al. (163) compared results from several different studies that analyzed the 
relationship between self-reported health status and mortality by sex. In six studies, 
mortality risks were greater for those with poor health compared to excellent health among 
women, although several of the differences were slight. In 10 studies, risks of poor health 
compared to excellent health were higher for men than women with six of these studies 
showing no significant effect of women at all. Perceived health may mean something 
different to men and to women, which could affect their own pre-existing knowledge of their 
health and their subsequent health risk behavior. 
RCMAS anxiety score 
The Revised Children's Manifest Anxiety Score (RCMAS), adapted from an earlier 
anxiety scale by Reynolds and Richmond ( 165), is a questionnaire to assess anxiety 
symptoms in children and adolescents. The questionnaire consists of items relating to 
subjective and psychological indexes, which are summed to form a general anxiety score. 
The RCMAS is divided into the following subscales: physiological anxiety, 
worry/oversensitivity, and social concerns/concentration. 
The RCMAS anxiety index was used to assess anxiety among HIV-infected 
adolescents (n=230) in the REACH study (166). Approximately 20% of this study showed 
moderate to high levels of anxiety and of depression. Stressful life events such as being 
prescribed medications, family financial problems, and parental abuse of alcohol were 
associated with higher levels of anxiety. Contrary to expectations, neither social support nor 
adaptive coping decreased anxiety. At the time of this study, the majority of the participants 
were healthy with low viral loads. HIV -infected adolescents with ineffective social support 
and coping mechanisms were at higher risk for developing depressive symptoms. 
Conceptual framework and study objectives 
The manuscripts in this thesis are from a supplemental cross-sectional study of 
dietary intake and nutritional status of HIV-infected and HIV-uninfected adolescents and 
young adults. Study participants were part of the "Reaching for Excellence in Adolescent 
Care and Health" (REACH) study, which was a prospective, observational cohort study of 
the progression of HIV infection in adolescents in 15 U.S. clinical sites in 13 cites (167,168). 
Based on this review of literature, an a priori model was developed to provide the conceptual 
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framework for the study design and statistical analysis used for following manuscripts 
(Figure 4). This model was based on individual characteristics, environmental factors, and 
health behaviors, which in tum affect dietary intake and weight status. 
The first manuscript (Chapter 3) focused on the association between micronutrient 
intakes and HIV infection among participants in the REACH study. Both macronutrient and 
micronutrient intakes are presented. The prevalence of inadequacy for micronutrient intakes 
was determined using the new DRis. The original hypothesis was: 
When controlling for other determinants, advanced stages of HIV infection would be 
negatively associated with the intake of the following micronutrients: vitamins A, C, 
and E, iron, and zinc. 
These micronutrients were selected because of their relationship to immune function and 
known inadequacy among adolescents. Additional results not presented in this manuscript 
are provided in Appendix D. 
The second manuscript (Chapter 4) focused on the relationship between dietary 
quality, weight, and HIV -infection among the REACH study participants. Dietary quality 
was determined using the modified Healthy Eating Index (HEI) (142). Overweight and 
obesity were determined using the BMI-for-age percentiles for adolescents (20) and the adult 
BMI classification guidelines (24). The original hypotheses for this manuscript were: 
When controlling for other determinants, advanced stages of HIV infection would be 
negatively associated with 1) dietary quality (HEI) and 2) obesity. 
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CHAPTER 3. MACRO- AND MICRONUTRIENT INTAKES DIFFER BETWEEN 
HIV-INFECTED AND HIV-UNINFECTED MALE ADOLESCENTS AND YOUNG 
ADULTS IN THE REACH COHORT STUDY 
A paper to be submitted to the American Journal of Clinical Nutrition 
Abstract 
Background: Adolescents with HIV are at increased nutritional risk because of the nutrient 
demands of growth as well as disease. 
Objective: We examined the association between micronutrient intakes and HIV infection in 
adolescents and young adults. 
Design: A cross-sectional dietary intake study was conducted with 264 HIV-infected and 
127 HIV-uninfected adolescents and young adults from the REACH cohort study (67% 
black/non-Hispanic; 75% female). Biochemical, clinical and sociodemographic data were 
collected through the REACH network. Dietary intake data were collected using the Block 
Food Frequency Questionnaire (98.2). CD4+ T-cells were stratified for HIV-infected 
participants: ~500, 200-499, and <200 cells/µL. Generalized liner regression was used to 
determine predictors of vitamins A, C, and E, iron, and zinc intake. 
Results: Almost half (49%) of HIV-infected participants had CD4+ T-cells ~500 cells/µL 
and were overweight or obese (53% HIV-infected, 55% HIV-uninfected participants). HIV 
was associated with dietary intake differences only among males. Intake of energy and 
protein intake (adjusted by weight), fat, saturated fat, cholesterol, and vitamins C and E were 
higher among HIV-infected males than HIV-uninfected males (p<0.05). However, HIV was 
not associated with differences in nutritional inadequacies. Energy intake was a positive 
predictor for vitamins A, C, and E, iron, and zinc intakes (p<0.001). After controlling for 
other factors, HIV-infected participants with CD4+ ~500 had decreased iron intake (p<0.05). 
HIV amplified the positive effect of anxiety on vitamin A intake. 
Conclusions: Energy intake was the strongest predictor of micronutrient intake. After 
controlling for energy intake, early HIV infection was associated with a slightly lower 
micronutrient intake. 
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Introduction 
Adolescents with human immunodeficiency virus (HN) infection may be at 
increased risk nutritionally due to the energy and nutrient demands necessary to support 
growth and development as well as compensate for infection. Adolescents and young adults 
often have lifestyle and eating habits that may lead to poor quality diets. For example, 
analysis of a nationally representative survey demonstrated inadequate intakes of calcium, 
zinc, iron, and vitamins A, B6, C, and E among U.S. adolescents (1). 
Some insight has been gained concerning the relationship between diet and HN in 
adults. Woods et al. (2) reported that macronutrient intakes increased with decreasing CD4+ 
T-cells. Micronutrient intakes from food and supplements did not differ significantly by 
CD4+ T-cells, although vitamin and mineral supplement use was greatest among those with 
CD4+ T-cells <200 cells/µL. Progression of HIV infection to AIDS and survival rate has 
been associated with specific micronutrient intakes during early HIV infection (3-6). Intakes 
ofthiamin, riboflavin, niacin, vitamins A, B6, C, and E, and iron during early HN infection 
have been positively associated with CD4+ T-cells and survival after a 6-8 y follow-up 
period (3-5). In contrast, vitamin A and ~-carotene intake during early HIV infection had a 
U-shaped relationship with risk of developing AIDS ( 4,5); both deficiencies and excessive 
intakes had a subsequent negative association with immune function and disease progression. 
A similar U-shaped relationship has been suggested for zinc intake as well. 
Little is known about the relationship between dietary intake and HN infection 
among adolescents and young adults. The primary objective of this study was to examine the 
association between micronutrient intakes and HIV infection in adolescents and young 
adults. Micronutrients of interest included vitamins A, C, and E, iron, and zinc because of 
their relationship to immune function and known inadequacy among adolescents. 
Subjects and methods 
Study population 
The "Reaching for Excellence in Adolescent Care and Health" (REACH) study was a 
prospective, observational, cohort study on the progression of HIV infection in adolescents in 
15 U.S. clinical sites (7,8). A standardized protocol was developed through the Adolescent 
Medicine HIV/AIDS Research Network. Between March 1996 and November 1999, 325 
60 
adolescents between 12 and 18 years of age who had acquired HIV infection through sexual 
activity or intravenous drug use were recruited. In addition, 171 HIV-uninfected adolescents 
were recruited from the same clinic sites based on risk-behavior profiles and demographic 
characteristics similar to HIV-infected individuals. This paper describes a supplemental 
cross-sectional study of individual dietary intake and nutritional status was conducted during 
one study visit between January and October 2000. One site did not participate due to 
logistical difficulties. Among the 436 participants active in the REACH network at the time 
of the dietary intake study, 391 agreed to participate (264 HIV-infected and 127 HIV-
uninfected). The study received approval by the human subjects review boards at Iowa State 
University, University of California at Davis, University of Alabama at Birmingham, and at 
each clinic site. All participants provided informed written consent. 
Data collection 
REACH data were collected with face-to-face interviews, interactive computer 
interviews, medical record abstractions, and physical and laboratory examinations. HIV-
infected subjects were seen every three months while HIV-uninfected subjects were seen 
every six months. A detailed description of the REACH study protocol is described 
elsewhere (7,8). 
Dietary intake 
The Block Food Frequency Questionnaire (version 98.2) (BFFQ) (9) was used to 
estimate usual dietary intake patterns over the past year (10,11,12) (Endnote 1). The BFFQ 
was administered in an interview format by trained clinic staff and was completed within 1.4 
days (95% CI: - 0.6 to 2.1 days) of the study visit (Endnote 2). In addition to the two-
dimensional serving size pictures included with each questionnaire, each site was provided 
with pictures, plates, and cups to help participants visualize portion sizes (Endnote 3). A 
registered dietitian reviewed the questionnaires and interviewers were contacted regarding 
missing information, unusual responses, or discrepancies prior to scanning. Results from 
computerized scanning included average intakes of macronutrients, vitamins, minerals, 
antioxidant nutrients, food group servings, and nutrients from supplements. 
Reported micronutrient intakes from food sources alone and food and supplement 
sources combined were compared to the Estimated Average Requirements (EAR) or 
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Adequate Intakes (AI) in the Dietary Reference Intakes (DRI) (13-16). The EAR Cut-Point 
Method was used to determine the prevalence of inadequacy for all nutrients except iron, 
calcium and vitamin D (17). With this method the number of individuals below the EAR for 
age, sex, and pregnancy status were counted to determine the prevalence of inadequacy. 
Since iron requirements are skewed, the probability approach was used to determine the 
prevalence of inadequacy (16). An EAR has not been established for calcium and vitamin D; 
therefore, the AI was used instead (13). The prevalence of adequacy was estimated by 
counting the number of individuals above the AI. 
Retinol activity equivalents (RAE) were calculated from retinol and carotenoid intake 
using current conversion guidelines (16). The Block Dietary Data Systems provided vitamin 
E intake in a-tocopherol equivalents (a-TE) and mg of a-tocopherol were estimated by a-TE 
x 0.8 (15). Since the form of the vitamin E supplement reported on the BFFQ was not 
known, a conservative estimate was made by mg of vitamin E from supplement x 0.45. 
Although the amount of folic acid fortification in foods was not available through the BFFQ, 
folic acid from supplements was converted to dietary folate equivalents (DFE) by µg folic 
acid x 1.7 (14). The folate intake was compared to the EAR; however, this may lead to an 
overestimation of the prevalence of inadequacy due to the higher bioavailability of fortified 
folic acid in foods. 
Anthropometric measurements 
Height and weight were taken during the physical examination at the study visit. 
Participants were gowned and weighed using digital scales accurate to one-tenth decimal 
place. Heights were measured using calibrated stadiometers installed at each study site. 
Body mass index (BMI) was calculated for each participant as weight (kg)/height (m)2. 
Body mass indices >50kg/m2 were verified with clinic staff for accuracy. BMI-for-age 
percentiles for adolescents (18) and adult BMI classification guidelines (19) were used to 
categorize weight status. Adult classification guidelines were used for participants 2::: 20 
years old or when the BMI-for-age percentile cut-off met or exceeded the BMI adult 
classification guidelines. Participants with BMI 2:::25 and <30kg/m2 or BMl-for-age2:::85th and 
<95th percentile were classified as overweight and those with BMI 2::: 30 kg/m2 or BMI-for-
age 2:::95th percentile were obese. The term "obese" is not recommended for use with 
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adolescents due to growth and body composition changes that occur as part of normal 
maturation and development and the negative connotation associated with this term (20). 
However, obesity is used within this study to provide consistency in classification 
terminology across the study group since 87% of the participants were ~18 years of age at the 
time of this cross-sectional study. 
HIV related information 
Laboratory tests were performed at local clinic sites according to REACH protocol 
described elsewhere (7,8). HIV serum antibody tests and CD4+ T-cells were obtained on all 
study participants. Quantitative immunophenotyping of CD4+ T-cells were determined at 
the individual clinical sites in certified laboratories using AIDS Clinical Trials Group 
(ACTG) standardized flow cytometry protocols. HIV status was used as a dichotomous 
variable. Absolute CD4+ T-cell counts for HIV-infected participants were stratified based on 
Centers for Disease Control and Prevention criteria for HIV/AIDS classification: ~500, 200-
499, and <200 cells/µL (21). Other HIV related information including date of first HIV 
seropositive test and use of antiretroviral therapies were obtained through face-to-face 
interview and medical record abstraction. 
Demographic, health, and behavior characteristics 
Demographic characteristics including race/ethnicity, family financial situation, 
living arrangements, and education were obtained through face-to-face interviews and 
interactive computer interviews. Other variables obtained from the BFFQ included 
vitamin/mineral and herbal supplement use, previous dieting history, hours spent watching 
television, cigarette smoking, pregnancy status, and self-reported health status. Hours of 
television watching served as an indirect indicator of physical inactivity (22). Self-reported 
health status ranged from poor to excellent. A Revised Children's Manifest Anxiety Scale 
(RCMAS), including two subscales of physiologic anxiety and worry/oversensitivity, (23) 
has been used previously in analysis of the REACH study (24). The RCMAS scale ranged 
from 0-21 with higher scores indicating greater anxiety. Data for the RCMAS scale was 
collected on all REACH participants through an interactive computer interview. Detailed 
information regarding psychological health among this population has been reported 
elsewhere (24). 
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Statistical analysis 
A model for statistical analysis was developed a priori based on a review of the 
literature and data available through the REACH study. Macronutrient and micronutrient 
intakes were reported as mean± standard error of mean (SE) and percentiles. For continuous 
variables, significant differences by HIV infection were determined by two-sample Student's 
t-tests. Differences by CD4+ T-cell stratification were determined using Analysis of 
Variance (ANOVA) with post-hoc differences using Bonferroni multiple comparisons. For 
categorical variables, differences were determined by Chi-squared test of goodness-of-fit. 
Generalized linear regression analysis was used to describe the associations between 
micronutrient intake of selected nutrients and the explanatory variables. The dependent 
variables, vitamins A, C, and E, iron and zinc, were skewed and, therefore, transformed using 
natural logarithms. Initial regression models were based on the a priori model and included 
the following explanatory variables: health behaviors such as supplement use, substance use, 
and television watching; environmental factors such as family financial situation, living 
arrangements and food security; participant characteristics such as sex, self-reported health 
status, race/ethnicity, education, and psychological health; and dietary intake information 
such as Food Guide Pyramid servings and macronutrient intake. Total energy was centered 
around the mean and the squared term was included in the equation. Variables with a 
significance of p<O. l 0 remained in the model. Statistical analysis was repeated without 
outliers. Since beta-coefficients and p-values did not change, all individuals were included in 
the models presented. SYSTAT (version 10.0) (25) and SPSS (version 10.0.5) (26) statistical 
software were used for all data analysis. Significance was set at p<0.05 unless otherwise 
indicated. 
Results 
Participant characteristics 
The BFFQ was completed with 391 participants (78.8% of the total REACH cohort); 
68% were HIV-infected (Table 1). The majority (96%) of the subjects were black/non-
Hispanic or Hispanic and three-quarters were female. More males were Hispanic compared 
to females (34.0% vs. 15.9%, p<0.001) while more females were black/non-Hispanic 
compared to males (71.1 % vs. 55. 7%, p<0.01 ). HIV-infected participants were older 
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(p<0.001), more likely to live on their own (p<0.001), and were less likely to have completed 
or be enrolled in high school or GED program than HIV-uninfected participants (p<0.01). 
HIV-related characteristics 
Of those with HIV infection (n=264), approximately half ( 48.9%) had CD4+ T-cells 
:2:500, 38% between 200-499, and 12.5% below 200 cells/µL. Almost half (46.2%) of the 
HIV-infected group were not on antiretroviral therapy (ART). Of those on ART, 34.5% were 
on a mono- or combination therapy without a protease inhibitor (PI) while 19.3% were on a 
combination therapy that included a PI. Almost all (96.7%) of the HIV-infected participants 
reported the date of their first HIV seropositive test. Of these, the mean number of years that 
individuals had known they were HIV-infected was 3.6 ± 0.1 years (range: 0.5 - 10.3 years). 
The mean age that individuals first learned they were HIV-infected was 16.4 ± 0.1 years 
(range: 11. 7 - 19 .0 years). 
Health and behavior characteristics 
About one-fifth (21.7%)ofthe participants were overweight and one-third (32.2%) 
were obese (Table 2). More females were overweight or obese compared to males (62.9% 
vs. 26.7% respectively, p<0.001). Over half (55%) of the HIV-uninfected participants and 
53% of the HIV-infected participants were overweight or obese. Among HIV-infected 
participants, the prevalence of overweight or obesity progressively decreased with decreasing 
CD4+ T-cell strata (60.5%, 51.0%, and 30.4% respectively, p<0.01). 
There was no significant difference in self-reported health between HIV-infected and 
HIV-uninfected participants; however, the proportion of fair or poor responses increased with 
decreasing CD4+ T-cell strata among HIV-infected participants (30.2%, 33.3%, 60.6%, 
respectively; p<0.01). Over one-third of participants reported using a vitamin or mineral 
supplement. Multivitamin/mineral supplements (n= 119) and the single nutrient supplements 
of iron (n=39) and vitamin C (n=32) were most frequently consumed while only three 
participants reported taking a calcium supplement. Although there was no significant 
difference in vitamin/mineral supplement or herbal supplement use by HIV status, more 
males (15.5%) than females (1.4%) used herbal supplements (p<0.001). Of those taking 
herbal supplements, over two-thirds consumed two or more different supplements with 
ginseng (n=12), ginkgo (n=lO) and echinacea (n=9) being the most commonly consumed. 
65 
Energy and macronutrient intake 
Reported energy and macronutrient intakes were compared by sex. When energy and 
protein intake were adjusted by body weight, males had higher intakes than females (p<0.01). 
No differences were noted in the percent of energy from macronutrients. For the total 
population, 48.9 ± 0.4% of the energy was from carbohydrates, 13.4 ± 0.2% from protein, 
38. l ± 0.3% from fat, and 11.9 ± 0.1 % from saturated fat. 
Fat (170.1±6.4 vs. 146.7 ± 7.4 g), saturated fat (53.l ± 2.0 vs. 44.9 ± 2.2 g; p<0.01), 
dietary cholesterol (491.1±18.6 vs. 410.0 ± 23.1 mg; p<0.01) and percent of energy from 
saturated fat (12.1 ± 0.1 vs. 11.4 ± 0.2%; p<0.01) were significantly higher for HIV-infected 
participants than HIV-uninfected participants. Saturated fat (55.3 ± 3.2 vs. 44.9 ± 2.2 gm) 
and cholesterol intake (509. l ± 31.6 vs. 410.0 ± 23.1 mg) were significantly higher among 
those with CD4+ T-cells between 200-499 cells/µL compared to HIV-uninfected 
participants. 
To understand the differences in intakes, results were compared by HIV infection 
separately for males and females (Table 3). Total fat, saturated fat, and dietary cholesterol 
intake were significantly higher only among HIV-infected compared to HIV-uninfected 
males. When adjusted by body weight, energy and protein intake was significantly higher 
among HIV-infected compared to HIV-uninfected males. 
Food Guide Pyramid servings were compared by sex and HIV status. For the total 
population, mean servings are reported for each food group: 8.2 ± 0.3 for grains, 1.5 ± 0.1 
for fruits, 3.1 ± 0.1 for vegetables, 1.8 ± 0.1 for dairy, and 4.1 ± 0.1 for meat. Grains, 
vegetables, and dairy servings were higher among males than females with the smallest 
difference seen in dairy (0.3 servings) and the greatest difference seen in grain intake (1.5 
servings). No significant differences were seen by HIV infection for males or females when 
compared separately. 
When adjusted by body weight, energy and protein intakes were lower among obese 
than non-obese participants (35.8 ± 1.9 vs. 61.3 ± 2.0 kcal/kg and 1.2 ± 0.1 vs. 2.0 ± 0.1 g/kg, 
respectively; p<0.001). A significant inverse relationship was seen between BMI and energy 
intake (Pearson's r2= -0.15). 
Micronutrient intake 
66 
Vitamin, mineral, and carotenoid intakes from food are reported by sex and HIV 
status (Tables 4, 5, and 6). Males had significantly higher intake of almost all of the 
micronutrients than females. Only zinc intake was significantly higher among HIV-infected 
compared to HIV-uninfected participants. Vitamin C and E intakes were significantly higher 
among HIV-infected males compared to HIV-uninfected males; no differences were seen 
among females. No significant differences were seen in micronutrient intakes when 
compared by CD4+ T-cell strata. 
Intake from both food and supplements were compared to the EAR or AI (Table 7). 
Almost 40% of all participants had vitamin E intakes below the EAR. Approximately 14% 
of all participants had inadequate folate intake; however, this is an overestimation since folic 
acid fortification of food was not available from the BFFQ. Inadequate intakes of vitamin A, 
magnesium, and zinc were reported among 18.7%, 28.4%, and 10.5% of participants, 
respectively. Prevalence of inadequacy of other micronutrients that were compared to the 
EAR was less than 10%. When prevalence of inadequacy was compared by sex, 
significantly more females had inadequate intake of iron compared to males. There were no 
significant differences in prevalence of inadequacy for micronutrients when compared by 
CD4+ T-cell strata or by HIV status. Almost half of all participants had calcium intakes 
above the AI and over 60% had vitamin D intakes above the AI. Significantly more HIV-
infected individuals had calcium intake above the AI compared to HIV-uninfected 
individuals. 
Individual generalized linear regression models were used to determine predictors of 
intakes of vitamins A, C, and E, iron, and zinc (Table 8). Increased energy intake was 
associated with higher micronutrient intake for all models. Positive associations between 
Food Guide Pyramid serving intake and micronutrient intakes varied: dairy and vegetable 
intake was associated with vitamin A intake, fruit with vitamin C intake, meat and vegetable 
with iron intake, and dairy and meat servings with zinc intake. The percent of energy from 
fat was positively associated with vitamin E intake. Vitamin and mineral supplement use 
was associated with higher intakes from food for vitamins A and E and zinc. While 
significant difference in micronutrient intakes were seen by sex, after controlling for energy 
intake, being female was associated with significantly lower zinc intake. Being black, non-
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Hispanic was associated with higher intakes for vitamin C. Living independently from 
family was associated with higher intakes of vitamins C and E. 
Being HIV-infected with CD4+ T-cells above 500 cells/µL was associated with lower 
intake of iron. The effect of anxiety on vitamin A intake was modified by HIV infection. 
When controlling for all other factors among HIV -uninfected participants, there was a 32 
RAE increase in Vitamin A intake associated with high anxiety (751h percentile RCMAS 
score) compared to those with low anxiety (251h percentile RCMAS score). This difference 
was approximately 6-fold higher (197 RAE) among HIV-infected participants. 
Discussion 
This is the first study to examine the associations of HIV infection and dietary intakes 
among adolescents and young adults. This study showed two indicators of poor quality diet: 
1) excessive intake of fat, saturated fat, and cholesterol and 2) inadequate intakes of vitamins 
A and E that are important for maintenance of a healthy immune response and have been 
associated with a slowed progression of HIV disease (3-6). Between 13-54% of the total 
REACH population had inadequate intakes of vitamins A and E, folic acid, zinc and 
magnesium when compared to the EAR. Woods et al. (2) reported similar results with high 
median intakes of many micronutrients but a significant proportion of subjects having intakes 
less than 7 5% of the DRI with a higher prevalence of inadequacy seen among women 
compared to men. This difference was similar to results seen in this study (Endnote 4). 
The median intakes of several micronutrients were above intakes reported by same 
age and sex subjects in the Third National Health and Nutrition Examination Survey 
(13,14,15,16). This would indicate that the prevalence of inadequacy is lower among this 
study compared to the general population. This discrepancy may be related to 1) 
measurement error associated with the food frequency questionnaire, 2) higher intakes 
related to HIV infection, or 3) a combination of factors. Other HIV dietary intake studies 
have reported intakes of several micronutrients above the RDA (3-5,27-29). In these studies, 
zinc was the most common nutrient that fell short of the recommendations. Several studies 
have reported higher intakes among HIV-infected subjects compared to HIV-uninfected 
subjects (27,28,30-32). A similar trend was seen by Sharkey et al. (33); however, did not 
reach significance. 
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Over one-third of the subjects in this study reported using a vitamin/mineral 
supplement. Supplement usage reported among RN-infected individuals is common and has 
increased in recent years (3,34,35). Abrams et al. (3) found that multivitamin use was 
associated with a 31 % decrease in risk of progression to AIDS after a 6-year follow-up 
period. As noted in the present study, they also reported that daily multivitamin users 
consumed significantly more nutrients from food alone (3). These results suggest that 
individuals who take supplements make more nutrient-dense food choices compared to those 
who do not take supplements. Studies on the general population of US adolescents also have 
shown improved micronutrient intakes from foods among vitamin/mineral supplement users 
compared to non-supplement users (1,36) (Endnote 5). 
HIV status was not a strong predictor of micronutrient intake in the regression 
analysis. Increased anxiety had a positive effect on vitamin A intake and had the greatest 
effect increase in vitamin A intake among HIV-infected individuals with CD4+ T-cells 
between 200-499 cells/µL. Among most macro- and micronutrients, there was a trend 
towards increased intake among HIV-infected individuals until CD4+ T-cells reached 200 
cells/µL, then intakes declined with CD4+ T-cells below 200. In this study, this trend did not 
reach significance possibly due to the small number of participants with CD4+ T-cells <200 
cells/µL. Hogg et al. (32) found that macronutrient intake did not differ by CD4+ T-cells 
(>200 vs. s200 cells/µL) while Woods et al. (2) found micronutrients were generally higher 
with decreasing CD4+ T-cells. 
There may be several explanations for these observed relationships. There may be a 
conscious effort to eat more nutrient-dense foods among HIV-infected individuals. Dietary 
quality may increase as disease progresses until intake is affected by complications relating 
to disease progression that affect eating or appetite such as drug therapy side effects or 
opportunistic infections. In addition, there may be overeating behaviors associated with 
anxiety (37), or other factors driving intakes that were not identified in this study. 
Serum concentrations of micronutrients were not presented here. Other researchers, 
however, have compared dietary intake with serum concentrations and have found lower 
serum concentrations in relation to dietary intake among HIV-infected individuals compared 
to HIV-uninfected participants (27,28). These discrepancies between dietary intake and 
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serum concentrations may be related to a variety of mechanisms including altered intestinal 
absorption, increased needs related to HIV infection and altered immune function, altered 
utilization related to metabolic changes, or a combination of factors (38,39). 
The observed high fat, saturated fat, and cholesterol intake and high prevalence of 
obesity among HIV-infected participants may have an increased effect on metabolic and 
body composition abnormalities, such as lipodystrophy, hyperlipidemia, and insulin 
resistance (40,41). For example, polyunsaturated fats, fiber and alcohol have been strongly 
associated with insulin resistance and hyperlipidemia among HIV-infected men and women 
with fat redistribution (41). While these abnormalities were thought to be an effect of ART 
(42,43), studies have shown metabolic abnormalities among HIV-infected individuals in the 
absence of ART (41,44). The implications for the obese patient need further investigation. 
In our study, there was an inverse relationship between energy intake and BMI 
suggesting under-reporting among those with increased weight. Other studies have found 
under-reporting of energy intake more common among overweight or obese subjects (45-47) 
and adolescents ( 48-50). Other factors relevant to our study population that have been 
associated with under-reporting included being female (46,47), being non-Hispanic black 
(46), and oflower socioeconomic status (45,46) (Endnote 6). Since the 95th percentile was 
high for several micronutrients, over-reporting is quite possible among some participants in 
this population. Other studies have shown over-reporting among those wanting to increase 
weight ( 4 7). 
Using the new DRis with this study posed some limitations. The IOM (17) suggested 
that repeated 24-hour recalls or diet records are the most appropriate data collection tools for 
use with the DRis. In addition, DRis are recommendations that should be applied to healthy 
population. In this analysis, the DRis have been used for comparison purposes only between 
groups. Finally, new conversion factors have been established for folate, vitamin E, and 
vitamin A based on current research on bioavailability. Most of the available food 
composition tables are not based on these new conversion factors. The increasing 
availability of fortification in food products poses a challenge to achieve an accurate up-to-
date representation of food composition. 
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Conclusions 
This study on dietary intake among minority adolescents and young adults increases 
our understanding of relationship between dietary intake and HIV infection. Micronutrient 
intakes were highest among HIV-infected males and intake decreased among those with 
more advanced HIV infection. Energy intake was the strongest predictor of micronutrient 
intake; after controlling for energy intake, early stages of HIV infection was associated 
slightly lower micronutrient intake. Vitamin/mineral supplement intake was common among 
this population and was associated with more nutrient-dense food choices. A significant 
portion of this population was obese creating additional potential health complications in 
addition to the demands of HIV infection. Obese HIV-infected individuals may be at even 
greater risk of developing the metabolic abnormalities associated with HIV infection. 
Nutritionists and healthcare professionals should focus on setting individualized behavioral 
goals emphasizing improved nutrient density, decreased fat and saturated fat intake and 
increased physical activity to improve all adolescents' quality of life. Additional research is 
needed to determine micronutrient needs for HIV -infected youth and determine the effect of 
excessive micronutrient intake on HIV disease progression. 
Endnotes 
1. A preliminary study (n=35) to determine the validity of the HHHQ was conducted at two 
REACH sites. Intake results from the HHHQ were compared to data from one 24-hour 
dietary recalls. The correlation coefficients were significant for all micronutrients (p<0.05) 
except vitamins C and A (known to have large daily variation) which tended to be significant 
(p<0.10) (Marquis, personal communication). The BFFQ was the most feasible choice for 
estimating intake in this study compared to other dietary intake methods such as food records 
or repeated 24-hour recalls due to time constraints during study visits. The number of days 
needed to accurately estimate micronutrient intakes with repeated food records or 24-hour 
recalls were also unrealistic with this population. In addition, obtaining accurate and 
thorough data necessary for food records would have been a challenge with this population. 
2. All interviewers received training either in person or via telephone on administering the 
questionnaires by a registered dietitian. Interviewers were given the opportunity to practice 
administration of the questionnaire at a training session held October 1999 as well as 
completing practice questionnaires prior to the start of the nutrition study. A question-by-
question guide was provided to each interviewer including information on seasonal intake of 
foods, common errors encountered, and appropriate questioning format to use during the 
interview. Laminated quick reference cards were created which included information about 
seasonality adjustments and response categories. 
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3. A comment sheet was provided with each questionnaire for the interviewer to make note 
of any food that was consumed but was unsure of how to code on the BFFQ or any 
observations regarding the interview process. Foods written on the comment sheet were 
added to the BFFQ if an appropriate food grouping was available. When possible, 
interviewers contacted participants to clarify missing information. Participant dietary intake 
information and dietary recommendations were returned to study sites. 
4. The appropriate and consistent use of reference standards is essential for researchers 
studying dietary intake. Since different reference values (i.e. 1989 RDA vs. new DRI values) 
and methods (i.e. percent below 75% ofDRI and EAR cut-point method) were used, direct 
comparisons between these dietary intake studies are not possible. 
5. While several micronutrients were significantly higher for males using bivariant analysis, 
one would expect that these differences would be accounted for by energy and food serving 
intakes. In regression analysis, being male remained a significant predictor for zinc intake 
only after controlling for energy intake, dairy and meat servings. This would suggest that the 
dietary quality of the specific foods consumed were unique among males. Participants living 
on their own may have different eating habits related to factors such as their parental 
independence, age, and their cooking abilities. These individuals may select more 
convenience items that tend to be higher in fat and, thus, higher in vitamin E. 
6. Since a majority of the subjects in our study are non-Hispanic black females with 
increased BMI, underreporting of dietary intake is quite possible; however, actual energy 
expenditure was not available in this study. In addition, accurate estimation of energy and 
protein needs was not possible due to limited information regarding activity and other health 
conditions that affect energy needs. High energy intakes reported in this study suggest that 
over-reporting occurred among some individuals. Controlling for energy intake in our 
regression models for micronutrients partially compensated for reporting errors in this study. 
Other studies have found earlier versions of the BFFQ to be reasonably valid for estimating a 
group's mean actual intake for a variety of nutrients ( 10, 11) and has been validated with 
black non-Hispanic populations (12). 
72 
Table 1. Participant sociodemographic characteristics by HIV status for the REACH cohort study 
Total HIV+ HIV-
n 391 264 127 
Age, y 19.8 ± 0.1 a 20.0 ± 0.1 *** 19.4 ± 0.1 *** 
Range 13.8 - 23.2 13.8 - 23.2 14.8 - 22.9 
Male 97 (24.8) b 68 (25.8) 29 (22.8) 
Female 294 (75.2) 196 (74.2) 98 (77.2) 
Race/ethnicity 
Hispanic 80 (20.5) 51(19.3) 29 (22.8) 
Black/non-Hispanic 263 (67.3) 186 (70.5) 77 (60.6) 
White/non-Hispanic 16 (4.1) 8 (3.0) 8 (6.3) 
Other 32 (8.2) 19 (7.2) 13 (10.2) 
Living arrangements*** 
Living in own apartment/house 110 (28.1) 88 (33.3) 22(17.3) 
Parents/family member 220 (56.3) 133 (50.4) 87 (68.5) 
Someone else's house/apt 28 (7.1) 19 (7.2) 9 (7.1) 
Other c 33 (8.4) 24 (9.1) 9 (7.1) 
Education** 
No HS diploma or GED 141 (36.1) 113 (42.8) 28 (22.0) 
Has HS diploma/GED or 250 (63.9) 151 (57.2) 99 (78.0) 
enrolled in school 
Highest grade completed by mother d 
No HS diploma or GED 109 (28.0) 83 (31.5) 26 (20.6) 
HS diploma or GED 108 (27.7) 63 (24.0) 44 (35.4) 
Trade or tech school 22 (5.6) 18(6.8) 4 (3.2) 
Some college 77 (19.7) 50 (19.0) 27(21.3) 
Don't know/unsure 74 (19.0) 49(18.6) 25 (19.7) 
Household financial situation** 
Struggling to survive 23 (5.9) 21 (8.0) 2 (1.6) 
Barely paying bills 21 (5.4) 13 (4.9) 8 (6.3) 
Have necessities sometimes 53 (13.6) 38 (14.4) 15 (11.8) 
Have necessities but little more 170 (43.4) 122 (46.2) 48 (37.8) 
Always have the necessities 124 (31.7) 70 (26.5) 54 (42.5) 
Food security# 
Food not available 15 (3.8) 14 (5.2) 1 (0.8) 
Food available most days 376 (96.2) 250 (94.7) 126 (99.2) 
•Mean± standard error; b n (% ); c Living in halfway house, foster or group home, or on the street; 
dtotal (n=390), HIV+ (n=263) 
***p <0.001; ** p <0.01; * p <0.05; # p <0.10 (Chi2 for categorical variables, t-tests for continuous variables) 
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Table 2. Health characteristics by sex and HIV status for the REACH cohort study 
Females Males 
HIV+ HIV- HIV+ HIV-
n 196 98 68 29 
Anthropometrics 
Height (cm) • # 163.9 ± 0.6 * 162.3 ± 0.7 173.3 ± 1.0 * 173.6± 1.7 
Weight (kg)•*** 79.9 ± 1.8 * 77.4 ± 2.4 70.8 ± 2.3 * 76.9 ± 3.6 
Weight classification b *** 
Overweight c 54 (27.6) 19 (19.4) 7 (10.3) 5(17.2) 
Obese d 71 (36.2) 41 (41.8) 8 (11.8) 6 (20.7) 
CD4+ T-cells (cells/µL) 
2:500 99 (50.5) 30 (44.1) 
200-499 76 (38.8) 26 (38.2) 
<200 21 (10.7) 12 (17.6) 
Pregnant (% of women) 16 (8.2) 11(11.2) 
Self-reported health status 
Excellent, very good, or good 125 (63.8) 52 (53.1) 46 (67.6) 20 (69.0) 
Fair or poor 71 (36.2) 46 (46.9) 22 (32.4) 9 (37.9) 
Vitamin/mineral supplement use 77 (39.3) 33 (44.8) 20 (29.4) 13 (36.6) 
Herbal Supplement Use*** 3 (1.5) 1 ( 1.0) 12 (17.6) 3 (10.3) 
Currently smoke 80(40.8) 31 (45.6) 31 (31.6) 13 (44.8) 
Television watching: >3 hr/d 98 (44.9) 44 (44.9) 36 (48.3) 14 (48.3) 
History of weight loss attempts * 71 (36.2) 45 (45.9) 16 (23.5) 10 (34.5) 
RCMAS anxiety score 7.2 ± 0.4 7.9 ± 0.6d 6.4 ± 0.8 7.5 ± 1.1 
Median 6.0 7.0 4.0 8.0 
•Mean± standard error; b n (%); c BMI 2:25 & <30 or BMI-for-age 2:85th and <95th percentile; c BMI 2:30 or 
BMI-for-age 2:95th percentile; d n=97 
*** p <0.001; **p <0.01; * p <0.05; #p <0.10 (ANOVA for continuous variables, Chi2 for categorical) 
Similar superscripts indicate significant difference of pairwise comparison 
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Table 3. Macronutrient intake from food by sex and HIV status for the REACH cohort study 
Mean± SE Median (51\ 951h percentile) 
Energy, kcal 
Females: HIV+ a 3691 ± 137 3454.0 (1152.5, 7248.1) 
HIV- b 3445 ± 191 3016.6 (1329.8, 7392.9) 
Males: HIV+c 4507 ± 304 # 4013.8 (1711.5, 9975.4) 
HIV-<l 3732 ± 333 # 3256.6 (1344.8, 8364.2) 
Carbohydrate, g 
Females: HIV+ 446.8 ± 16.4 416.3 (137.5, 864.6) 
HIV- 427.0 ± 24.2 368.3 (171.4, 834.0) 
Males: HIV+ 528.7 ± 35.8 451.5 (196.9, 1108.8) 
HIV- 466.0 ± 46.3 384.9 (182.8, 1094.9) 
Protein, g 
Females: HIV+ 121.9 ± 5.0 108.0 (39.7, 285.8) 
HIV- 112.3 ± 6.4 94.1(41.1,256.6) 
Males: HIV+ 148.9 ± 10.4 # 123.2 (57.3, 336.2) 
HIV- 122.1±11.7# 106.8 (52.7, 297.9) 
Fat, g 
Females: HIV+ 159.8 ± 6.7 138.5 (44.5, 341.3) 
HIV- 145.1 ± 8.7 126.4 (54.7, 309.3) 
Males: HIV+ 200.1 ± 14.8 * 177.2 (64.5, 451.2) 
HIV- 152.0 ± 13.2 * 131.6 (45.0, 335.7) 
Saturated fat, g 
Females: HIV+ 50.2 ± 2.1 # 44.6 (13.6, 101.6) 
HIV- 44.2 ± 2.6 # 38.0 (14.8, 106.0) 
Males: HIV+ 61.6 ± 4.4 * 56.8 (18.8, 131.4) 
HIV- 47.0 ± 4.0 * 40.7 (11.5, 99.2) 
Dietary fiber, g 
Females: HIV+ 22.1±0.9 19.2 (7.9, 48.8) 
HIV- 22.1±1.6 18.3 (6.6, 44.8) 
Males: HIV+ 26.8 ± 2.2 21. l (8.3, 62.8) 
HIV- 23.9 ± 2.3 22.4 (8.3, 51.8) 
Dietary cholesterol, mg 
Females: HIV+ 464.6 ± 21.2 # 384.6 (136.5, 1141.1) 
HIV- 404.3 ± 26.8 # 321.8 (118.6, 980.1) 
Males: HIV+ 567.6 ± 37.1 * 503.4 (169.7, 1220.5) 
HIV- 429.4 ± 45.4 * 365.6 (107.6, 1091.1) 
Energy, kcal/kg 
Females: HIV+ 50.8 ± 2.2 47.4 (12.7, 107.3) 
HIV- 49.0 ± 3.2 41.8 (15.4, 108.1) 
Males: HIV+ 66.4 ± 4.5 * 61.7 (22.9, 162.9) 
HIV- 51.1±5.2 * 41.2 (16.5, 127.7) 
Protein, gm/kg 
Females: HIV+ 1.7 ± 0.1 1.4 (0.4, 4.0) 
HIV- 1.6 ± 0.1 1.3 (0.4, 3.5) 
Males: HIV+ 2.2 ± 0.2 * 1.9 (0.7, 4.9) 
HIV- 1.7 ± 0.2 * 1.4 (0.6, 4.6) 
"n=196; 6n=98; c n=68; a n=29; Differences by HIV status for males and females tested separately using two-
sample t-tests; * p <0.05; # p <0.10 
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Table 4. Vitamin intake from food by sex and HIV status for the REACH cohort study 
Mean± SE Median (51h, 95th percentile) 
Vitamin A, RAE a 
Females: HIV+ b 1025.0 ± 55.3 821.4 (256.5, 2477.8) 
HIV- c 944.0 ± 72.2 762.6 (231.8, 2244.7) 
Males: HIV+ a 1241.0 ± 101.2 978.6 (359.4, 3136.4) 
HIV- e 994.4 ± 139.3 784.8 (349.7, 3262.2) 
Thiamin (B1), mg 
Females: HIV+ 2.5 ± 0.1 2.3 (0.7, 5.9) 
HIV- 2.4 ± 0.2 2.0 (0.9, 5.1) 
Males: HIV+ 3.2 ± 0.2 2.7 (1.1, 6.7) 
HIV- 2.7 ±0.3 2.3 (1.1, 6.8) 
Riboflavin (B2), mg 
Females: HIV+ 2.7±0.1 2.5 (0.7, 6.2) 
HIV- 2.6 ± 0.2 2.1 (0.9, 5.4) 
Males: HIV+ 3.4 ± 0.2 # 2.8 (1.2, 7.6) 
HIV- 2.8 ± 0.3 # 2.4 (1.3, 6.9) 
Niacin, mg 
Females: HIV+ 36.1±1.5 30.7 (11.1, 85.7) 
HIV- 34.4 ± 2.2 28.2 (11.0, 73.3) 
Males: HIV+ 45.5 ± 3.3 37.5 (15.9, 99.3) 
HIV- 38.0 ± 4.1 34.8 (14.1, 106.2) 
Vitamin B6, mg 
Females: HIV+ 2.9 ± 0.1 2.6 (0.9, 6.2) 
HIV- 2.7 ± 0.2 2.3 (0.9, 5.6) 
Males: HIV+ 3.5 ± 0.2 3.0 (1.1, 7.6) 
HIV- 3.2 ± 0.4 2.9 (1.1, 8.8) 
Vitamin C, mg 
Females: HIV+ 246.5 ± 11.4 204.4 (54.8, 562.9) 
HIV- 255.0 ± 16.8 255.0 (52.8, 585.2) 
Males: HIV+ 285.1±22.1* 244.2 (52.3, 646.6) 
HIV- 275.2 ± 31.5 * 282.6 (67.2, 656.6) 
Folic Acid, µg 
Females: HIV+ 588.0 ± 24.5 503.5 (184.5, 1300.3) 
HIV- 586.0 ± 40.1 586.0 (185.5, 1166.5) 
Males: HIV+ 719.5 ± 48.6 628.6 (251.3, 1525.4) 
HIV- 620.7 ± 55.4 530.9 (256.3, 1421.1) 
Vitamin D, IU 
Females: HIV+ 257.6 ± 18.5 174.0 (33.3, 818.1) 
HIV- 236.7 ± 22.7 162.8 (35.1, 667.8) 
Males: HIV+ 323.4 ± 32.2 228.4 (76.3, 973.7) 
HIV- 228.7 ± 34.2 165.0 (55.0, 691.2) 
Vitamin E, mg 
Females: HIV+ 12.8 ± 0.5 11.2 (3.6, 27.6) 
HIV- 12.4 ± 0.8 10.0 (4.0, 27.1) 
Males: HIV+ 16.0±1.1* 14.0(5.2,37.1) 
HIV- 15.1±1.0 * 10.4 (5.2, 24.1) 
• Retinol activity equivalents; bn=196; cn=98; ct n=68; e n=29; r As a-tocopherol 
Differences by HIV status for males and females tested separately using two-sample t-tests with separate 
variance; *p<0.05; #p<0.10 
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Table 5. Mineral intake from food by sex and HIV status for the REACH cohort study 
Mean± SE Median (51h, 951h percentile) 
Calcium, mg 
Females: HIV+ a 1093.2 ± 43.6 1026.l (309 .1, 2362.6) 
HIV- b 1056.4 ± 67.6 825.l (329.6, 2727.5) 
Males: HIV+c 1353.1 ± 90.5 # 1125.6 (390.1, 2775.2) 
HIV-d 1107.3 ± 91.0 # 994.5 (400.0, 2312.0) 
Phosphorus, mg 
Females: HIV+ 1887.9 ± 69.6 1745.2 (551.3, 3844.9) 
HIV- 1763.6 ± 100.9 1468.l (653.6, 3892.1) 
Males: HIV+ 2308.9 ± 155.5 # 1883.l (911.9, 4883.3) 
HIV- 1901.7 ± 166.8 # 1650.6 (970.5, 4209.2) 
Iron, mg 
Females: HIV+ 23.9 ± 1.1 20.0 (6.9, 58.3) 
HIV- 23.4 ± 1.8 18.8 (8.0, 52.9) 
Males: HIV+ 31.1±2.5 25.2 (10.3, 86.1) 
HIV- 26.0 ± 3.1 23.0 (9.8, 75.1) 
Zinc, mg 
Females: HIV+ 16.8 ± 0.8 13.7 (4.5, 40.5) 
HIV- 14.9 ± 0.9 12.5 (5.3, 34.2) 
Males: HIV+ 21.9 ± 1.9 # 17:0 (7.7, 61.0) 
HIV- 17.6 ± 1.3 # 16.1(8.1,30.1) 
Magnesium, mg 
Females: HIV+ 397.4± 15.1 351.5 ( 121.3, 866.3) 
HIV- 385.5 ± 22.7 323.7 (135.1, 743.2) 
Males: HIV+ 488.0 ± 34.7 430.3 (165.6, 1106.7) 
HIV- 427.7 ± 34.0 417.1(188.8,857.9) 
•n=196; 6n=98; c n=68; a n=29; Differences by HIV status for males and females tested separately using two-
sample t-tests with separate variance; # p<O. l 0 
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Table 6. Retinol and carotenoid intake from food by sex and HIV status for the REACH cohort study 
Mean± SE Median (51h, 951h percentiles) 
Retinol, ug 
Females: HIV+ a 731.5±44.2 565.6 (137.0, 1830.6) 
HIV-b 629.2 ± 48.7 521.7 (172.1, 1825.0) 
Males: HIV+ 0 849.7 ± 65.9 653.7 (244.3, 1995.3) 
HIV-d 683.7 ± 86.6 565.6 (230.1, 2053.5) 
Alpha-carotene, µg 
Females: HIV+ 369.9 ± 30.9 209.0 (36.6, 1279.7) 
HIV- 468.1±99.6 205.2 (45.6, 2015.6) 
Males: HIV+ 638.9 ± 96.2 384.6 (50.8, 2800.1) 
HIV- 423.4 ± 108.l 275.5 (20.3, 2104.6) 
Beta-carotene, µg 
Females: HIV+ 3214.8 ± 229.3 2263.3 (569.2, 10137.7) 
HIV- 3398.l ± 354.1 2142.l (520.7, 10837.4) 
Males: HIV+ 4222.6 ± 626.6 2589.0 (641.5, 14800.4) 
HIV- 3352.4 ± 697.9 2256.6 (372.1, 14298.2) 
Cryptoxanthin, µg 
Females: HIV+ 242.5 ± 16.5 161.0 (16.6, 743.7) 
HIV- 289.8 ± 28.0 212.0 (16.2, 830.1) 
Males: HIV+ 307.1±36.4 208.4 (22.9, 992.5) 
HIV- 343.2 ± 52.8 256.0 (62.9, 1080.5) 
Lutein, µg 
Females: HIV+ 2063.0 ± 187.9 1232.9 (239.9, 6147.7) 
HIV- 1818.9 ± 197.0 1205.9 (192.2, 6423.5) 
Males: HIV+ 1919.4 ± 264.7 1248.0 (179.8, 5669.5) 
HIV- 1939.6 ± 553.4 1133.6 (352.1,10255.3) 
Lycopene, µg 
Females: HIV+ 8877.0 ± 698.9 5311.4 (557.6, 30162.2) 
HIV- 8284.5 ± 896.3 5852.9 (1127.0, 25746.3) 
Males: HIV+ 11569.7 ± 1346.3 7323.3 (1450.9, 40876.6) 
HIV- 10856.0 ± 1689.8 7333.8 (597.1, 31531.6) 
•n=196; 6n=98; c n=68; a n=29; No significant differences were found by HIV status for males and females 
tested separately using two-sample t-tests with separate variance 
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Table 7. Prevalence of inadequate micronutrient intake from food and supplements for the REACH 
cohort study 
CD4+ T-cells (cells/µL) 
Total Female Male HIV+ HIV- ~500 200-499 <200 
n 391 294 97 264 127 129 102 33 
Prevalence of inadequacy--Percent below Estimated Average Requirement (EAR) 
Vitamins 
Vitamin A 18.7 18.7 18.6 17.8 20.5 16.3 16.7 27.3 
Thia min 4.0 5.1 # 1.0 # 4.1 3.9 3.9 2.9 9.1 
Riboflavin 3.8 4.8 # 1.0 # 4.2 3.2 4.7 2.9 6.1 
Niacin 3.3 4.1 1.0 3.4 3.2 3.9 2.0 6.1 
Vitamin B6 4.9 5.8 2.1 4.5 5.5 4.7 # 2.0 # 12.1 # 
Vitamin C 4.3 4.1 5.2 4.9 3.2 6.2 2.9 6.1 
Folic Acid 14.1 15.6 9.2 14.4 13.4 13.2 14.7 18.2 
Vitamin E 38.1 39.5 34.0 36.0 42.5 33.3 37.3 42.4 
Minerals 
Phosphorus NIA 
Iron 4.8 6.1 * 1.0 * 4.8 4.9 4.4 4.2 7.8 
Zinc 10.5 10.2 11.3 11.0 11.0 9.3 10.8 12.1 
Ma nesium 28.4 26.5 34.0 26.9 31.5 26.5 25.5 33.3 
Prevalence of adequacy-Percent above Adequate Intake (AI) 
Calcium 48.1 45.9 54.6 52.3 * 39.4 * 50.4 52.9 57.6 
VitaminD 61.4 60.5 63.9 63.3 57.5 62.8 63.8 63.6 
* p <0.05; p <0.10; Fisher's exact test for differences by sex and by HIV infection for cells with frequency <5; 
Chi2 Goodness-of-fit test for differences by CD4 cell count. 
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Table 8. Multiple linear regression models predicting the log of micronutrient intakes for the REACH 
cohort stud~ 
Dependant variable Vitamin A Vitamin C Vitamin E Iron Zinc 
(Natural log) 1:1:gRAE mg mg mg mg 
Explanatory variables Coefficients 
{Std Error} 
Constant 6.118 4.871 1.876 2.950 2.329 
(0.069) (0.063) (0.091) (0.047) (0.050) 
Energy/l 000 kcal 0.158*** 0.190*** 0.284*** 0.263*** 0.170*** 
(centered) (0.016) (0.016) (0.009) (0.014) (0.013) 
Female -0.089** 
Black/non-Hispanic 0.073 # 
(0.031) 
0.226*** 
(0.043) (0.055) 
Living on own 0.155** 0.061 * 
(0.057) (0.030) 
Vitamin/mineral 0.135** 0.090** 0.096** 
supplement use (0.043) (0.029) (0.032) 
RCMAS anxiety index • 0.003 
(0.004) 
HIV-infected:CD4+ T- -0.094# -0.048# -0.079* 
cells ~500 cells/µL (0.055) (0.029) (0.032) 
HIV-infected: CD4+ T- -0.032 
cells 200-499 cells/µL (0.069) 
Food Guide Pyramid 
servmgs 
Dairy 0.161 *** 0.075*** 
(0.017) (0.012) 
Vegetables 0.077*** 0.026** 
(0.012) (0.009) 
Fruit 0.229*** 
(0.022) 
Meat/other protein 0.020* 0.085*** 
(0.009) (0.008) 
Percent of energy from 0.015*** 
fat (0.002) 
Interactions 
Energy ( centered)2 -0.011 *** -0.014*** -0.017*** -0.019*** -0.018*** 
(0.003) (0.003) (0.002) (0.002) (0.002) 
RCMAS anxiety* CD4+ 0.014# 
T-cells: 200-499 cells/µL (0.008) 
n 390 391 391 391 391 
Adjusted R2 0.652 0.508 0.787 0.760 0.804 
Std error of estimate 0.393 0.500 0.268 0.295 0.263 
•Revised Children's Manifest Anxiety Scale 
Significance of explanatory variables: *** p <0.001; ** p <0.01; * p <0.05; # p <0.10 
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CHAPTER 4. DIETARY QUALITY AND PREVALENCE OF OBESITY AMONG 
HIV-INFECTED AND HIV-UNINFECTED ADOLESCENTS AND YOUNG ADULTS 
IN THE REACH COHORT STUDY 
A paper to be submitted to the Journal of the American Dietetic Association 
Abstract 
Objective: Examine the relationship between dietary quality, weight status and HIV 
infection among HIV-infected and HIV-uninfected adolescents/young adults. 
Design: A cross-sectional study of dietary intake with the REACH cohort, a multi-centered 
observational study of HIV-infected and HIV-uninfected but at-risk adolescents/young 
adults. 
Subjects/setting: 248 HIV-infected and 116 HIV-uninfected participants (73% female; 67% 
black/non-Hispanic) at 14 U.S. clinic sites. 
Methods: Biochemical, clinical, and sociodemographic data were available through the 
REACH network. Dietary intake was collected using the Block Food Frequency 
Questionnaire (98.2) and modified Healthy Eating Index (HEI) was calculated to measure 
dietary quality. 
Statistical analysis: x2 test, t-tests, ANOV A, Pearson's correlation, logistic and generalized 
linear regression. 
Results: Half (50.4%) of HIV-infected and 54.3% of HIV-uninfected participants were 
overweight or obese. Being female, living independently from parents/family, watching 
television ~3 hours/d, previous dieting, and being from the Northeast or South were 
positively associated with obesity. Obesity was lower among participants with CD4+ T-cells 
~500 cells/µL. For all participants, the modified HEI was 56.2±0.6. Being from the Chicago 
area, HIV-infected, and watching television ~3 hr/d were associated with a lower HEI 
(poorer diet) while being female and having good self-perceived health were associated with 
a higher HEI (better diet). 
Conclusions/applications: Obese, HIV-infected individuals may be at risk of developing 
metabolic abnormalities associated with HIV. Dietary quality was poor among HIV-infected 
participants; although, the majority of this young population did not meet dietary 
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recommendations. Nutrition education should focus on improving dietary quality and 
physical activity for all adolescents and young adults. 
Introduction 
The alarming increase in obesity among the U.S. population has become a growing 
public health concern not only among adults but also among adolescents. Recent findings 
from the 1999 National Health and Nutrition Examination Survey (NHANES N) revealed 
approximately 61 % of adults over age 20 were overweight or obese, a 5% increase from 
NHANES III (1988-1994), and 14% of adolescents aged 12-19 years had body mass index 
(BMI)-for-age above the 95th percentile, a 3% increase from NHANES III (1,2). Results 
from NHANES III demonstrated that obesity was highest among ethnic minorities, 38% of 
black non-Hispanic and 35% of Hispanic women were obese compared to 24% of white 
women (3). The effect of ethnicity appears to be less pronounced among adolescents; 13-
14% of the Hispanics and black non-Hispanics were overweight or obese compared to 11 % 
of white adolescents. 
Adolescence and young adulthood are critical periods when eating and lifestyle 
behaviors are established. Behaviors during these periods could have both immediate and 
long-term health consequences. Overweight teenagers have increased risk of hypertension, 
hyperlipidemia, development of type 2 diabetes and other chronic diseases during 
adolescence (4-6). Overweight adolescents are more likely to be overweight as adults (7-10) 
and have increased morbidity associated with hypertension, cardiovascular disease, type 2 
diabetes, stroke, gallbladder disease, osteoarthritis, respiratory problems, sleep apnea and 
some cancers (11). For obese adults, the risk of mortality from all causes especially 
cardiovascular disease increased by 50-100% over those with a normal BMI. Besides the 
physiologic consequences of obesity, numerous psychosocial consequences such as social 
stigmatization, depression, binge eating disorder, and altered body image have been 
identified in both adolescents and adults ( 4, 11) 
Many chronic conditions associated with obesity have been linked to modifiable 
lifestyle and dietary behaviors. Researchers have examined dietary quality and intake among 
adolescents and young adults. In a nationally representative study, 25% of adolescents had 
intakes of calcium, zinc, iron, and vitamins A, B6, C and E <75% of the US Recommended 
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Dietary Allowance (12) while over 30% of adolescents had total fat intake above 30% of 
energy and saturated fat intake above 10% of energy (3). The USDA developed the Healthy 
Eating Index (HEI) (13) as a measure of diet quality based on the Food Guide Pyramid (14) 
and Dietary Guidelines for Americans recommendations (15.). The average score for both 
males and females aged 15-19 years (HEI score: 61 out of 100) indicated dietary intake fell 
short of these recommendations (13). 
In addition to the nutritional concerns of dietary intake and increased weight, human 
immunodeficiency virus (HIV)-infected adolescents and young adults face additional 
challenges related to the demands of HIV infection. Those who are obese are at even greater 
risk of developing metabolic and body composition abnormalities such as lipodystrophy, 
hyperlipidemia, and insulin resistance associated with HIV-infection and antiviral therapies 
(16, 17). Clinical features of lipodystrophy, or fat redistribution syndrome, include peripheral 
fat loss especially in the face, limbs, and buttocks with a central fat accumulation in the 
abdominal region, breasts, and over the dorsocervical vertebrate (referred to as the "buffalo 
hump") (16,18). Little is known about the relationship between nutritional status and health 
among U.S. adolescents and young adults infected with HIV. The primary purpose of this 
study was to examine the relationship between dietary quality, weight status, and HIV 
infection among HIV-infected and HIV-uninfected adolescents and young adults. 
Subjects and methods 
Study population 
The "Reaching for Excellence in Adolescent Care and Health" (REACH) study was a 
prospective, cohort study of the progression of HIV infection in adolescents in 15 U.S. 
clinical sites (19,20). A standardized treatment protocol was developed through the 
Adolescent Medicine HIV/AIDS Research Network. Between March 1996 and November 
1999, 325 adolescents between 12 and 18 years of age who had acquired HIV infection 
through sexual activity or intravenous drug use were recruited. In addition, 171 HIV-
uninfected adolescents were recruited from the same clinic sites based on risk-behavior 
profiles and demographic characteristics similar to HIV-infected individuals. This paper 
describes a supplemental cross-sectional study of dietary intake and nutritional status was 
conducted during one study visit between January and October 2000. One site did not 
86 
participate in this study due to logistical difficulties with handling laboratory samples. 
Among the 436 participants active in the REACH network, 391 agreed to participate in the 
dietary intake study. Pregnant subjects (n=27) were excluded from the present analysis 
resulting in 364 subjects (248 HIV-infected and 116 HIV-uninfected). The study received 
approval by the human subjects review boards through Iowa State University, University of 
California at Davis, University of Alabama at Birmingham, and at each clinic site. All 
participants provided informed written consent. 
Data collection 
Data collection for the longitudinal study occurred through face-to-face interviews, 
interactive computer interviews, medical record abstractions, and physical and laboratory 
examinations. A detailed description of the REACH study protocol is described elsewhere 
(19,20). 
Dietary intake 
The Block Food Frequency Questionnaire (version 98.2) (BFFQ) (21) was used to 
estimate usual dietary patterns over the past year. The BFFQ was administered in an 
interview format by trained clinic staff and was completed within 1.4 days (95% CI: - 0.6 to 
2.1 days) of the study visit. A registered dietitian reviewed the questionnaires and 
interviewers were contacted regarding missing information, unusual responses, or 
discrepancies prior to scanning. Results from computerized scanning included average 
intakes of macronutrients, vitamins, minerals, antioxidant nutrients, food group servings, and 
nutrients from supplements. 
Anthropometric measurements 
Height and weight were taken during the physical examination at the study visit. 
Participants were gowned and weighed using digital scales accurate to one-tenth decimal 
place. Weight at the previous 6-mo visit was compared to current weight for assessment of 
weight change. Body mass index (BMI) was calculated for each participant as weight 
(kg)/height (m)2. Body mass indices >50 kg/m2 were verified with clinic staff for accuracy. 
BMI-for-age percentiles for adolescents (22) and adult BMI classification guidelines (11) 
were used to categorize weight status. Adult classification guidelines were used for 
participants ~20 years old or when the BMI-for-age percentile cut-off met or exceeded the 
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BMI adult classification guidelines. Participants with BMI 2::25 kg/m2 and <30 kg/m2 or 
BMI-for-age 2::851h and <951h percentile were classified as overweight and those with BMI 
2::30 kg/m2 or BMI-for-age 2::951h percentile were obese. The term "obese" is not 
recommended for use with adolescents due to growth and body composition changes that 
occur as part of normal maturation and development and the negative connotation associated 
with this term (23). However, obesity is used within this study to provide consistency in 
classification terminology across the study group since 87% of the participants were 2::18 
years of age at the time of this cross-sectional study. 
Modified Healthy Eating Index 
The USDA's HEI, a measure of dietary quality, assesses how well American's eating 
habits meet the recommendations of the Dietary Guidelines and the Food Guide Pyramid 
(13). This study used a modified version (24) that included 9 of the original 10 dietary 
components representing various aspects of a healthy diet with each component having equal 
weight. Components 1-5 related to meeting the recommended servings based on the Food 
Guide Pyramid food groups: grains, vegetables, fruit, milk products, and meat and meat 
alternatives. Component 6 and 7 measured total fat and saturated fat intake as a percent of 
energy. Component 8 and 9 measured total cholesterol and sodium intake. Since accurate 
information regarding dietary variety (component 10 of original HEI) was not available 
through the BFFQ, this component was excluded. Each component of the HEI had a 
maximum score of 10 and a minimum score of 0. Higher scores represented intakes closer to 
the recommended goals. Scores between the minimum and maximum values were computed 
proportionally. All HEI scores on the modified version were adjusted to a 100-point scale. 
A modified HEI score >80 implied a "good" diet, a score between 51 and 80 implied the diet 
"needs improvement", and a score of <51 indicated a "poor" diet (25). 
HIV related information 
Laboratory tests were performed at local clinic sites according to REACH protocol 
described elsewhere (19,20). HIV serum antibody tests and CD4+ T-cells were obtained on 
all study participants. Quantitative immunophenotyping of CD4+ T-cells were determined at 
the individual clinical sites in certified laboratories using AIDS Clinical Trials Group 
(ACTG) standardized flow cytometry protocols. HIV status was used as a dichotomous 
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variable. In addition, total CD4+ T-cells for HIV-infected participants were stratified based 
on Centers for Disease Control and Prevention criteria for HIV I AIDS classification: ;;::500, 
200-499, and <200 cells/µL (26). Other HIV related information such as use of antiretroviral 
therapies was obtained through face-to-face interview and medical record abstraction. 
Demographic, health and behavior characteristics 
Demographic characteristics including race/ethnicity, family financial situation, 
living arrangements, education, and substance use were obtained through face-to-face 
interviews and interactive computer interviews. Other variables obtained from the BFFQ 
included vitamin/mineral and herbal supplement use, hours spent watching television, 
pregnancy status, previous dieting history, cigarette smoking, alcohol use, and self-reported 
health status. Hours of television watching served as an indirect indicator of physical 
inactivity. To determine regional differences in dietary quality, study sites were group by 
geographic locations. The majority of study sites were located in the Northeast area (New 
York City area, Philadelphia PA, Baltimore MD, and Washington DC) and South (Florida, 
Alabama, Tennessee, and Louisiana) with only one study site in the Chicago area and one in 
the Los Angeles area. 
Statistical analysis 
Continuous variables were reported as mean± standard error of mean (SE); 
significant differences by HIV infection were determined by two-sample Student's t-tests. 
Differences by CD4+ T-cell stratification were determined using Analysis of Variance 
(ANOV A) with post hoc differences using Bonferroni multiple comparisons. For categorical 
variables, differences were determined by Chi-squared test of goodness-of-fit. Correlations 
between continuous variables were determined using Pearson's correlations test. 
A model was developed a priori based on a review of the literature and data available 
through the REACH project to explain the relationships between HEI, BMI, and HIV-
infection. Generalized linear regression analysis was used to describe the associations 
between HEI and the explanatory variables; logistic regression was used for risk of obesity. 
Initial regression models included the following explanatory variables: health behaviors such 
as supplement use, antiretroviral therapy use, history of previous weight loss attempts, and 
television watching; environmental factors such as family financial situation, living 
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arrangements and food security; participant characteristics such as sex, self-reported health 
status, race/ethnicity, HIV infection and CD4+ T-cell strata; and dietary intake information 
such as energy intake. Dummy variables were created for categorical variables. Variables 
that reached a significance of p<0.10 or were central to the primary hypothesis remained in 
the model. SYSTAT (version 10.0) statistical software (27) was used for all data analysis. 
Significance was set at p<0.05 unless otherwise indicated. 
Results 
Participant characteristics 
A total of 364 participants were included in the analysis. HIV-infected participants 
were older, more likely to on their own, and likely to have completed or be enrolled in high 
school or GED program than HIV-uninfected participants (Table 1). Almost half (46.8%) of 
the HIV-infected group were not on antiretroviral therapy (ART). Of those on ART, 34.3% 
were on a mono- or combination therapy without a protease inhibitor (PI) while 19.0% were 
on a combination therapy that included a PL The mean BMI for this population was 28.1 ± 
0.5 kg/m2 (Median: 25.6, range: 15.3-64.6 kg/m2). The average 6-mo weight gain for all 
participants was 1.5 ± 0.3 kg. Obese participants gained significantly more weight over the 
past six months than non-obese participants (2.7 ± 0.6 vs. 0.9 ± 0.3 kg, p<0.01). Due to 
growth differences and BMI differences by age and sex during adolescents, interpretation of 
absolute BMI values in this population was difficult. Weight classification described earlier 
was used to provide a basis for equivalent comparisons in this population. Among all 
participants in this study, over half were overweight or obese (Table 1). More females were 
overweight or obese compared to males (60.6% vs. 26. 7% respectively, p<0.001). Over half 
(54.3%) of the HIV-uninfected participants and 49.4% of HIV-infected participants were 
overweight or obese. Among HIV-infected participants, the prevalence of overweight or 
obesity decreased with decreasing CD4+ T-cell strata (59.7%, 45.7%, and 28.1 % 
respectively, p<0.01). The prevalence of overweight and obesity was compared by CD4+ T-
cell strata and by sex (Figure 1 ). There was no significant difference in prevalence of 
overweight when compared by CD4+ T-cell strata for either males or females. When the 
prevalence of obesity was compared by CD4+ T-cell strata, no significant difference was 
seem among males; however, females had a significant decrease in obesity as CD4+ T-cells 
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decreased. A higher prevalence of obesity was seen in the South (37.3%) and the Northeast 
(32.0%) than the Chicago and Los Angeles area (14.3%, p<0.05). A significant inverse 
relationship was found between energy and BMI (Pearson's r = -0.15). Additional 
information about participant characteristics, including macro- and micronutrient intakes for 
this population was reported elsewhere (Chapter 3). 
Using logistic regression, HIV-infected participants with CD4+ T-cells ~500 cells/µL 
were 15% more likely to be obese compared to the HIV-uninfected participants; however, the 
risk of obesity decreased progressively as the CD4+ T-cells dropped below 500 cells/µL 
(Table 2). Being female was associated with an almost 3-fold increase in obesity compared 
to males. Individuals living on their own were almost twice as likely to be obese compared 
to those who had other living arrangements such as with family members or friends. 
Watching three or more hours of television per day was associated with a two-fold increase 
in obesity while having a history of previous weight loss attempts had an over 7-fold increase 
in the risk of obesity. Participants from the Northeast and the South were about four times 
more likely to be obese compared to participants from the Chicago or Los Angeles area. 
Race/ethnicity, financial status, antiretroviral therapy use, modified Healthy Eating Index and 
energy intake were not significant predictors of obesity and were dropped from the final 
model. 
Modified Healthy Eating Index 
The modified HEI score for the REACH population was 56.2 ± 0.6 out of 100. Of the 
9 component scores, the highest was the meat score at 9.0 ± 0.1 and sodium, fruit and fat 
scores were the lowest (3.8 ± 0.2, 4.3 ± 0.2, and 4.6 ± 0.2; respectively). Approximately 
68% of the participants had a diet that needed improvement while 31 % had a poor diet. 
Modified HEI scores varied by HIV status, sex, and region. HIV -infected 
participants had a lower HEI score (poorer diet) than HIV-uninfected participants {Table 3, 
p<0.01). When comparing HEI component scores, total fat, saturated fat (p<0.001), and 
cholesterol (p<0.01) scores were significantly lower (indicating higher intake) for HIV-
infected participants than HIV-uninfected participants. HEI component scores were 
compared by sex; males had a higher average dairy score than females (5.9 ± 0.3 vs. 4.8 ± 
0.2, p<0.01). Females, however, had significantly higher scores for fruits, cholesterol, and 
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sodium compared to males (4.6 ± 0.2 vs. 3.6 ± 0.3, 5.1±0.3 vs. 3.5 ± 0.4, and 4.2 ± 0.3 vs. 
2.9 ± 0.4, respectively; p<0.01) contributing to the overall higher total HEI score seen among 
females than males (57.l ± 0.7 vs. 53.5 ± 1.1, p<0.01). Total HEI scores did not differ by 
race/ethnicity. While overall HEI scores did not differ between obese and non-obese 
participants, fruit and dairy component scores were significantly lower among obese 
compared to non-obese while cholesterol and sodium component scores were significantly 
higher (indicating lower intake) among obese than the non-obese. Participants from the 
Chicago area had lower HEI scores compared to those from the Northeast, South, or Los 
Angeles area (47.2 ± 2.3 vs. 56.7 ± 0.6, p<0.001). HIV-infected females had significantly 
lower HEI scores than HIV-uninfected females (Table 3); only saturated fat was significantly 
lower (indicating higher intake) among HIV-infected females compared to HIV-uninfected 
females (p<0.01). HEI scores were lower among HIV-infected males compared to HIV-
uninfected males with cholesterol and fat component scores contributing to the overall 
difference. Vitamin C and folate intakes (data not shown) were positively correlated with 
HEI (r=0.38, p<0.001; r=0.23, p<0.01, respectively) while dietary fiber tended to be 
positively correlated (r=0.19, p=0.051 ). 
Predictors of modified HEI using generalized linear regression were identified (Table 
4). Being from the Chicago area, HIV-infected, and watching television three or more 
hours/day were significant negative predictors of overall HEI score while being female and 
having a self-perceived health status of good, very good, or excellent were positive 
predictors. In this model, other factors such as living arrangements, weight status, energy 
intake, family financial status, race/ethnicity, age, and education were not significant. To 
better illustrate this model, best and worst examples are presented. A HIV -uninfected female 
from the South with excellent self-perceived health who watched fewer than three hours of 
television per day had an estimated HEI of 61.8 (diet needs improvement). A HIV-infected 
male from the Midwest with a poor self-perceived health who watched more than three hours 
of television per day would have an estimated HEI of 42.2 (poor diet). When the 
dichotomous HIV infection variable was replaced by the three CD4+ T-cell strata variables 
(data not shown), the regression coefficients were negative and the largest effect was among 
those with a CD4+ T-cells 200-499 cells/µL (-3.78; 95% CI: -6.87, -0.68). 
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Discussion 
The high prevalence of overweight and obesity seen in this population is consistent 
with the increasing prevalence of obesity seen among U.S. adolescents and young adults in 
recent national surveys (1,2). This trend is particularly evident in black/non-Hispanic and 
Hispanic adolescents (28,29). In this study population, the majority were black/non-Hispanic 
females, while 20% of the subjects reported Hispanic ethnicity. Approximately 31 % were 
obese, twice as high as the prevalence among U.S. adolescents from the 1999 NHANES IV 
(2). 
Many factors no doubt contribute to this high prevalence of obesity. One possibility 
is that female subjects in this present study see a larger body size as desirable. Anecdotal 
reports from clinicians in our study tend to support this supposition, as they suggest that 
weight gain occurred in some subjects after being diagnosed with HIV infection in reaction 
to the fear of weight loss associated with advanced HIV infection (Wilson, personal 
communications, 2002). While information relating to body image and attitudes are not 
available in this study, others have reported ethnic differences that could influence BMI 
among women with HIV infection (30). Black, HIV-infected women were more likely to 
want a larger body size while Caucasian, HIV-infected women wanted to lose weight. These 
findings did not depend on stage of illness or history of opportunistic infections. These 
ethnic differences in body image and obesity reported among HIV-infected women were 
similar to those seen among other black non-Hispanics adults and adolescents (31-33). 
While the strong association of obesity with weight loss attempts seen in our subjects argues 
against intentional weight gain, the possibility remains that BMis in the overweight and 
obese range are not seen as negatively by subjects in this study as they are by other 
population groups. 
Regional differences were seen in the prevalence of obesity in the REACH subjects. 
In this study, participants from the South were more likely to be black/non-Hispanic, a group 
with high rates of obesity (3). Subjects from the South also reported lower food security and 
family financial situation compared to participants from other regions (data not shown). 
Food insecurity has been associated with higher BMis in U.S. women (34). When BMI was 
compared by region, the South had significantly higher mean BMI than the Northeast area 
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and the Los Angeles site. The Northeast area was as significant predictor of obesity. This 
region had the second highest prevalence of obesity following the South. Participants from 
the Northeast had more educated mothers and tended to be more educated themselves. There 
were no other sociodemographic differences seen in participants from this area compared to 
the other regions. It is unclear what factors in this region are influencing obesity. 
Weight loss and wasting are often associated with advanced HIV infection (35,36). 
However, most previous studies have not been done in populations with a high prevalence of 
overweight and obesity. In the REACH population, wasting was rare but the prevalence of 
obesity was lower in those with the most advanced disease (i.e., lowest CD+ T-cells). This 
effect could be the result of decreased intake, or altered digestion, absorption, or metabolism 
of nutrients resulting from HIV infection, opportunistic infections or drug therapy side 
effects (37,38). Thus the lower prevalence of obesity in REACH subjects with more 
advanced infection may be due to the same factors that cause wasting in populations where 
the overall BMI is lower than in the present study. Overweight and obesity in this study 
population could lead to increased complications relating to obesity, which may be further 
compounded by metabolic complications such as hyperlipidemia and insulin resistance 
associated with HIV infection and antiretroviral therapies (16,17). 
The HEI scores of this population were lower than those reported from a nationally 
representative survey. U.S. adolescent females aged 15-18 years had HEI scores of 60.8 
while males of the same age were slightly lower at 60.7 (13). Nationally, whites had higher 
average HEI scores than black/non-Hispanics among all ages; however, no significant 
difference in HEI scores by race/ethnicity was seen in this study. Regional differences in 
HEI scores reported in this study differ from those reported by Bowman et al. (13). They 
found that people from the Northeast region had the highest average HEI scores at 65 while 
those from the South had the lowest average scores of 62. In our study, participants from the 
Chicago area had the lowest average HEI scores. They had significantly lower component 
scores for grains, fruits, fat, and saturated fat, which contributed to their overall lower HEI 
score. More males were from the Chicago area (43%) compared to other areas (26%); 
however, after controlling for sex, being from the Chicago area remained a significant 
negative predictor of dietary quality. No other significant differences in sociodemographic 
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characteristics were seen between participants from the Chicago area compared to other 
regions. Fewer participants were obese compared to the Northeast or South. It is difficult to 
draw any conclusions between these regional variances noted since our sample was not 
designed to be regionally representative. 
Although no relationship was seen between overall HEI scores and BMI in this study, 
other researchers have reported that a higher HEI score was associated with a lower BMI 
(13). In our study, there was an inverse relationship between energy intake and BMI 
suggesting under-reporting among those with increased weight. Factors that are commonly 
associated with under-reporting that are relevant to this analysis include being obese, female, 
black non-Hispanic, and oflower socioeconomic status (39-41). 
Unlike the results from this study, other researchers have found a positive relationship 
among income, education and HEI scores (13,42,43). In this study, variables representing 
these socio-demographic characteristics were not significantly associated with HEI scores. 
Our study population may have had less diversity in income and education variables than did 
other studies, thus making it difficult to find an association with HEI. Income was not 
significant in this study, which could relate to the variable used in the analysis. Participants 
may have been being unaware of detailed family finances especially for those still living with 
parents. Thus, variables in this study reflecting household income and education may not be 
accurately represented. This could explain why only 8% of the total variance was explained 
using linear regression in this study. 
Correlations between vitamin C, folate, fiber and the HEI found in this study are 
consistent with those reported by Hann et al (43). Although serum micronutrients are not 
reported here, HEI has been positively correlated with vitamin C and various carotenoids and 
negatively correlated with serum cholesterol (43). Since the HEI was developed based on 
current dietary recommendations and has been strongly correlated to certain micronutrient 
intake and serum concentrations, the HEI served as a useful tool to describe overall dietary 
quality in this population. 
Applications/conclusions 
To our knowledge, this is the first study to examine dietary quality using the HEI and 
the prevalence of overweight and obesity in minority adolescents and young adults with HIV 
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infection. The growing prevalence of overweight and obesity seen among the U.S. 
population was also seen among this study population composed primarily of black, non-
Hispanic females. Overweight and obese individuals with HIV infection may be at even 
greater risk of developing metabolic abnormalities associated with HIV infection. Dietary 
quality was lower among HIV-infected than HIV-uninfected participants, and the majority of 
this population fell short of the dietary recommendations measured by the modified HEI. 
Since underreporting has been identified among obese individuals, nutrition educators should 
utilize various assessment techniques that provide an accurate reflection of dietary intake. In 
addition, improving self-awareness of eating behaviors through use of food records, food 
models, and other educational strategies may help promote healthy eating behaviors. 
Nutrition education should focus on developing individualized behavioral goals emphasizing 
improved dietary quality and physical activity to improve the quality of life for all 
adolescents and young adults. 
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Table 1. Participant sociodemographic characteristics by HIV status for the REACH cohort study• 
n 
Age,y 
Range 
Male 
Female 
Race/ethnicity# 
Hispanic 
Black/non-Hispanic 
White/non-Hispanic 
Other 
Living arrangements** 
Living in own apartment/house 
Parents/family member 
Someone else's house/apt 
Otherd 
Education *** 
No diploma or GED 
Diploma/GED or emolled in school 
CD4+ T-cells (cells/µL) 
~500 
200-499 
<200 
Weight classification 
Overweight e 
Obese r 
Self-reported health status 
Excellent, very good, good 
Fair, poor 
Vitamin/mineral supplement use 
Television watching ~3 hr/d 
History of weight loss attempts * 
Total HIV+ HIV-
364 248 116 
19.8 ± 0.1 b 20.0 ± 0.1 *** 19.4 ± 0.1 *** 
13.8 - 23.2 13.8 - 23.2 14.8 - 22.9 
97 (26.6) c 
267 (73.4) 
75 (20.6) 
242 (66.5) 
16 (4.4) 
31 (8.5) 
101 (27.7) 
207 (56.9) 
25 (6.9) 
31 (8.5) 
127 (34.9) 
237 (65.1) 
73 (20.1) 
115 (31.6) 
229 (62.9) 
135 (37.1) 
129 (35.4) 
177(48.6) 
130 (35.7) 
68 (27.4) 
180 (72.6) 
47(19.0) 
175 (70.6) 
8 (3.2) 
18 (7.3) 
81 (32.7) 
127 (51.2) 
17 (6.9) 
23 (9.3) 
103 (41.5) 
145 (58.5) 
124 (50.0) 
92 (37.1) 
32 (12.9) 
53 (21.4) 
72 (29.0) 
160 (64.5) 
88 (35.5) 
89 (35.9) 
127 (51.2) 
81 (32.7) 
29 (25.0) 
87 (75.0) 
28(24.1) 
67 (57.8) 
8 (6.9) 
13 (11.2) 
20(17.3) 
80 (69.0) 
8 (6.9) 
8 (6.9) 
24 (20.7) 
92 (79.3) 
20(17.2) 
43(37.1) 
69 (59.5) 
47 (40.5) 
40 (34.4) 
50(43.1) 
52 (44.8) 
Currently smoke 151 (41.5) 109 (44.0) 42 (36.2) 
•Pregnant women excluded; b Mean ± standard error; c n (%) 
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r BMI ~30 kg/m2 or BMI-for-age ~95th percentile 
*** p <0.001, ** p <0.01, * p <0.05, # p <0.10 (Chi2 for categorical variables; Two sample t-tests for continuous 
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Table 2. Logistic regression model predicting obesity in the REACH cohort study • (n=364) 
Dependant variable Obesity 
Independent variables Coefficient SE Odds ratio 
Constant -4.14 0.66 
Female 1.09 0.36 
Living in own apartment/house 0.64 0.30 
HIV+/CD4+ T-cells (cells/µL): b 
~500 
200-499 
<200 
Northeast region c 
South region d 
Television watching ~3 hr/d 
History of weight loss attempts 
•Pregnant women excluded 
0.14 0.32 
-0.83 0.37 
-1.16 0.63 
1.32 0.50 
1.42 0.52 
0.82 0.28 
2.06 0.29 
b HIV-uninfected participants are 0 for all three CD4+ T-cell variables 
2.97 
1.90 
1.15 
0.44 
0.31 
3.74 
4.11 
2.26 
7.83 
c Includes New York City area, Philadelphia PA, Baltimore MD, and Washington DC 
d Includes Florida, Alabama, Tennessee, and Louisiana 
p-value 
0.000 
0.003 
0.030 
0.658 
0.025 
0.066 
0.009 
0.006 
0.003 
0.000 
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Table 4. Multiple linear regression model predicting the modified Healthy Eating Index in the REACH 
cohort study3 (n=364) 
Dependant variable 
Constant 
Female 
Independent variables 
Health status: excellent, very good or good 
HIV-infected 
Chicago area 
Television watching ~3 hr/d 
N 
Adjusted R2 
Std error of estimate 
•Pregnant women excluded 
Modified Healthy Eating Index 
Coefficient SE t p-value 
56.4 1.8 32.1 0.000 
3.2 1.3 2.4 0.016 
2.2 1.2 1.8 0.069 
-3.4 1.3 -2.7 0.007 
-8.4 2.5 -3.3 0.001 
-2.4 1.2 -2.0 0.046 
364 
0.079 
11.2 
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CHAPTER 5. GENERAL CONCLUSIONS 
To our knowledge, this study was the first to examine dietary intake among HIV-
infected and HIV-uninfected adolescents and young adults. The first study focusing on 
micronutrient intakes showed two indicators of poor diet quality: 1) excessive fat, saturated 
fat, and cholesterol, and 2) inadequate intakes of micronutrients that are important for 
maintenance of a healthy immune response and have been associated with a slowed 
progression of HIV disease. Energy intake was a significant positive predictor for vitamins 
A, C, E, iron and zinc. After controlling for energy intake, early HIV infection was 
associated with a slightly lower micronutrient intake. Vitamin/mineral supplement use was 
common in this population and was related to more nutrient-dense food choices. 
In the second study, overweight and obesity was common in this population 
composed primarily of black/non-Hispanic females. Prevalence of obesity decreased with 
decreased CD4+ T-cells. In addition, overweight or obese HIV-infected individuals may 
have increased weight-related complications, which may further compound metabolic 
complications such as hyperlipidemia and insulin resistance associated with HIV infection 
and ART. Overall dietary quality as measured by the HEI was lower among HIV-infected 
participants. However, the majority of all participants fell short of the dietary 
recommendations measured by the HEI. Factors positively associated HEI scores included 
being female and having a higher self-perceived health status, while being HIV-infected and 
increased television watching were negatively associated with HEI. Another finding in this 
population was an inverse relationship between energy intake and BMI suggesting under-
reporting occurred among those with increased weight. 
While this project provides insight on the dietary intake among HIV-infected and 
HIV-uninfected adolescents and young adults, further research is needed in this area. 
Additional studies are needed to determine the optimal amounts of micronutrient intake 
among HIV-infected youth. Since this was a cross-sectional study on dietary intake, we were 
unable to examine the relationship between dietary intake and disease progression. Since 
both deficient and excessive micronutrient intakes have been related to advanced disease 
progression among adults, studies are needed to examine this relationship among HIV-
infected adolescents. In addition, biochemical and body composition information was not 
105 
available on these subjects to examine the relationship between dietary intake, obesity and 
complications associated with HIV infection and ART such as insulin resistance, 
hyperlipidemia, or lipodystrophy. Further investigation on body image and attitudes among 
HIV-infected individuals of different ethnic backgrounds would also be beneficial. By 
understanding the psychological reasons for weight preference, health professionals would be 
better informed for assisting clients in improved their health status. Nutrition education 
should focus on developing individualized behavioral goals emphasizing improved dietary 
quality and physical activity to improve quality of life for all adolescents and young adults. 
106 
APPENDIX A. BODY MASS INDEX-FOR-AGE GROWTH CHARTS 
CDC Growth Charts: United States 
2 3 4 5 6 7 6 9 10 11 12 13 14 15 16 17 18 19 20 
Age (years) 
SOURCE: Developed b~ lhe Na6onal Center for - Stall9tlca In c:ollabo .. tion with 
lhe National Center for Chronic DlaeaH Prevenllon and Health Promotion (2000). 
Reference 
Centers for Disease Control and Prevention, National Center for Health Statistics. CDC 
growth charts: United States. 2000. Available at: http://www.cdc.gov/growthcharts/. 
Accessed: October 15, 2001. 
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APPENDIX B. 1993 REVISED CLASSIFICATION SYSTEM FOR HIV INFECTION 
Table 1. 1993 revised classification system for HIV infection and expanded surveillance 
case definition for AIDS amon2 adolescents and adults ;;:::13 y. (CDC, 1992). 
Clinical Categories 
CD4 T-cell (A) Asymptomatic (B) Symptomatic (C) AIDS-indicator 
categories HIV infectiona HIV infectionb conditionsc 
(1) ~500 Al Early Bl Early Cl Intermediate 
(2) 200-499 A2 Early B2 Intermediate C2 Late 
(3) <200 A3 Intermediate B3 Late C3 Late 
a Category A: 
One or more of the conditions listed below in an adolescent or adult (> 13 y) with 
documented HIV infection. Conditions listed in categories B and C must not have occurred. 
• Asymptomatic HIV infection 
• Persistent generalized lymphadenopathy 
• Acute (primary) HIV infection with accompanying illness or history of acute HIV 
infection 
b Category B: 
Symptomatic conditions occurring in an HIV-infected adolescent or adult that are not 
included among conditions listed in clinical category C, and that meet at least on of the 
following criteria: 
• Bacillary angiomastosis 
• Candidiasis, oropharyngeal (thrush) 
• Candidiasis, vulvovaginal; persistent, frequent, or poorly responsive to therapy 
• Cervical dysplasia (moderate to severe) or cervical carcinoma 
• Consititutional symptoms, such as fever (38.5 C) or diarrhea lasting> 1 month 
• Hairy leukoplakia, oral 
• Herpes zoster (shingles), involving at least two distinct episodes or more than one 
dermatome 
• Idiopathic thrombocytopenic purpura 
• Listeriosis 
• Pelvic inflammatory disease, particularly if complicated by tubo-ovarian abscess 
• Peripheral neuropathy 
c Category C: 
Any condition listed in the 1987 surveillance case definition for AIDS and affecting an 
adolescent or adult. These conditions are strongly associated with severe immunodeficiency, 
occur frequently in HIV-infected individuals, and cause serious morbidity or mortality. Once 
a category C condition has occurred, the person will remain in category C. 
1. Candidiasis of bronchi, trachea, or lungs 
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2. Candidiasis, esophageal 
3. Cervical cancer, invasive 
4. Coccidioidomycosis, disseminated or extrapulmonary 
5. Cyrptocovvosis, extrapulmonary 
6. Cryptosporidiosis, chronic intestinal (>l month's duration) 
7. Cytomegalovirus disease (other than liver, spleen, or nodes) 
8. Cytomegalovirus retinitis (with loss of vision) 
9. Encephalopathy, HIV-related 
10. Herpes simplex: chronic ulcer(s) (>1 month's duration); or bronchitis, pneumonitis, or 
esophagi tis 
11. Histoplasmosis, disseminated or extrapulmonary 
12. Isosporiasis, chronic intestinal(> 1 month's duration) 
13. Kaposi's sarcoma 
14. Lymphoma, Burkitt's (or equivalent term) 
15. Lymphoma, immunoblastic (or equivalent term) 
16. Lymphoma, primary, of brain 
17. Mycobacterium avium complex of M kansasii, disseminated or extrapulmonary 
18. Mycobacterium tuberculosis, any site (pulmonary or extrapulmonary) 
19. Mycobacterium, other species or unidentified species, disseminated or extrapulmonary 
20. Pneumocystis carinii pneumonia 
21. Pneumonia, recurrent 
22. Progressive multifocal leukeoencephalopathy 
23. Salmonella septicemia, recurrent 
24. Toxoplasmosis of brain 
25. Wasting syndrome due to HIV 
Reference 
Centers for Disease Control and Prevention. 1993 Revised classification system for HIV 
infection and expanded surveillance case definition for AIDS among adolescents and adults. 
Mor Mortal Wkly Rep CDC Surveill Summ. 1992;41(No. RR-17):1-17. 
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APPENDIX D. ADDITIONAL PARTICIPANT RESULTS 
Table 1. Macronutrient and micronutrient intake from food for the REACH cohort stud~ 
Percentiles 
n=391 Mean± SE 5th 25th 5oth 75th 95tli 
Energy, kcal 3774.5 ± 103.4 1351.7 2254.7 3350.1 4758.9 7439.2 
Carbohydrate, gm 457.5 ± 12.5 157.3 282.6 403.9 586.3 896.4 
Protein, gm 124.2 ± 3.6 45.0 73.7 107.7 149.1 280.8 
Fat, gm 162.5 ± 4.9 53.2 92.9 138.5 207.6 342.2 
Saturated fat, gm 50.4 ± 1.5 14.8 29.2 50.4 66.0 106.3 
Dietary fiber, gm 23.1±0.7 7.4 9.4 19.4 29.8 52.0 
Dietary cholesterol, mg 464.8 ± 14.7 136.1 260.2 464.8 586.4 1134.9 
Energy distribution (% of total) 
Carbohydrate 48.9 ± 0.4 36.9 44.6 48.8 53.1 61.1 
Protein 13.4 ± 0.2 9.0 11.1 12.9 15.1 19.8 
Fat 38. l ± 0.3 27.8 34.4 38.3 42.3 48.2 
Saturated fat 11.9 ± 0.1 8.3 10.4 11.9 13.1 15.5 
Adjusted by body weight 
Energy, kcal/kg 53.1±1.6 14.8 28.9 47.3 69.5 112.1 
Protein, gm/kg 1.7±0.1 0.5 0.9 1.5 2.2 4.0 
Vitamins 
Vitamin A, RAE 1 1040.0 ± 39.l 268.8 542.9 824.5 1261.2 2455.6 
Thiamin (B 1), mg 2.6 ± 0.1 0.9 1.6 2.3 3.4 5.7 
Riboflavin (B2), mg 2.8 ± 0.1 0.9 1.6 2.4 3.6 6.2 
Niacin, mg 37.5 ± 1.2 12.6 22.0 31.5 46.0 85.2 
Vitamin B6' mg 3.0 ± 0.1 1.0 1.7 2.6 3.8 6.4 
Vitamin C, mg 257.5 ± 8.4 55.5 129.2 211.9 358.3 590.5 
Folic Acid, µg 612.8 ± 18.6 207.l 359.5 523.2 761.6 1349.2 
Vitamin D, IU 261.6 ± 12.5 40.6 98.5 178.2 330.5 786.4 
Vitamin E, mg 13.2 ± 0.4 4.0 7.8 11.3 16.8 27.7 
a-tocopherol 
Carotenoids 
Alpha-carotene, µg 445.2 ± 34.9 38.9 114.1 236.6 519.1 1600.0 
Beta-carotene, µg 3446.2 ± 188.8 546.9 1230.2 2313.6 4213.6 10962.7 
Cryptoxanthin, µg 273.0 ± 13.2 18.4 84.9 183.7 401.5 798.9 
Lutein, µg 1967.7 ± 122.5 237.2 705.5 1233.5 2395.8 6073.7 
Lycopene, µg 9343.6 ± 495.5 886.6 2909.0 5813.0 12067.8 31033.6 
Minerals 
Calcium, mg 1130.2 ± 32.8 359.2 638.6 994.5 1463.4 2404.2 
Phosphorus, mg 1931.1±53.0 703.2 1168.1 1694.3 2380.8 4076.6 
Iron, mg 25.2 ± 0.9 8.2 14.3 20.8 30.6 59.8 
Zinc, mg 17.3±0.6 5.6 9.6 14.1 21.1 40.4 
Magnesium, mg 412.4 ± 11.6 146.6 244.4 357.4 507.8 869.1 
Food Pyramid Servings 
Grains 8.2 ± 0.3 1.9 4.4 6.7 10.7 19.1 
Vegetables 3.1±0.1 0.8 1.5 2.4 3.7 7.7 
Fruits 1.5±0.1 0.2 0.7 1.2 2.0 4.0 
Dairy 1.8 ± 0.1 0.2 0.7 1.4 2.6 4.4 
Meat 4.1±0.1 1.2 2.3 3.3 5.0 10.1 
1 Retinol activity equivalents 
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Table 2. Micronutrient intake from food and sueelements for the REACH cohort stud~ 
Percentiles 
n=391 Mean±SE 5th 25th 5oth 75th 95th 
Vitamins 
Vitamin A, RAE 1 1452.7 ± 53.4 281.1 662.0 1121.6 2129.6 3499.7 
Thiamin (B 1), mg 3.2 ± 0.1 1.0 1.8 2.7 4.0 6.9 
Riboflavin (B2), mg 3.4±0.1 1.0 1.9 3.0 4.4 6.9 
Niacin, mg 44.3 ± 1.4 13.4 25.8 38.8 55.9 94.4 
Vitamin Bfo mg 3.6 ± 0.1 1.1 2.1 3.2 4.6 7.3 
Vitamin C, mg 308.3 ± 11.2 68.2 152.5 241.5 414.3 678.4 
Folic Acid, DFE 2 828.2 ± 26.3 224.4 439.2 691.6 1139.6 1844.8 
Vitamin D, IU 369.7 ± 15.4 48.6 122.1 290.8 546.4 934.5 
Vitamin E, mg 17.0±0.7 4.2 8.9 15.1 21.0 34.0 
a-tocopherol 
Minerals 
Calcium, mg 1171.0 ± 33.3 364.9 663.6 1052.3 1556.3 2521.0 
Phosphorus, mg NA3 
Iron, mg 34.2 ± 1.3 8.5 16.8 27.7 41.2 91.5 
Zinc, mg 21.2±0.7 6.0 11.2 19.2 27.7 46.3 
Magnesium, mg 439.4 ± 11.9 156.9 277.5 390.0 559.0 885.4 
Retinol activity equivalents 
2 Dietary folate equivalents 
3Not available 
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Table 3. Macronutrient intake and energy distribution by sex for the REACH cohort study 
Percentiles 
Males (n=97) Mean±SE 5th 25th 50th 75th 95th 
Energy, kcal 4275.l ± 237.3 * 1700.0 2659.5 3617.5 5330.4 8981.3 
Carbohydrate, gm 509.9 ± 28.7 * 198.0 304.6 437.0 664.5 1098.3 
Protein, gm 140.9 ± 8.1 * 56.5 86.3 118.6 179.0 306.1 
Fat, gm 185.7 ± 11.3 * 61.4 110.3 160.7 228.8 407.0 
Saturated fat, gm 57.2 ± 3.4 * 18.1 33.3 53.4 70.6 121.3 
Dietary fiber, gm 25.9 ± 1.7 # 8.3 14.0 22.0 32.9 56.5 
Dietary cholesterol, mg 526.3 ± 29.9 * 148.8 317.5 447.4 668.6 1145.5 
Energy distribution 
(%of total) 
Carbohydrate 47.8 ± 0.7 # 38.1 43.9 47.3 51.9 59.0 
Protein 13.4 ± 0.3 9.0 11.7 12.9 15.2 17.7 
Fat 38.7 ± 0.6 28.3 35.7 38.8 41.9 48.7 
Saturated fat 12.0 ± 0.2 8.0 11.0 12.0 13.l 15.4 
Adjusted by body weight 
Energy, kcal/kg 61.8 ± 3.6 ** 21.l 34.3 52.2 80.3 135.4 
Protein, gm/kg 2.0 ± 0.1 ** 0.7 1.2 1.7 2.7 4.7 
Females (n=294) 
Energy, kcal 3609.3 ± 111.6 * 1230.4 2144.1 3272.9 4732.2 7251.6 
Carbohydrate, gm 440.2 ± 13.6 * 153.0 275.2 393.5 570.9 845.8 
Protein, gm 118.7±4.0* 41.0 69.7 106.0 144.2 273.9 
Fat, gm 154.9 ± 5.4 * 50.2 87.6 133.9 205.1 334.4 
Saturated fat, gm 48.2 ± 1.6 * 14.6 27.4 43.0 64.5 101.8 
Dietary fiber, gm 22.1±0.8 # 6.9 13.1 19.0 28.3 47.9 
Dietary cholesterol, mg 444.5 ± 16.8 * 134.9 237.l 378.3 548.7 1133.6 
Energy distribution 
(%of total) 
Carbohydrate 49.2 ± 0.4 # 36.3 44.9 49.3 53.6 61.5 
Protein 13.4 ± 0.2 8.8 11.0 12.9 15.0 20.0 
Fat 38.0 ± 0.4 27.6 34.0 38.2 42.4 47.9 
Saturated fat 11.8±0.1 8.3 10.2 11.8 13.1 15.6 
Adjusted by body weight 
Energy, kcal/kg 50.2 ± 1.8 ** 13.5 26.8 44.6 66.1 107.1 
Protein, gm/kg 1.6 ± 0.1 ** 0.4 0.8 1.4 2.1 3.7 
Differences by sex tested using two-sample t-tests, ** p <0.01; * p <0.05; p <0.10 
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Table 4. Macronutrient intake and energy distribution by HIV status for the REACH cohort study 
Percentiles 
HIV+ (n=264) Mean ±SE 5th 25th 50th 75th 95th 
Energy, kcal 3901.3 ± 130.3 # 1296.7 2297.6 3544.2 4932.9 7488.8 
Carbohydrate, gm 467.9 ± 15.4 152.8 285.3 423.2 614.6 906.9 
Protein, gm 128.9 ± 4.6 # 46.3 73.8 112.4 159.6 288.8 
Fat, gm 170.1 ± 6.4 * 49.9 95.5 146.8 219.4 358.3 
Saturated fat, gm 53.1±2.0 ** 14.9 30.1 47.0 69.8 109.2 
Dietary fiber, gm 23.3 ± 0.9 8.2 13.4 19.5 30.0 52.3 
Dietary cholesterol, mg 491.1 ± 18.6 ** 137.4 282.6 416.4 629.7 1146.5 
Energy distribution (% of total) 
Carbohydrate 48.5 ± 0.5 36.2 44.6 48.1 52.8 61.3 
Protein 13.4 ± 0.2 8.7 11.1 12.9 15.1 20.0 
Fat 38.5 ± 0.4 # 27.6 34.7 38.7 42.7 48.6 
Saturated fat 12.1 ± 0.1 * 8.3 10.8 12.2 13.4 15.9 
Adjusted by body weight 
Energy, kcal/kg 54.8 ± 2.0 14.3 29.6 49.8 72.7 112.5 
Protein, gm/kg 1.8 ± 0.1 # 0.5 0.9 1.6 2.3 4.2 
HIV- (n=l27) 
Energy, kcal 3510.9 ± 165.7 # 1345.8 2155.2 3069.5 4260.8 7665.1 
Carbohydrate, gm 435.9 ± 21.4 173.2 280.8 369.2 550.5 895.2 
Protein, gm 114.5 ± 5.6 # 43.6 70.8 94.2 143.9 256.9 
Fat, gm 146.7 ± 7.4 * 54.9 88.3 128.6 190.7 321.3 
Saturated fat, gm 44.9 ± 2.2 ** 14.7 27.4 39.4 56.8 99.8 
Dietary fiber, gm 22.5 ± 1.3 6.8 13.4 19.0 29.3 47.7 
Dietary cholesterol, mg 410.0 ± 23.1 ** 123.9 233.8 335.1 493.6 1019.6 
Energy distribution (% of total) 
Carbohydrate 49.6 ± 0.6 40.0 44.5 49.7 53.6 60.8 
Protein 13.3 ± 0.3 9.1 11.3 12.8 15.2 18.6 
Fat 37.3 ± 0.5 # 28.0 34.2 37.8 40.7 46.9 
Saturated fat 11.4 ± 0.2 ** 7.9 10.0 11.5 12.7 14.9 
Adjusted by body weight 
Energy, kcal/kg 49.5 ± 2.7 15.7 26.7 41.7 62.8 110.8 
Protein, gm/kg 1.6 ± 0.1 # 0.5 0.9 1.3 2.0 3.6 
Differences by HIV status tested using two-sample t-tests, ** p <0.01; * p <0.05; p <0.10 
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Table 5. Macronutrient intake from food by CD4+ T-cells (cells/µL) for the REACH cohort study 
Percentiles 
Mean±SE 5th 25th so th 75th 95th 
Energy, kcal 
HIV+ CD4+ 2500 a 3872.l ± 187.5 1328.0 2333.8 3581.0 4866.2 7610.7 
HIV+ CD4+ 200-499 b 4025.6 ± 216.6 1377.5 2375.3 3476.2 5506.6 8729.0 
HIV+ CD4+ <200 c 3631.0 ± 322.5 905.4 2113.5 3582.3 4604.0 7217.9 
HIV-d 3510.9 ± 165.7 1345.8 2155.2 3069.5 4260.8 7665.1 
Carbohydrate, g 
HIV+ CD4+ 2500 468.7 ± 22.7 147.4 283.6 417.9 627.3 874.0 
HIV+ CD4+ 200-499 477.7 ± 24.9 160.4 287.3 434.9 625.8 1069.6 
HIV+ CD4+ <200 435.4 ± 38.3 120.0 284.7 398.7 557.4 901.8 
HIV- 435.9±21.4 173.2 280.8 369.2 550.5 895.2 
Protein, g 
HIV+ CD4+ 2500 126.1±6.7 42.8 72.9 112.5 155.4 288.9 
HIV+ CD4+ 200-499 135.1±7.8 47.2 80.0 112.2 177.9 322.1 
HIV+ CD4+ <200 120.5 ± 10.6 23.7 69.1 112.7 164.6 252.4 
HIV- 114.5 ± 5.6 43.6 70.8 94.2 143.9 256.9 
Fat, g 
HIV+ CD4+ 2500 168.5 ± 9.0 52.1 93.8 114.8 215.6 357.7 
HIV+ CD4+ 200-499 177.9±11.0# 52.5 98.9 145.9 239.1 404.5 
HIV+ CD4+ <200 152.9 ± 14.6 31.5 84.3 147.0 206.2 332.6 
HIV- 146.7 ± 7.4 # 54.9 88.3 128.6 190.7 321.3 
Saturated fat, g 
HIV+ CD4+ 2500 52.7 ± 2.8 16.0 30.1 46.6 69.7 114.1 
HIV+ CD4+ 200-499 55.3 ± 3.2 * 13.8 31.5 49.4 74.8 118.8 
HIV+ CD4+ <200 48.0 ± 4.5 8.7 27.6 45.9 63.6 110.4 
HIV- 44.9 ± 2.2 * 14.7 27.4 39.4 56.8 99.8 
Dietary fiber, g 
HIV+ CD4+ 2500 22.6 ± 1.2 7.1 13.2 19.2 29.6 51.9 
HIV+ CD4+ 200-499 24.9 ± 1.5 8.7 14.1 20.0 30.9 56.2 
HIV+ CD4+ <200 21.0 ± 1.9 5.7 12.0 17.3 31.1 40.7 
HIV- 22.5 ± 1.3 6.8 13.4 19.0 29.3 47.7 
Dietary cholesterol, mg 
HIV+ CD4+ 2500 484.4 ± 26.3 133.5 292.0 409.4 629.5 1112.0 
HIV+ CD4+ 200-499 509.1±31.6 * 139.1 288.0 428.7 663.5 1169.6 
HIV+ CD4+ <200 461.4 ± 44.0 108.9 287.0 387.l 634.2 1065.6 
HIV- 410.0±23.1 * 123.9 233.8 335.1 493.6 1019.6 
Energy, kcal/kg 
HIV+ CD4+ 2500 51.4 ± 2.7 14.1 27.6 47.9 69.2 103.5 
HIV+ CD4+ 200-499 58.9 ± 3.7 15.2 31.1 50.1 79.5 125.6 
HIV+ CD4+ <200 55.5 ± 5.0 11.4 34.1 52.3 65.4 117.6 
HIV- 49.5 ± 2.7 15.7 26.7 41.7 62.8 110.8 
Protein, gm/kg 
HIV+ CD4+ 2500 1.7 ± 0.1 0.4 0.8 1.3 2.2 3.7 
HIV+ CD4+ 200-499 2.0 ± 0.1 # 0.5 1.0 1.7 2.7 4.6 
HIV+ CD4+ <200 1.8 ± 0.2 0.3 1.0 1.8 2.3 3.8 
HIV- 1.6 ± 0.1 # 0.5 0.9 1.3 2.0 3.6 
•n=129; 6n=102; c n=33; a n=127; * p <0.05; # p <0.10 (ANOV A) Similar superscripts indicate significant 
differences by pairwise comparison. 
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Table 6. Macronutrient intake from food bl: sex and HIV status for the REACH cohort studl'. 
Percentiles 
Mean±SE 5th 25th 5oth 75th 95tli 
Energy, kcal 
Females: HIV+ a 3691±137 1152.5 2157.1 3454.0 4706.2 7248.1 
HIV-b 3445 ± 191 1329.8 2125.8 3016.6 4109.2 7392.9 
Males: HIV+c 4507 ± 304 # 1711.5 2795.9 4013.8 5653.3 9975.4 
HIV-d 3732 ± 333 # 1344.8 2529.0 3256.6 4739.2 8364.2 
Carbohydrate, g 
Females: HIV+ 446.8 ± 16.4 137.5 273.9 416.3 588.5 864.6 
HIV- 427.0± 24.2 171.4 276.3 368.3 522.4 834.0 
Males: HIV+ 528.7 ± 35.8 196.9 306.5 451.5 694.2 1108.8 
HIV- 466.0 ± 46.3 182.8 294.4 384.9 561.4 1094.9 
Protein, g 
Females: HIV+ 121.9 ± 5.0 39.7 70.3 108.0 146.5 285.8 
HIV- 112.3 ± 6.4 41.1 69.3 94.1 139.8 256.6 
Males: HIV+ 148.9 ± 10.4 # 57.3 86.2 123.2 183.5 336.2 
HIV- 122.1 ± 11.7 # 52.7 86.6 106.8 146.4 297.9 
Fat,g 
Females: HIV+ 159.8 ± 6.7 44.5 89.3 138.5 210.5 341.3 
HIV- 145.1±8.7 54.7 86.4 126.4 191.1 309.3 
Males: HIV+ 200.1 ± 14.8 * 64.5 113.3 177.2 239.7 451.2 
HIV- 152.0 ± 13.2 * 45.0 103.6 131.6 190.3 335.7 
Saturated fat, g 
Females: HIV+ 50.2 ± 2.1 # 13.6 28.9 44.6 68.8 101.6 
HIV- 44.2 ± 2.6 # 14.8 24.8 38.0 57.0 106.0 
Males: HIV+ 61.6 ± 4.4 * 18.8 35.1 56.8 74.8 131.4 
HIV- 47.0±4.0 * 11.5 33.0 40.7 58.4 99.2 
Dietary fiber, g 
Females: HIV+ 22.1±0.9 7.9 12.9 19.2 28.7 48.8 
HIV- 22.1±1.6 6.6 13.3 18.3 26.4 44.8 
Males: HIV+ 26.8 ± 2.2 8.3 14.0 21.1 33.8 62.8 
HIV- 23.9 ± 2.3 8.3 14.0 22.4 31.3 51.8 
Dietary cholesterol, mg 
Females: HIV+ 464.6 ± 21.2 # 136.5 263.2 384.6 587.3 1141.1 
HIV- 404.3 ± 26.8 # 118.6 230.1 321.8 503.1 980.1 
Males: HIV+ 567.6±37.1 * 169.7 343.7 503.4 746.6 1220.5 
HIV- 429.4 ± 45.4 * 107.6 291.5 365.6 469.3 1091.1 
Energy, kcal/kg 
Females: HIV+ 50.8 ± 2.2 12.7 27.5 47.4 67.6 107.3 
HIV- 49.0± 3.2 15.4 25.3 41.8 63.0 108.1 
Males: HIV+ 66.4 ± 4.5 * 22.9 34.4 61.7 90.0 162.9 
HIV- 51.1±5.2 * 16.5 34.3 41.2 62.3 127.7 
Protein, gm/kg 
Females: HIV+ 1.7±0.1 0.4 0.9 1.4 2.1 4.0 
HIV- 1.6 ± 0.1 0.4 0.8 1.3 2.1 3.5 
Males: HIV+ 2.2 ±0.2 * 0.7 1.2 1.9 2.9 4.9 
HIV- 1.7 ± 0.2 * 0.6 1.1 1.4 1.9 4.6 
"n=l96; 6n=98; c n=68; a n=29; Differences by HIV status for males and females tested separately using two-
sample t-tests 
* p <0.05; # p <0.10 
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Table 7. Food Guide P~ramid servings b~ sex for the REACH cohort stud~ 
Percentiles 
Mean±SE 5th 25th 5oth 7516 95th 
Grains 
Males a 9.3 ± 0.6 # 2.7 5.0 7.7 13.8 21.5 
Females b 7.8±0.3# 1.8 4.2 6.4 10.3 18.0 
Vegetables 
Males 3.5 ±0.2 * 1.0 1.9 2.6 4.4 10.2 
Females 2.9 ± 0.1 * 0.6 1.4 2.3 3.6 7.1 
Fruits 
Males 1.5 ± 0.1 0.3 0.8 1.2 1.9 4.3 
Females 1.5 ± 0.1 0.2 0.7 1.2 2.1 4.0 
Dairy 
Males 2.0 ± 0.1 * 0.2 0.8 1.7 2.9 4.6 
Females 1.7±0.1* 0.2 0.6 1.3 2.3 4.4 
Meats 
Males 4.6 ± 0.3 # 1.5 2.7 3.9 5.2 10.3 
Females 4.0 ± 0.2 # 1.1 2.2 3.2 4.7 9.9 
• n=97; 6 n=294; * p <0.05; # p <0.10 (two sample t-tests with separate variance) 
Table 8. Food Guide P~ramid servings b~ sex and HIV status for the REACH cohort stud~ 
Percentiles 
Mean±SE 5th 25th 5016 75th 95th 
Grains 
Females: HIV+• 7.7 ± 0.3 1.7 4.0 6.6 10.8 17.9 
HIV-b 8.0±6.5 2.3 4.5 6.3 9.0 20.2 
Males: HIV+c 9.7 ±0.7 2.6 5.1 8.1 15.1 21.8 
HIV-d 8.2 ±0.9 2.3 4.9 7.1 10.3 21.4 
Vegetables 
Females: HIV+ 3.0 ± 0.1 0.6 1.4 2.6 3.8 7.3 
HIV- 2.7 ±0.2 0.7 1.4 2.2 3.4 6.4 
Males: HIV+ 3.0 ± 0.3 1.0 2.0 2.7 4.4 9.1 
HIV- 3.7 ±0.6 1.0 1.7 2.2 5.0 12.6 
Fruits 
Females: HIV+ 1.5 ± 0.1 0.2 0.6 1.2 2.0 4.1 
HIV- 1.6 ± 0.1 0.2 0.7 1.2 2.2 4.1 
Males: HIV+ 1.5 ± 0.1 0.2 0.6 1.2 1.9 3.9 
HIV- 1.7 ± 0.2 0.4 1.1 1.2 2.3 4.6 
Meats 
Females: HIV+ 4.1±0.2 1.1 2.2 3.4 5.0 10.2 
HIV- 3.7 ± 0.3 1.3 2.1 2.9 4.6 9.3 
Males: HIV+ 4.1±0.4 1.5 2.5 4.1 5.6 12.0 
HIV- 4.0 ± 0.5 1.2 2.7 3.2 4.7 10.7 
Dairy 
Females: HIV+ 1.7±0.1 0.2 0.6 1.4 2.7 4.4 
HIV- 1.6 ± 0.1 0.3 0.6 1.2 2.0 4.5 
Males: HIV+ 1.7 ± 0.2 0.2 0.9 2.0 3.2 5.0 
HIV- 1.7 ± 0.2 0.1 0.8 1.5 2.7 3.7 
•n=l96; 6n=98; c n=68; a n=29; Differences by HIV status for males and females tested separately using two-
sample t-tests-no differences found 
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Table 9. Vitamin and mineral intake from food b~ sex for the REACH cohort stud~ 
Percentiles 
Mean±SE 5th 25th 5otb 75th 95th 
Vitamin A, RAE 
Males• 1167.2 ± 82.7 # 365.l 627.5 849.3 1376.0 3041.2 
Females b 998.0 ± 44.0 # 254.7 506.3 814.5 1222.7 2413.0 
Thiamin (B1), mg 
Males 3.0 ± 0.2 ** 1.1 1.7 2.6 3.9 6.5 
Females 2.5 ± 0.1 ** 0.7 1.5 2.2 3.0 5.6 
Riboflavin (B2), mg 
Males 3.3 ± 0.2 ** 1.3 1.9 2.8 4.2 7.2 
Females 2.7 ± 0.2 ** 0.8 1.5 2.3 3.4 5.7 
Niacin, mg 
Males 43.3 ± 2.9 * 15.7 25.7 35.6 53.6 97.9 
Females 35.6 ± 2.6 * 11.2 20.6 30.1 45.0 81.9 
Vitamin B6, mg 
Males 3.4 ± 0.2 ** 1.1 2.1 2.9 4.4 7.5 
Females 2.8 ± 0.1 ** 0.9 1.7 2.4 3.6 5.9 
Vitamin C, mg 
Males 282.1±18.0 # 55.7 148.5 249.4 387.7 634.9 
Females 249.3 ± 9.4 # 54.8 126.1 206.9 351.9 564.8 
Folic Acid, µg 
Males 690.0 ± 38.0 * 256.4 400.1 593.2 894.1 1459.0 
Females 587.3 ± 21.1 * 187.8 349.6 505.4 724.1 1276.4 
Vitamin D, JU 
Males 295.1±25.1 62.6 112.7 215.4 385.9 880.0 
Females 250.6 ± 14.5 35.0 95.4 172.1 320.5 713.9 
Vitamin E, mg 
a-tocopherol 
Males 14.8 ± 0.9 * 5.3 8.6 12.9 18.9 33.5 
Females 12.6 ± 0.4 * 3.9 7.3 10.3 16.2 27.2 
Calcium, mg 
Males 1279.6 ± 69.7 ** 395.3 800.4 1065.6 1714.7 2554.5 
Females 1080.1±36.7 ** 321.3 613.2 937.6 1435.3 2398.4 
Phosphorus, mg 
Males 2187.2 ± 120.9 * 921.8 1280.3 1801.0 2755.8 4501.6 
Females 1846.6 ± 57.3 * 582.6 1122.5 1668.3 2257.8 3849.4 
Iron, mg 
Males 29.6 ± 2.0 ** 10.3 16.4 23.8 36.4 85.0 
Females 23.8 ± 0.9 ** 7.2 13.5 19.6 29.6 56.5 
Zinc, mg 
Males 20.6 ± 1.4 ** 7.9 11.0 16.9 25.8 50.4 
Females 16.2 ± 0.6 ** 4.9 9.3 13.4 19.9 37.9 
Magnesium, mg 
Males 470.0 ± 26.4 ** 171.0 295.9 422.5 544.1 1020.4 
Females 393.4 ± 12.6 ** 128.7 236.0 347.7 498.1 854.3 
• n=97; 6 n=294; ** p <0.01; * p <0.05; # p <0.10 (two sample t-tests with separate variance) 
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Table 10. Retinol and carotenoid intake from food by sex for the REACH cohort study 
Percentiles 
Mean±SE 5th 25th 5oth 75th 95th 
Retinol, µg 
Males a 799.8 ± 53.3 243.8 417.6 618.2 1015.2 1949.l 
Females b 697.4 ± 33.7 148.1 331.7 554.9 845.8 1820.5 
Alpha-carotene, ug 
Males 574.5 ± 75.1 * 40.7 147.l 306.3 609.4 2483.7 
Females 402.6 ± 39.0 * 37.3 104.8 208.8 476.8 1342.4 
Beta-carotene, ug 
Males 3962.4 ± 486.0 474.6 1629.8 2492.1 4687.2 13704.6 
Females 3275.9 ± 192.8 565.1 1182.0 2225.2 3961.7 10207.8 
Cryptoxanthin, ug 
Males 317.9±29.9# 25.4 89.2 225.1 477.2 994.1 
Females 258.2 ± 14.4 # 16.9 78.5 167.1 386.1 761.2 
Lutein, ug 
Males 1925.4 ± 246.9 193.4 787.6 1242.6 2406.7 5273.9 
Females 1981.6 ± 141.4 238.8 699.2 1232.9 2395.8 6156.8 
Lycopene, ug 
Males 11356.3 ± 1066.2 * 1170.2 4179.2 7333.8 15716.9 35230.8 
Females 8679.5 ± 552.8 * 737.1 2702.8 5554.4 11248.6 27090.1 
a n=97; n=294; * p <0.05; p <0.10 (two sample t-tests with separate variance) 
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Table 11. Vitamin and carotenoid intake from food by HIV status for the REACH cohort study 
Percentiles 
HIV+ (n=264) Mean ±SE 5th 25th 50th 75th 95th 
Vitamin A, RAE 1080.6 ± 48.9 266.3 563.3 836.2 1351.9 2739.9 
Thiamin (B 1), mg 2.7 ± 0.1 0.8 1.6 2.4 3.5 6.1 
Riboflavin (B2), mg 2.9 ± 0.1 # 0.9 1.7 2.6 3.9 6.3 
Niacin, mg 38.6 ± 1.4 12.9 22.1 33.4 46.8 86.5 
Vitamin B6, mg 3.0 ± 0.1 1.0 1.7 2.6 3.9 6.6 
Vitamin C, mg 256.4 ± 10.2 55.2 129.7 210.4 353.4 601.6 
Folic Acid, µg 621.9 ± 22.3 211.8 356.6 523.1 780.9 1404.1 
Vitamin D, IU 274.5 ± 16.1 40.0 106.6 187.4 333.0 910.7 
Vitamin E, mg 13.6 ± 0.5 4.2 7.7 10.1 15.4 26.8 
a-tocopherol 
Carotenoids 
a-carotene, µg 439.2 ± 34.4 40.1 114.5 250.0 547.4 1593.l 
~-carotene, µg 3474.4 ± 235.5 577.3 1231.3 2415.6 4266.4 10558.3 
Cryptoxanthin, µg 259.1±15.5 17.9 84.5 163.8 386.7 777.0 
Lutein, µg 2026.0 ± 155.1 223.2 724.3 1233.5 2440.3 6081.1 
Lycopene, µg 9570.6 ± 626.9 718.0 2905.6 5738.5 12345.7 33864.6 
Minerals 
Calcium, mg 1160.2 ± 40.4 337.7 648.l 1093.0 1548.9 2425.7 
Phosphorus, mg 1996.3 ± 66.2 # 662.6 1165.8 1784.1 2549.9 4187.4 
Iron, mg 25.8 ± 1.0 8.1 10.4 21.0 31.1 63.7 
Zinc, mg 18.1±0.8 * 5.1 9.5 14.5 22.6 45.1 
Magnesium, mg 420.8 ± 14.5 133.7 241.0 361.2 525.0 883.3 
HIV- (n=l27) 
Vitamin A, RAE 955.5 ± 63.9 268.6 472.5 775.2 1199.6 2249.4 
Thiamin (B 1), mg 2.5 ± 0.1 0.9 1.5 2.1 3.0 5.3 
Riboflavin (B2), mg 2.6 ± 0.1 # 0.9 1.6 2.1 3.2 5.6 
Niacin, mg 35.2 ± 1.9 11.6 21.6 29.1 41.7 78.2 
Vitamin Bfo mg 2.8 ± 0.1 1.0 1.7 2.4 3.3 5.6 
Vitamin C, mg 259.6 ± 14.8 58.0 128.5 212.7 369.4 577.4 
Folic Acid, µg 594.0 ± 33.4 205.3 364.2 524.9 709.2 1207.9 
Vitamin D, IU 234.8 ± 19.l 39.0 89.4 165.0 320.8 677.1 
Vitamin E, mg 13.2 ± 0.7 3.9 7.8 11.8 17.4 30.0 
a-tocopherol 
Carotenoids 
a-carotene, µg 457.9 ± 80.5 36.4 104.3 216.5 456.2 1879.3 
~-carotene, µg 3387.7 ± 315.0 511.0 1195.7 2214.5 3812.2 11884.l 
Cryptoxanthin, µg 302.0 ± 24.7 18.0 95.0 225.0 495.0 834.9 
Lutein, µg 1846.4 ± 196.5 268.3 669.5 1176.4 2247.3 5990.0 
Lycopene, µg 8871.7 ± 794.6 1121.8 2960.2 6109.3 11224.6 26413.6 
Minerals 
Calcium, mg 1068.0 ± 56.0 366.2 635.5 889.4 1352.5 2400.1 
Phosphorus, mg 1795.3 ± 86.5 # 717.2 1168.1 1488.4 2201.6 3974.l 
Iron, mg 24.0 ± 1.6 8.8 13.8 20.0 28.8 55.5 
Zinc, mg 15.5 ± 0.7 * 5.8 9.6 13.5 19.5 30.2 
Magnesium, mg 395.2 ± 19.2 154.5 253.7 339.1 490.6 770.0 
* p <0.05; p <0.10 (t-test with separate variance) 
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Table 12. Vitamin intake from food b;y CD4+ T-cells 1cells/!;!:L} for the REACH cohort stud;y 
Percentiles 
Mean ±SE 5th 25th 5oth 75th 95th 
Vitamin A, RAE 
HIV+ CD4+ 2500 a 1050.6 ± 68.8 261.4 565.2 837.7 1284.8 2810.3 
HIV+ CD4+ 200-499 b 1161.2 ± 85.8 308.0 608.3 817.8 1539.2 2928.2 
HIV+ CD4+ <200 c 948.8 ± 100.5 179.2 497.3 865.2 1400.1 2141.2 
HIV-d 955.5 ± 63.9 268.6 472.5 775.2 1200.6 2249.4 
Thiamin (B1), mg 
HIV+ CD4+ 2500 2.6 ± 0.1 0.8 1.6 2.4 3.2 5.7 
HIV+ CD4+ 200-499 2.9 ±0.2 0.9 1.6 2.4 3.9 6.8 
HIV+ CD4+ <200 2.4 ± 0.2 0.6 1.4 2.3 3.5 4.7 
HIV- 2.5 ± 0.1 0.9 1.5 2.1 3.0 5.3 
Riboflavin (B2), mg 
HIV+ CD4+ 2500 2.8 ± 0.1 0.8 1.6 2.4 3.6 6.1 
HIV+ CD4+ 200-499 3.1±0.2# 1.0 1.8 2.7 4.1 6.7 
HIV+ CD4+ <200 2.7 ±0.2 0.6 1.6 2.6 3.6 5.3 
HIV- 2.6 ± 0.1 # 0.9 1.6 2.1 3.2 5.6 
Niacin, mg 
HIV+ CD4+ 2500 36.9 ± 2.0 11.5 22.0 30.9 45.5 85.8 
HIV+ CD4+ 200-499 41.4 ± 2.5 14.1 22.5 34.7 57.9 89.0 
HIV+ CD4+ <200 36.3 ± 3.4 8.5 21.4 35.4 45.7 75.4 
HIV- 35.2 ± 1.9 11.6 21.6 29.1 41.7 78.2 
Vitamin B6, mg 
HIV+ CD4+ 2500 2.9 ± 0.1 1.0 1.7 2.6 3.8 6.5 
HIV+ CD4+ 200-499 3.2 ± 0.2 1.3 1.9 2.6 4.2 7.3 
HIV+ CD4+ <200 2.9 ± 0.3 0.8 1.4 2.7 4.0 5.8 
HIV- 2.8 ± 0.1 1.0 1.7 2.4 3.3 5.6 
Vitamin C, mg 
HIV+ CD4+ 2500 253.8 ± 15.1 49.7 113.1 222.1 365.7 603.2 
HIV+ CD4+ 200-499 269.8 ± 16.5 72.7 149.3 219.6 349.8 620.4 
HIV+ CD4+ <200 225.3 ± 24.9 40.9 114.2 182.9 344.7 559.0 
HIV- 259.6 ± 14.8 58.0 128.5 212.7 369.4 577.4 
Folic Acid, µg 
HIV+ CD4+ 2500 602.1±31.0 204.0 366.6 507.7 739.2 1302.1 
HIV+ CD4+ 200-499 664.6 ± 39.3 219.0 352.0 551.5 905.1 1482.6 
HIV+ CD4+ <200 567.2 ± 49.3 145.7 317.4 529.7 737.7 1084.2 
HIV- 594.0 ± 33.4 205.3 364.2 524.9 709.2 1207.9 
Vitamin D, IU 
HIV+ CD4+ 2500 253.8 ± 21.1 37.5 106.2 176.5 308.6 772.4 
HIV+ CD4+ 200-499 295.4 ± 28.1 47.3 115.9 221.3 363.3 915.4 
HIV+ CD4+ <200 291.1 ± 48.0 29.6 92.8 224.4 371.4 1046.0 
HIV- 234.8 ± 19.1 39.0 89.4 165.0 320.8 667.1 
Vitamin E, mg 
a-tocopherol 
HIV+ CD4+ 2500 13.2 ± 0.7 3.9 7.8 11.7 17.5 27.0 
HIV+ CD4+ 200-499 14.5 ± 0.9 4.8 8.0 12.2 18.4 33.3 
HIV+ CD4+ <200 12.1±1.1 2.6 6.6 12.2 16.8 25.5 
HIV- 12.3 ± 0.7 4.2 7.7 10. l 15.4 26.8 
"n=129; 6n=102; c n=33; a n=127; # p <0.10 (ANOVA) Similar superscripts indicate significant differences by 
pairwise comparison. 
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Table 13. Mineral intake from food by CD4+ T-cells (cells/µL) for the REACH study 
Percentiles 
Mean± SE 5th 25th 5oth 75th 95th 
Calcium, mg 
HIV+ CD4+ :2:500 a 1154.8 ± 58.9 306.6 657.6 1062.l 1532.5 2356.7 
HIV+ CD4+ 200-499 b 1207.0 ± 65.7 364.3 648.4 1120.6 1595.5 2586.2 
HIV+ CD4+ <200 c 1036.3 ± 101.3 165.5 501.8 1055.0 1363.0 2317.3 
HIV-d 1068.0 ± 56.0 366.2 635.5 889.4 1352.5 2400.l 
Phosphorus, mg 
HIV+ CD4+ :2:500 1958.5 ± 94.7 618.0 1138.7 1824.7 2513.8 4220.7 
HIV+ CD4+ 200-499 2092.9 ± 111.7 715.6 1198.4 1763.6 2702.1 4548.0 
HIV+ CD4+ <200 1845.8 ± 156.7 419.9 1148.7 1806.7 2340.0 3608.0 
HIV- 1795.3 ± 86.5 717.2 1168.1 1488.4 2201.6 3974.l 
Iron, mg 
HIV+ CD4+ ::::500 24.5 ± 1.4 6.7 13.7 20.6 28.2 60.7 
HIV+ CD4+ 200-499 27.9 ± 1.8 8.3 15.3 21.8 36.6 67.7 
HIV+ CD4+ <200 24.1±2.29 6.4 12.2 23.0 31.4 51.0 
HIV- 24.0 ± 1.6 8.8 13.8 20.0 28.8 55.5 
Zinc, mg 
HIV+ CD4+ :2:500 17.4±1.l 4.6 9.4 13.8 20.8 45.5 
HIV+ CD4+ 200-499 19.3 ± 1.3 5.9 10.0 15.3 24.2 45.9 
HIV+ CD4+ <200 17.4±2.4 2.7 8.8 13.3 23.0 46.8 
HIV- 15.5±0.7 5.8 9.7 13.5 19.5 30.2 
Magnesium, mg 
HIV+ CD4+ :2:500 405.9 ± 19.8 122.l 238.8 351.4 511.6 854.0 
HIV+ CD4+ 200-499 446.9 ± 25.5 162.7 258.7 368.3 596.4 1001.3 
HIV+ CD4+ <200 398.3 ± 35.9 94.8 238.8 371.8 527.0 833.9 
HIV- 395.2 ± 19.2 154.5 253.7 339.1 490.6 770.0 
"n=l29; 6n=102; c n=33; a n=l27; No significant differences found using ANOVA 
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Table 14. Carotenoid intake from food bl'. CD4+ T-cells ~ cells/t±L} for the REACH cohort studl'. 
Percentiles 
Mean±SE 5th 25th 5oth 75th 95th 
Alpha-carotene, µg 
HIV+ CD4+ ~500 • 445.8 ± 54.1 42.2 113.8 236.6 492.9 1934.1 
HIV+ CD4+ 200-499 b 480.2 ± 55.1 36.6 118.7 252.8 669.8 1581.8 
HIV+ CD4+ <200 c 286.2 ± 39.6 27.0 99.4 257.0 396.5 739.1 
HIV-d 457.9 ± 80.5 36.4 104.3 216.5 456.2 1879.3 
Beta-carotene, µg 
HIV+ CD4+ ~500 3419.8 ± 365.9 560.2 1198.1 2150.4 4221.8 10624.2 
HIV+ CD4+ 200-499 3641.9 ± 368.4 596.0 1296.5 2514.5 4496.0 12477.6 
HIV+ CD4+ <200 3170.1 ±471.2 285.8 1085.6 2527.2 4176.9 9990.5 
HIV- 3387.7 ± 315.0 511.0 1195.7 2214.5 3812.2 11884.1 
Cryptoxanthin, µg 
HIV+ CD4+ ~500 252.3 ± 22.7 16.l 71.9 151.0 397.9 836.1 
HIV+ CD4+ 200-499 283.3 ± 24.9 20.7 113.1 218.3 403.5 799.3 
HIV+ CD4+ <200 211.0 ± 38.4 14.7 79.3 144.8 252.5 775.8 
HIV- 302.0 ± 24.7 18.0 95.0 255.0 495.0 834.9 
Lutein, µg 
HIV+ CD4+ ~500 2156.2 ± 250.4 236.1 706.7 1233.6 2566.4 6631.7 
HIV+ CD4+ 200-499 1718.6 ± 171.3 193.4 770.2 1243.4 2171.6 4687.0 
HIV+ CD4+ <200 2466.9 ± 544.7 183.4 647.9 1218.1 2871.4 10755.3 
HIV- 1846.4 ± 196.5 268.3 669.5 1176.5 2247.3 5990.0 
Lycopene, µg 
HIV+ CD4+ ~500 8880.0 ± 813.8 499.1 2315.1 5096.9 12256.2 28918.5 
HIV+ CD4+ 200-499 10571.1 ± 1135.6 976.9 3431.3 6829.0 12690.8 41422.2 
HIV+ CD4+ <200 9959.1 ± 1646.4 661.3 4076.7 6148.8 12320.1 37465.0 
HIV- 8871.7 ± 794.6 1121.8 2960.2 6109.3 11224.6 26413.6 
• n=129; 6 n=102; c n=33; a n=127; No significant differences found using ANOV A 
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Table 15. Vitamin intake from food b~ sex and HIV status for the REACH stud~ 
Percentiles 
Mean±SE 5th 25th 501h 75th 95th 
Vitamin A, RAE 
Females: HIV+ a 1025.0 ± 55.3 256.5 512.8 821.4 1254.7 2477.8 
HIV- b 944.0 ± 72.2 231.8 465.l 762.6 1193.6 2244.7 
Males: HIV+c 1241.0± 101.2 359.4 648.3 978.6 1490.7 3136.4 
HIV-d 994.4 ± 139.3 349.7 546.3 784.8 1210.8 3262.2 
Thiamin (B1), mg 
Females: HIV+ 2.5 ± 0.1 0.7 1.5 2.3 3.2 5.9 
HIV- 2.4 ± 0.2 0.9 1.5 2.0 2.9 5.1 
Males: HIV+ 3.2 ±0.2 1.1 1.7 2.7 4.1 6.7 
HIV- 2.7 ± 0.3 1.1 1.7 2.3 3.4 6.8 
Riboflavin (B2), mg 
Females: HIV+ 2.7±0.1 0.7 1.6 2.5 3.4 6.2 
HIV- 2.6 ± 0.2 0.9 1.5 2.1 3.2 5.4 
Males: HIV+ 3.4 ± 0.2 # 1.2 1.9 2.8 4.4 7.6 
HIV- 2.8 ± 0.3 # 1.3 1.9 2.4 3.2 6.9 
Niacin, mg 
Females: HIV+ 36.l ± 1.5 11.1 20.9 30.7 45.2 85.7 
HIV- 34.4 ± 2.2 11.0 20.2 28.2 42.5 73.3 
Males: HIV+ 45.5 ± 3.3 15.9 25.0 37.5 61.5 99.3 
HIV- 38.0 ± 4.1 14.1 26.4 34.8 42.0 106.2 
Vitamin B6, mg 
Females: HIV+ 2.9 ± 0.1 0.9 1.6 2.6 3.7 6.2 
HIV- 2.7 ± 0.2 0.9 1.7 2.3 3.3 5.6 
Males: HIV+ 3.5 ±0.2 1.1 2.1 3.0 4.5 7.6 
HIV- 3.2 ± 0.4 1.1 2.1 2.9 3.7 8.8 
Vitamin C, mg 
Females: HIV+ 246.5 ± 11.4 54.8 124.6 204.4 344.9 562.9 
HIV- 255.0 ± 16.8 52.8 128.0 255.0 369.6 585.2 
Males: HIV+ 285.1±22.1 * 52.3 153.4 244.2 387.8 646.6 
HIV- 275.2 ± 31.5 * 67.2 132.8 282.6 386.7 656.6 
Folic Acid, µg 
Females: HIV+ 588.0 ± 24.5 184.5 349.l 503.5 729.2 1300.3 
HIV- 586.0 ± 40.l 185.5 351.7 586.0 705.3 1166.5 
Males: HIV+ 719.5 ± 48.6 251.3 406.0 628.6 922.8 1525.4 
HIV- 620.7 ± 55.4 256.3 391.0 530.9 745.4 1421.1 
Vitamin D, IU 
Females: HIV+ 257.6 ± 18.5 33.3 100.0 174.0 321.4 818.1 
HIV- 236.7 ± 22.7 35.l 90.8 162.8 320.5 667.8 
Males: HIV+ 323.4 ± 32.2 76.3 136.8 228.4 460.5 973.7 
HIV- 228.7 ± 34.2 55.0 75.6 165.0 363.6 691.2 
Vitamin E, mg 
a.-tocopherol 
Females: HIV+ 12.8 ± 0.5 3.6 7.1 11.2 16.7 27.6 
HIV- 12.4 ± 0.8 4.0 7.5 10.0 15.3 27.1 
Males: HIV+ 16.0± 1.1* 5.2 8.7 14.0 19.9 37.l 
HIV- 15.1±1.0 * 5.2 8.1 10.4 15.5 24.l 
• n= 196; 6 n=98; c n=68; a n=29; Differences by HIV status for males and females tested separately using two-
sample t-tests with separate variance; * p <0.05; # p <0.10 
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Table 16. Retinol and carotenoid Intake from food b~ sex and HIV status for the REACH cohort stud~ 
Percentiles 
Mean±SE 5th 25th 5oth 75th 95th 
Retinol, ug 
Females: HIV+ a 731.5 ± 44.2 137.0 343.2 565.6 886.3 1830.6 
HIV- b 629.2 ± 48.7 172.1 294.3 521.7 766.9 1825.0 
Males: HIV+c 849.7 ± 65.9 244.3 448.2 653.7 1126.2 1995.3 
HIV-d 683.7 ± 86.6 230.1 382.7 565.6 885.8 2053.5 
Alpha-carotene, µg 
Females: HIV+ 369.9 ± 30.9 36.6 105.7 209.0 487.8 1279.7 
HIV- 468.1 ±99.6 45.6 104.0 205.2 440.7 2015.6 
Males: HIV+ 638.9 ± 96.2 50.8 157.4 384.6 681.8 2800.1 
HIV- 423.4± 108.1 20.3 112.5 275.5 570.2 2104.6 
Beta-carotene, µg 
Females: HIV+ 3214.8 ± 229.3 569.2 1172.2 2263.3 3919.5 10137.7 
HIV- 3398.1 ± 354.1 520.7 1184.1 2142.1 4135.6 10837.4 
Males: HIV+ 4222.6 ± 626.6 641.5 1653.0 2589.0 5069.1 14800.4 
HIV- 3352.4 ± 697.9 372.1 1305.9 2256.6 3461.8 14298.2 
Cryptoxanthin, µg 
Females: HIV+ 242.5 ± 16.5 16.6 79.0 161.0 365.6 743.7 
HIV- 289.8 ± 28.0 16.2 78.2 212.0 455.7 830.1 
Males: HIV+ 307.1 ± 36.4 22.9 85.7 208.4 454.4 992.5 
HIV- 343.2 ± 52.8 62.9 118.1 256.0 512.0 1080.5 
Lutein, µg 
Females: HIV+ 2063.0 ± 187.9 239.9 706.4 1232.9 2430.3 6147.7 
HIV- 1818.9 ± 197.0 192.2 683.6 1205.9 2260.7 6423.5 
Males: HIV+ 1919.4 ± 264.7 179.8 881.4 1248.0 2453.7 5669.5 
HIV- 1939.6 ± 553.4 352.1 628.6 1133.6 2203.6 10255.3 
Lycopene, µg 
Females: HIV+ 8877.0 ± 698.9 557.6 2593.l 5311.4 11608.5 30162.2 
HIV- 8284.5 ± 896.3 1127.0 2794.6 5852.9 9645.0 25746.3 
Males: HIV+ 11569.7 ± 1346.3 1450.9 4177.4 7323.3 15477.6 40876.6 
HIV- 10856.0 ± 1689.8 597.1 3982.9 7333.8 16504.2 31531.6 
•n=l96; 6 n=98; c n=68; a n=29; Differences by HIV status for males and females tested separately using two-
sample t-tests with separate variance-no significant difference found. 
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Table 17. Mineral intake from food bl'. sex and mv status for the REACH cohort studl'. 
Percentiles 
Mean±SE 5tli 25th soih 75th 95tii 
Calcium, mg 
Females: HIV+" 1093.2 ± 43.6 309.l 620.2 1026.l 1444.0 2362.6 
HIV- b 1056.4 ± 67.6 329.6 580.5 825.1 1356.5 2727.5 
Males: HIV+c 1353.1±90.5 # 390.1 743.6 1125.6 1786.7 2775.2 
HIV-d 1107.3 ± 91.0 # 400.0 841.3 994.5 1364.5 2312.0 
Phosphorus, mg 
Females: HIV+ 1887.9 ± 69.6 551.3 1135.0 1745.2 2371.5 3844.9 
HIV- 1763.6 ± 100.9 653.6 1115.0 1468.1 2205.6 3892.1 
Males: HIV+ 2308.9 ± 155.5 # 911.9 1361.0 1883.1 2958.3 4883.3 
HIV- 1901.7 ± 166.8 # 970.5 1236.9 1650.6 2104.0 4209.2 
Iron, mg 
Females: HIV+ 23.9 ± 1.1 6.9 13.5 20.0 30.0 58.3 
HIV- 23.4 ± 1.8 8.0 12.8 18.8 28.5 52.9 
Males: HIV+ 31.1±2.5 10.3 16.0 25.2 38.7 86.1 
HIV- 26.0 ± 3.1 9.8 16.9 23.0 29.9 75.1 
Zinc, mg 
Females: HIV+ 16.8 ± 0.8 4.5 9.2 13.7 21.0 40.5 
HIV- 14.9 ± 0.9 5.3 9.6 12.5 17.2 34.2 
Males: HIV+ 21.9 ± 1.9 # 7.7 10.9 17.0 26.5 61.0 
HIV- 17.6 ± 1.3 # 8.1 11.4 16.1 24.3 30.1 
Magnesium, mg 
Females: HIV+ 397.4 ± 15.1 121.3 230.9 351.5 503.4 866.3 
HIV- 385.5 ± 22.7 135.1 239.2 323.7 488.4 743.2 
Males: HIV+ 488.0 ± 34.7 165.6 297.2 430.3 611.7 1106.7 
HIV- 427.7 ± 34.0 188.8 293.0 417.1 495.6 857.9 
"n=196; 6n=98; c n=68; a n=29; Differences by HIV status for males and females tested separately using two-
sample t-tests with separate variance; # p <0.10 
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Table 18. Vitamin intake from food and sueeiements b~ sex and HIV status for the REACH stud~ 
Percentiles 
Mean± SE 5th 25th 5oth 75tii 95th 
Vitamin A, RAE 
Females: HIV+ a 1469.9 ± 73.9 260.4 678.0 1164.9 2187.8 3328.8 
HIV- b 1322.3 ± 108.0 231.8 573.6 1014.2 2055.6 3096.0 
Males: HIV+c 1587 .6 ± 131.2 359.4 683.9 1237.0 2378.7 3812.5 
HIV- d 1459.9 ± 205.2 354.0 718.3 1199.6 1959.2 4762.2 
Thiamin (B1), mg 
Females: HIV+ 3.1±0.1 0.7 1.7 2.7 3.9 6.6 
HIV- 2.9 ±0.2 0.9 1.6 2.4 4.0 5.8 
Males: HIV+ 3.7 ±0.3 1.1 2.0 3.1 5.2 7.8 
HIV- 3.1±0.3 1.2 2.0 2.8 3.6 8.3 
Riboflavin (B2), mg 
Females: HIV+ 3.4 ± 0.2 0.8 2.0 3.1 4.4 6.7 
HIV- 3.1 ±0.2 0.9 1.6 2.7 4.1 6.6 
Males: HIV+ 4.0 ± 0.3 1.3 2.2 3.6 5.2 8.5 
HIV- 3.3 ±0.3 1.4 2.3 3.0 3.7 8.6 
Niacin, mg 
Females: HIV+ 43.6 ± 1.9 12.4 25.1 39.1 54.1 92.6 
HIV- 40.6 ± 2.6 11.3 23.5 36.0 51.5 85.0 
Males: HIV+ 51.6 ± 3.6 16.7 28.3 41.7 70.7 115.0 
HIV- 44.2 ± 4.8 15.9 30.8 37.8 46.7 126.2 
Vitamin B6, mg 
Females: HIV+ 3.5±0.l 0.9 2.1 3.3 4.6 7.3 
HIV- 3.2 ±0.2 1.0 1.8 2.8 4.3 6.2 
Males: HIV+ 4.0 ± 0.3 1.2 2.3 3.4 5.8 8.0 
HIV- 3.8 ± 0.4 1.4 2.8 3.3 4.6 10.8 
Vitamin C, mg 
Females: HIV+ 289.8 ± 14.0 69.2 150.3 233.0 380.2 644.4 
HIV- 297.3 ± 20.9 65.3 140.3 241.5 430.0 663.3 
Males: HIV+ 356.6 ± 33.6 56.7 167.5 260.8 494.4 968.0 
HIV- 357.3 ± 50.9 80.1 163.2 299.5 464.6 1107.2 
Folic Acid, µg 
Females: HIV+ 836.3 ± 36.4 201.7 441.0 716.3 1159.0 1842.3 
HIV- 768.4 ± 57.9 185.5 419.2 590.1 1083.8 1925.3 
Males: HIV+ 889.5 ± 59.6 262.9 478.8 851.9 1267.2 1846.3 
HIV- 889.5 ± 87.9 279.0 481.1 709.2 1023.6 2101.1 
Vitamin D, IU 
Females: HIV+ 376.2 ± 22.8 40.6 129.6 299.1 542.4 992.8 
HIV- 329.4 ± 30.0 35.7 94.1 240.3 517.5 810.9 
Males: HIV+ 415.9 ± 34.7 76.3 160.2 385.1 603.3 981.6 
HIV- 352.8 ± 49.6 55.0 110.7 351.0 512.9 990.6 
Vitamin E, mg 
a-tocopherol 
Females: HIV+ 16.4 ± 0.9 3.6 8.8 15.2 20.9 33.0 
HIV- 15.0 ± 0.9 4.0 8.8 14.0 19.0 29.1 
Males: HIV+ 21.3 ± 2.8 6.4 9.9 16.7 25.0 47.2 
HIV- 18.0 ± 2.6 6.0 9.4 15.1 22.3 56.0 
• n=l96; 6 n=98; c n=68; a n=29; Differences by HIV status for males and females tested separately using two-
sample t-tests with separate variance-no significant differences found. 
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Table 19. Mineral intake from food and su~~lement by sex and HIV status_for the REACH cohort study 
Percentiles 
Mean ±SE 5th 25th 5oth 75th 95th 
Calcium, mg 
Females: HIV+ a 1131.1 ±43.8 317.4 653.4 1088.1 1507.3 2382.1 
HIV- b 1093.8 ± 69.5 329.9 630.2 856.6 1422.7 2733.9 
Males: HIV+c 1394.6 ± 91.1 390.l 787.3 1210.1 1920.4 2775.2 
HIV-ct 1177.6 ± 96.8 465.0 856.0 1024.8 1532.5 2377.0 
Phos~horus, mg Surrlement information not available 
Iron, mg 
Females: HIV+ 35.2 ± 1.8 8.0 18.3 29.4 42.5 95.8 
HIV- 32.1±2.9 8.0 15.4 23.7 38.2 100.1 
Males: HIV+ 35.8 ± 2.7 10.4 11.8 17.5 29.3 86.1 
HIV- 30.9 ± 3.7 10.3 17.7 28.3 34.3 93.1 
Zinc, mg 
Females: HIV+ 21.2 ± 0.9 * 4.6 12.0 20.3 28.1 46.7 
HIV- 18.4 ± 1.1 * 5.4 9.9 16.2 25.6 35.9 
Males: HIV+ 22.2 ± 2.1 7.7 11.6 20.4 31.7 64.5 
HIV- 25.0 ± 2.0 8.3 13.6 21.2 27.3 46.1 
Magnesium, mg 
Females: HIV+ 427.1 ± 15.4 123.6 276.9 379.5 557.2 868.6 
HIV- 408.7 ± 23.5 153.2 254.3 358.3 512.6 838.2 
Males: HIV+ 511.2 ± 35.1 176.1 301.0 451.3 649.2 1157.8 
HIV- 458.8 ± 36. l 198.8 298.8 430.3 522.2 957.9 
•n=196; n=98; c n=68; n=29; Differences by HIV status for males and females tested separately using two-
sample t-tests with separate variance; * p <0.05 
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Table 20. Dietar~ Reference Intakes b~ age and sex 
Nutrient Age{~} Males Females Pregnant 
Estimated Average Intake (EAR) 
Vitamin A, µg RAE 1 9-13 445 420 
14-18 630 485 530 
19-30 625 500 550 --------------------· 
Thiamin, mg 9-13 0.7 0.7 
14-18 1.0 0.9 1.2 
19-30 1.0 0.9 1.2 
Riboflavin, mg 9-13 0.8 0.8 
14-18 1.1 0.9 1.2 
19-30 1.1 0.9 1.2 
---··-·- -- . .. -
Niacin, mg NE 9-13 9 9 
14-18 12 11 14 
19-30 12 11 14 
Vitamin B6, mg 9-13 0.8 0.8 
14-18 1.1 1.0 1.6 
19-30 1.1 1.1 1.6 
--------~---·-------~---
Vitamin C, mg 9-13 39 39 
14-18 63 56 66 
19-30 75 60 70 
Folate, µg DFE 9-13 250 
14-18 330 330 520 
19-30 320 320 520 
·-· 
Vitamin E, mg 9-13 9 9 
a-tocopherol 2 14-18 12 12 12 
19-30 12 12 12 ... -"·----·-·---·" -·- ----·--·-··· 
Phosphorus, mg 9-13 1055 1055 
14-18 1055 1055 1055 
19-30 580 580 580 
Iron, mg 9-13 5.9 5.7 
14-18 7.7 7.9 23 
6.0 8.1 22 
Zinc, mg 9-13 8.0 8.0 
14-18 8.5 7.5 10.5 
19-30 9.4 6.8 9.5 
Magnesium, mg 9-13 200 200 
14-18 340 300 335 
19-30 330 255 390 
Adequate Intakes (AI) 
Calcium, mg 9-13 1300 1300 
14-18 1300 1300 1300 
19-30 1000 1000 1000 -
Vitamin D, µg 9-13 5.0 (200 IU) 5.0 
14-18 5.0 5.0 5.0 
19-30 5.0 5.0 5.0 
Adapted from: Institute of Medicine, Dietary Reference Intakes, 1997, 1998, 2000, 2001. 
1 Retinol Activity Equivalents; 1 RAE=l µg retinol +(a-carotene+ cryptoxanthin)/24 + ~-carotene/12 
2As dietary folate equivalents; 1 DFE =1 µg folate from food; Over-estimation of prevalence of inadequacy 
since amount of folic acid fortified in foods not available. 
3 As a-tocopherol; 1 mg a-tocopherol= 1 a-tocopherol equivalents from food x 0.8 
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Table 21. Prevalence of inadequate micronutrient intake from food for the REACH cohort study 
CD4+ T-cell counts 
Total Female Male HIV+ HIV- ~500 200-499 <200 
n 391 294 97 264 127 129 102 33 
Prevalence of inadequacy--Percent below Estimated Avera e Requirement (EAR) 
Vitamins 
Vitamin A 24.6 24.5 24.7 23.1 27.6 23.3 19.6 33.3 
Thiamin 5.9 7.1 # 2.1 # 6.4 4.7 6.2 5.9 9.1 
Riboflavin 4.3 5.4 # 1.0 # 4.9 3.2 5.4 3.9 6.1 
Niacin 4.3 4.8 1.0 3.8 3.9 4.7 2.0 6.1 
Vitamin B6 6.7 8.2 * 2.1 * 6.4 7.1 6.2 4.9 12.1 
Vitamin C 6.4 6.1 7.2 7.2 4.7 10.1 2.9 9.1 
Folic Acid 20.7 23.1 * 13.4 * 22.0 18.l 20.9 22.5 24.2 
Vitamin E 53.5 55.4 47.4 50.4 # 59.8 # 52.7 48.0 48.5 
Minerals 
Phosphorus 5.4 6.5 2.1 5.7 4.7 6.2 3.9 9.1 
Iron 6.4 8.1 * 1.0 * 6.6 5.9 6.9 5.7 8.5 
Zinc 13.3 12.9 14.4 13.3 13.4 12.4 12.7 18.2 
Ma nesium 34.3 33.0 38.1 33.0 37.0 34.9 30.4 33.3 
Prevalence of adequacy--Percent above Adequate Intake (Al) 
Calcium 45.8 44.2 50.5 50.0 * 37.0 * 47.3 52.0 54.5 
VitaminD 46.3 44.6 51.5 48.1 42.5 43.4 52.0 54.5 
* p <0.05; p <0.10; Fisher's exact test for differences by sex and by HIV infection for cells with frequency <5; 
Chi2 Goodness-of-fit test for differences by CD4 cell count. 
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Table 22. Regression models predicting the log of micronutrient intakes with exclusions1 for the REACH 
cohort stud~ 
Dependant variable Vitamin A Vitamin C Vitamin E Iron Zinc 
(Natural log) ~gRAE mg mg mg mg 
Explanatory variables Coefficients 
{Std Error) 
Constant 6.143 4.895 1.893 2.945 2.337 
(0.068) (0.063) (0.091) (0.046) (0.048) 
Energy/1000 kcal 0.161 *** 0.198*** 0.289*** 0.262*** 0.175*** 
(centered) (0.016) (0.017) (0.009) (0.014) (0.013) 
Male -0.088** 
(0.030) 
Black/non-Hispanic 0.064 0.223*** 
(0.042) (0.055) 
Living on own 0.153*** 0.060* 
(0.056) (0.030) 
Vitamin/mineral 0.127** 0.091 ** 0.087** 
supplement use (0.042) (0.028) (0.031) 
RCMAS anxiety index 0.000 
(0.004) 
HIV+ CD4+ T-cells ~ -0.104# -0.054# -0.080* 
cells/µL (0.055) (0.029) (0.031) 
HIV+ CD4+ T-cells -0.045 
200-499 cells/µL (0.068) 
Food pyramid servings 
Dairy 0.165*** 0.077*** 
(0.017) (0.011) 
Vegetables 0.073*** 0.027 
(0.011) (0.008)** 
Fruit 0.232** 
(0.022) 
Meat/other protein 0.027** 0.085*** 
(0.008) (0.008) 
Percent of energy from 0.015*** 
fat (0.002) 
Interactions 
Energy ( centered)2 -0.010** -0.021 *** -0.022*** -0.023*** -0.022*** 
(0.003) (0.004) (0.002) (0.003) (0.002) 
RCMAS anxiety * 0.016* 
CD4+ T-cells 200-499 (0.007) 
cells/µL 
N 388 390 390 389 389 
Adjusted R2 0.663 0.512 0.787 0.766 0.820 
Std error of estimate 0.383 0.497 0.266 0.288 0.249 
Significance of explanatory variables: ***p <0.001; ** p <0.01; * p <0.05; # p <0.10 
1 Participants with high leverage values and outliers were excluded from models 
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